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Summary	
	
DNA	is	a	stable	and	inert	chemical	but	its	integrity	is	constantly	threatened	by	a	large	
number	of	endogenous	and	exogenous	agents.	DNA	double	strand	breaks	(DSBs)	are	
the	 most	 lethal	 kind	 of	 DNA	 damage.	 If	 DSBs	 are	 not	 repaired	 immediately	 and	
accurately,	 they	can	 lead	 to	chromosomal	 instability	and	thus	corrupt	 the	genomic	
integrity,	which	is	a	critical	step	into	oncogenesis.	To	counter	the	constant	threat	to	
the	 genetic	 integrity,	 cells	 have	 evolved	 sophisticated	 DNA	 repair	 and	 signaling	
processes,	 collectively	 known	 as	 the	 DNA-damage	 response	 (DDR),	 to	 detect	 DNA	
damage,	 signal	 its	 presence	 and	mediate	 its	 repair.	 Various	 studies	 using	 different	
experimental	 systems	 have	 led	 to	 the	 conclusion	 that	 whereas	 there	 are	 many	
variations	 on	 the	 precise	mechanisms	 of	 DSB	 repair,	 these	 events	 can	 be	 broadly	
categorized	 into	 these	 two	 distinct	 and	 complementary	 pathways:	 homologous	
recombination	(HR)	and	non-homologous	end-joining	(NHEJ).	One	crucial	difference	
between	HR	and	NHEJ	is	that	HR	requires	a	homologous	sequence	(usually	the	sister	
chromatid)	as	template,	whereas	NHEJ	does	not.	Moreover,	 in	order	to	 initiate	HR,	
the	DNA	ends	need	to	be	resected.	Thus,	DNA-end	resection	is	crucial	for	DSB	repair	
pathway	choice,	as	it	commits	cells	to	HR.		
	
In	vertebrates,	DNA	end	resection	is	initiated	by	the	concerted	action	of	the	MRE11-
RAD50-NBS1	(MRN)	complex	and	CtIP.	The	precise	role	of	NBS1	subunit	of	the	MRN	
complex	in	DNA	end	resection	has	not	yet	been	described	in	detail.	The	N-terminal	
region	 of	 NBS1	 comprises	 a	 forkhead-associated	 (FHA)	 domain	 and	 2	 BRCA1	 C-
terminal	 (BRCT)	 domains.	 These	 domains	 compose	 a	 unique	 bivalent	
phosphopeptide	 recognition	 module	 that	 modulates	 the	 activities	 of	 the	 MRN	
complex	through	phosphorylation-dependent	protein-protein	interactions.		
		
In	 the	 first	 part	 of	 this	 PhD	 thesis,	 a	 new	 NBS1	 complementation	 system	 was	
developed	with	the	aim	to	perform	detailed	structure/function	analysis	of	the	role	of	
the	FHA/BRCT	domains	of	NBS1	in	DSB	repair	by	HR.	Thereby,	we	specifically	focused	
on	 NBS1’s	 role	 in	 DNA	 end	 resection.	 This	 analysis	 revealed	 that	 in	 response	 to	
irradiation	the	FHA	and	BRCT	domains	of	NBS1	contribute	in	an	additive	manner	to		
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DNA	end	resection	during	the	HR	branch	of	DSB	repair.	Moreover,	we	could	gather	
experimental	 evidence	 suggesting	 that	mechanistically,	 NBS1	may	 act	 in	 DNA	 end	
resection	through	a	direct	interaction	between	its	N-terminal	FHA/BRCT	domain	and	
phosphorylated	CtIP.	
	
	The	second	part	of	this	PhD	thesis	dealt	with	the	role	of	the	FHA/BRCT	domains	of	
NBS1	 in	 G2M	 checkpoint	 activation	 and	 G2M	 checkpoint	 maintenance.	 Using	 our	
functional	 complementation	 system	 of	 NBS1	 as	well	 as	 a	 new	NBS1	 knockout	 cell	
line,	 we	 demonstrated	 that	 NBS1	 is	 important	 for	 the	 activation	 of	 the	 G2M	
checkpoint.	Similar	to	the	situation	in	the	HR	branch	of	DSB	repair,	the	FHA	and	BRCT	
domains	 of	 NBS1	 contribute	 towards	 G2M	 checkpoint	 function	 in	 an	 additive	 and	
non-redundant	manner.	Surprisingly,	we	didn’t	observe	any	effect	of	NBS1	depletion	
on	 G2M	 checkpoint	maintenance,	 even	 though	 G2M	 checkpoint	maintenance	 has	
recently	been	linked	to	DNA	end	resection.			
	
In	 summary,	we	 conclude	 that	NBS1	 is	 important	 for	DNA	end	 resection	and	G2M	
checkpoint	activation.	The	FHA	and	BRCT	domains	of	NBS1	are	critical	for	the	overall	
role	of	NBS1	in	the	DDR	and	they	act	in	an	additive	and	non-redundant	manner,	both	
in	DNA	resection,	as	well	as	in	the	G2M	checkpoint	activation.		
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Zusammenfassung	
	
DNA	 ist	eine	 stabile	und	 inerte	 chemische	Substanz,	 aber	 ihre	Unversehrtheit	wird	
ständig	durch	eine	grosse	Anzahl	von	exogenen	und	endogenen	Einflüssen	bedroht.	
DNA	 Doppelstrangbrüche	 gehören	 zu	 den	 gefährlichsten	 Arten	 von	 DNA	 Schäden.	
Wenn	 DNA	 Doppelstrangbrüche	 nicht	 sofort	 und	 sehr	 genau	 repariert	 werden	
besteht	die	Gefahr	dass	 sich	chromosomale	 Instabilität	ausbreitet	und	dadurch	die	
genomische	 Integrität	 verloren	 geht,	 was	 letztlich	 zur	 Krebsentstehung	 beitragen	
kann.	Um	dieser	Bedrohung	entgegen	zu	wirken	haben	Zellen	im	Laufe	der	Evolution	
ausgeklügelte	 DNA	 Reparatur	 und	 Signalkaskaden	 entwickelt	 welche	 kollektiv	 als	
‚DNA	 damage	 respone’	 (DDR)	 bezeichnet	 werden.	 Diese	 zellulären	 Prozesse	
erkennen	 DNA	 Schäden,	 signalisieren	 ihr	 Vorhandensein	 und	 regulieren	 die	 DNA	
Reparatur.	
	
Verschiedene	 Untersuchungen	 haben	 zum	 Schluss	 geführt	 dass	 DNA	
Doppelstrangbrüche	 grundsätzlich	 durch	 zwei	 mechanistisch	 verschiedene	
Reparaturprozesse	 repariert	 werden.	 Homologe	 Rekombination	 (HR)	 und	 nicht-
homologe	 Zusammenfügung	 der	 DNA	 Enden	 (‚non-homolgous	 end	 joining’;	 NHEJ).	
Ein	wichtiger	Unterschied	zwischen	diesen	zwei	Reparaturwegen	ist	der	Bedarf	eines	
homologen	DNA	Moleküls	 (vorzugsweise	des	 Schwesterchromatids)	 als	Matrize	 für	
die	 Reparatur	 im	 Falle	 der	 HR	 jedoch	 nicht	 bei	 der	 NHEJ.	 Zusätzlich	 bedarf	 HR	
zwingend	der	sogenannten	DNA	End-Resektion.	Deshalb	kann	der	Prozess	der	DNA	
End-Resektion	 als	 ausschlaggebend	 für	 die	 Auswahl	 des	 Doppelstrangbruch	
Reparaturwegs	gesehen	werden.	
	
In	 Zellen	 von	 Wirbeltieren	 wird	 die	 DNA	 End-Resektion	 durch	 die	 gemeinsame	
Aktivität	 des	 MRE11-RAD50-NBS1	 (MRN)	 Proteinkomplexes	 und	 des	 Faktors	 CtIP	
eingeleitet.	 Dabei	 ist	 die	 Funktion	 der	 NBS1	 Untereinheit	 des	MRN	 Komplexes	 im	
Prozess	 der	 DNA	 End-Resektion	 noch	 nicht	 genau	 verstanden.	 Die	 N-terminale	
Region	 von	 NBS1	 ist	 zusammengesetzt	 aus	 einer	 ‚Forkhead	 associated’	 (FHA)	
Domäne	 und	 zwei	 ‚BRCA1	 C-terminal’	 (BRCT)	 Domänen.	 Diese	 beiden	 Domänen	
formen	 ein	 einmaliges,	 bivalentes	 Phosphopeptid-Erkennungsmodul	 welches	 die	
Funktionen	des	MRN	Komplexes	durch	phosphorylierungsabhängige	Protein-Protein	
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Interaktionen	 moduliert.	 Im	 ersten	 Teil	 dieser	 Doktorarbeit	 wurde	 ein	 neues	
zelluläres	 Komplementierungssystem	 für	 NBS1	 entwickelt	mit	 dem	 Ziel	 detaillierte	
Struktur/Funktion	 Analysen	 zur	 Rolle	 der	 FHA/BRCT	 Domänen	 von	 NBS1	 in	 der	
Doppelstrangbruch	Reparatur	durchzuführen.	Dabei	sollte	das	Augenmerk	vor	allem	
auf	der	Funktion	von	NBS1	in	der	DNA	End-Resektion	liegen.	Diese	Analysen	zeigten	
dass	 nach	 der	 Bestrahlung	 von	 Zellen	mit	 ionisierender	 Strahlung	 die	 FHA	und	die	
BRCT	Domänen	von	NBS1	 in	einer	additiven	und	nicht	 redundanten	Art	und	Weise	
zur	 DNA	 End-Resektion	während	 des	HR	DNA	Reparaturwegs	 beitragen.	 Zusätzlich	
konnten	 Daten	 gesammelt	 werden	 die	 darauf	 hinweisen	 dass	 eine	 direkte	
Interaktion	 zwischen	 den	 N-terminalen	 FHA	 und	 BRCT	 Domänen	 von	 NBS1	 mit	
phosphoryliertem	CtIP	die	Rolle	von	NBS1	 in	der	DNA-End	Resektion	mechanistisch	
erklären	könnte.	
	
Im	zweiten	Teil	dieser	Doktorarbeit	wurde	die	Aufgabe	von	NBS1	und	seiner	FHA	und	
BRCT	 Domänen	 in	 der	 Aktivierung	 und	 Aufrechterhaltung	 des	 G2M	 Checkpoints	
untersucht.	 Dazu	 kam	 neben	 dem	 oben	 genannten	 zellulären	
Komplementierungssystem	 auch	 eine	 neue	 NBS1	 ‚knockout’	 Zelllinie	 zum	 Einsatz.	
Damit	 konnte	 gezeigt	 werden	 dass	 NBS1	 für	 die	 Aktivierung	 des	 G2M	 Checkpoint	
eine	wichtige	Rolle	 spielt	und	dass	 in	Analogie	 zum	HR	Reparaturweg	die	FHA	und	
BRCT	Domänen	von	NBS1	 in	einer	additiven	und	nicht-redundanten	Art	und	Weise	
zur	 Aktivierung	 des	 G2M	 Checkpoints	 beitragen.	 Überraschenderweise	 löste	 der	
Verlust	von	NBS1	keinen	Defekt	in	der	Aufrechterhaltung	des	G2M	Checkpoints	aus,	
obschon	die	Aufrechterhaltung	dieses	Checkpoints	kürzlich	mit	dem	Prozess	der	DNA	
End-Resektion	kausativ	in	Zusammenhang	gebracht	wurde.	
	
Zusammenfassend	 konnte	 darauf	 geschlossen	 werden	 dass	 NBS1	 sowohl	 für	 den	
Prozess	 der	 DNA	 End-Resektion	 sowie	 für	 die	 Aktivierung	 des	 G2M	 Checkpoints	
wichtig	 ist.	 Dabei	 sind	 die	 FHA	 und	 BRCT	 Domänen	 von	 NBS1	 kritisch	 für	 diese	
Aktivitäten	und	sie	 tragen	 in	einer	additiven	und	nicht-redundanten	Art	und	Weise	
sowohl	zum	Prozess	der	DNA	End-Resektion	sowie	zur	G2M	Checkpoint	Aktivierung	
bei.	
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ABBREVIATIONS:	
53BP1	
8-oxo-dG	
6-4	PPs	
p53	binding	protein	
8-oxo-deoxyguanosine	
6-4	photoproducts	
Aa	 Amino	acid	
AT	 ataxia	telangiectasia		
ATR	 ataxia	telangiectasia	mutated	
BRCA1/2	 breast	cancer	susceptibility	gene	1/2		
BRCT	
BrdU	
BRCA1	C-terminus	domain	
bromodeoxyuridine	
Chk1/2	 checkpoint	kinase	1/2		
CDKs	 cyclin-dependent	kinases	
CIN	
CPDS	
chromosomal	instability	
cyclobutane	pyrimidine	dimers	
CPT	 camptothecin	
CSR	 class	switch	recombination	
CtIP	 CtBP	interacting	protein		
CO	
DOX	
Crossover	
doxycycline	
DDR	 DNA	damage	response	
DSBs	 DNA	double	strand	breaks	
dHJ	
EdU	
Double	Holliday	junction	
5-ethynyl-2ʹ-deoxyuridine	
EXO1	 Exonuclease	1	
ETOP	 etoposide	
FHA	 forkhead-associated	domain	
GFP	 green	fluorescent	protein	
HR	 homologous	recombinaton	
ICL	 interstrand	crosslink	
IR	 Ionizing	radiation	
LigIV	
MDA	
DNA	ligase	
malondialdehyde	
MDC1	 mediator	of	DNA	damage	checkpoint	1	
MEFs	 mouse	embryonic	fibroblasts	
MMC	 Mitomycin	C	
MMS	 methyl	methanesulfonate	
MRE11			 meiotic	recombination	11	homolog	1	
MRN	 MRE11-RAD50-NBS1	
NBS1	 Nijmegen	breakage	syndrome	
NCO	 non	crossover	
													ABBREVIATIONS	
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NER	 Nucleotide	excision	repair	
NHEJ	 non-homologous	end-joining	
alt-NHEJ	 alternative	NHEJ	
c-NHEJ	 classical	NHEJ	
PCNA	
PI	
proliferating	cell	nuclear	antigen	
propidium	iodide	
PIKK	 phosphatidylinositol	3-kinase-like	protein	kinase	
pRb	 retinoblastoma	protein	
RAD50	 radiation	sensitive	50	
RIF	1	 Rap-interacting	factor	1	
RPA	 replication	protein	A	
RNF8	 ring	finger	protein	8	
ROS	 reactive	oxygen	species	
Sae2	 sporulation	in	absence	of	spo11		
SDSA	 synthesis	dependent	strand	annealing	
SD	 Standard	deviation	
SEM	 Standard	error	of	mean	 	
SMC	 structural	maintenance	of	chromosomes	
Spo11	 sporulation-specific	protein	11	
SSA	 single-strand	annealing	
TLS	 translesion	DNA	synthesis	
Top	i/II	 Topoisomerase	i/II	
UV	 ultraviolet	light	
XLF	 XRCC4-like	factor		
XRCC4	 X-ray	repair	cross-complementing	protein	4	
Xrs2	
	
X-ray	sensitive	protein	2	
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1.			Introduction	
	
1.1. Genomic	Instability	and	cancer	
	
One	of	the	major	endeavors	of	a	cell	is	to	safeguard	the	encoded	information	in	the	
genetic	material,	a	task	that	is	pivotal	for	the	faithful	maintenance	and	propagation	
of	life.	In	living	cells,	the	genetic	material	is	DNA,	in	which	two	polynucleotide	chains	
wrap	 around	one	 another	 to	 form	 the	 famous	 structure,	 popularly	 known	 as	DNA	
double	helix.	James	Watson	and	Francis	Crick	discovered	DNA	double	helix	structure	
in	1953	and	this	marked	a	new	era	of	modern	biology.	The	structural	organization	of	
DNA	makes	 it	 a	 very	 stable	 and	 inert	 chemical,	 however	 its	 structural	 integrity	 is	
under	constant	threat	by	a	 large	number	of	exogenous	and	endogenous	threats.	 In	
addition,	changes	that	occur	during	physiological	cellular	processes	like	DNA	repair,	
DNA	 duplication,	 and	 recombination	 further	 challenge	 the	 genomic	 integrity	 by	
inciting	alterations	 in	 the	structure	of	 the	DNA	double	helix.	 It	has	been	estimated	
that	 each	of	 the	 approx.	 1013	 cells	 in	 a	 human	 body	 experience	 around	 105	
spontaneous	lesions	per	cell	per	day	(Ciccia	and	Elledge,	2010;	Hoeijmakers,	2009).		
	
A	cell	is	prone	to	a	large	repertoire	of	genetic	alterations	that	can	range	from	point	
mutations,	 small	 insertions	 and	 deletions	 of	 nucleotides	 to	 gross	 chromosomal	
rearrangements	 such	as	 translocations,	duplications,	 inversions	or	deletions.	 These	
alterations	also	include	a	condition	known	as	aneuploidy,	in	which	the	cell	has	one	or	
several	 extra	 chromosomes	or	one	 chromosome	 is	 entirely	missing	 (Draviam	et	 al,	
2004).	 Changes	 in	 chromosome	 number	 and	 structure	 are	 also	 referred	 to	 as	
chromosomal	 instability	 (CIN)	 (Gonzalez-Suarez	 et	 al)	 and	 it	 is	 the	 most	 common	
form	of	genomic	instability	in	cancer	cells	(Negrini	et	al.,	2010).	Cancer	is	a	complex	
disease,	 with	 multiple	 genes	 of	 diverse	 pathways	 involved	 in	 different	 stages	 of	
initiation,	progression,	 invasion,	and	metastasis.	 If	a	normal	cell	acquires	 too	many	
genetic	 alterations	 it	 can	 become	 carcinogenic	 in	 a	multistep	 process.	 In	 fact,	 it	 is	
widely	 accepted	 that	 the	 sequential	 accumulation	 of	 mutations	 that	 activate	
oncogenes	 and	 disrupt	 tumor	 suppressor	 genes,	 combined	with	multiple	 cycles	 of	
clonal	 selection	 and	 evolution	 facilitate	 the	 process	 of	 carcinogenesis.	 Because	
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genetic	instability	increases	the	rate	at	which	genetic	alterations	occur,	chances	that	
some	cells	acquire	genetic	alterations	 that	provide	proliferative	advantage	are	also	
increased,	 thus	 paving	 the	 way	 to	 carcinogenesis.	 It	 has	 been	 estimated	 that	
disruption	 of	 about	 eight	 cellular	 barriers	 is	 required	 for	 the	 malignant	
transformation	of	cells	to	ensue	(Hanahan	and	Weinberg,	2011).		
	
	
	
	
Figure	1.	Genomic	Instability	is	an	“enabling	characteristic”	of	cancer.	In	addition	to	the	six	
established	hallmarks	of	 cancer	 four	additional	hallmarks	of	 cancer	have	emerged.	Two	of	
them	 (including	 genome	 instability	 and	 mutation)	 are	 also	 considered	 enabling	
characteristics	 as	 they	 progressively	 promote	 neoplastic	 transformation	 (Adapted	 from	
Hanahan	and	Weinberg,	2011).	
	
A	 very	 recent	 model	 classifies	 genomic	 Instability	 as	 one	 of	 the	 “enabling	
characteristic”	among	 the	hallmarks	of	 cancer	 (Figure	1).	Genomic	 instability	 could	
be	 initiated	 due	 to	 defects	 in	 genes	 of	 DNA	 maintenance	 and	 repair	 and	 once	
initiated,	 it	 provides	 further	 impetus	 to	 circumvent	 or	 abrogate	 other	 cellular	
barriers	to	carcinogenesis.	For	example,	mutations	in	DNA	double-strand	break	(DSB)	
repair	genes	breast	cancer	susceptibility	1	(BRCA1)	and	breast	cancer	susceptibility	2	
(BRCA2)	 are	 frequently	 found	 in	 breast	 and	 ovarian	 cancer	 patients,	 whereas	
alterations	 in	 DNA	 mismatch	 repair	 proteins	 hMLH1,	 hMLH2	 and	 hMSH2	 are	
frequently	 observed	 in	 colorectal	 cancer	 patients	 (Dietlein	 et	 al.,	 2014).	 	 Prostate	
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cancer	 patients	 also	 exhibit	 frequent	 inactivating	 mutations	 in	 the	 DNA	 repair	
pathways	(Leongamornlert	et	al.,	2014).	
	
Inherited	 defects	 in	 DDR	 genes	 also	 give	 rise	 to	 some	 rare	 hereditary	 diseases,	
marked	by	phenotypes	such	as	neurodegeneration,	 infertility,	 immune	deficiencies,	
growth	retardation,	premature	aging	and	a	marked	predisposition	to	cancer.	Many	
of	 these	 inherited	 diseases	 share	 common	 phenotypes.	 For	 example,	 Xeroderma	
pigmentosum	(XP)	was	the	first	rare	autosomal	recessive	syndrome	identified	with	a	
defect	 in	 a	 DNA	 repair	 pathway.	 The	 cells	 from	 all	 XP	 patients	 show	 an	 increased	
frequency	of	mutations	after	exposure	to	UV	light	that	is	correlated	with	defects	in	
repair	 of	 thymidine	 dimers.	 XP	 patients	 also	 develop	 progressive	 neurological	
problems	 (Menck	 and	 Munford,	 2014).	 One	 of	 the	 most	 extensively	 studied	
neurodegenerative	 diseases	 associated	 with	 defect	 in	 DNA	 repair	 genes	 is	 ataxia	
telangiectasia	 (A-T),	 which	 is	 caused	 by	 mutations	 in	 the	 ataxia–telangiectasia	
mutated	 (ATM)	 gene.	 A-T	 patients	 exhibit	 profound	 ataxia,	 other	 neurological	
defects	 such	 as	 defective	 eye	 movement,	 speech	 defects,	 and	 non-neurological	
symptoms	 such	 as	 the	 absence	 or	 the	 rudimentary	 appearance	 of	 a	 thymus,	
immunodeficiency,	 insulin-resistant	 diabetes,	 radiosensitivity,	 cell	 cycle	 checkpoint	
defects,	 chromosomal	 instability	 and	 predisposition	 to	 cancer.	 A-T	 patients	 are	
confined	to	wheelchair	 in	very	early	years	of	 life	and	usually	die	of	malignancies	 in	
their	teens	(Biton	et	al.,	2008).	As	described	before	the	role	of	DNA	damage	repair	in	
the	generation	of	gametes	and	the	development	of	the	 immune	system,	defects	 in	
the	genes	of	DNA	repair	often	results	in	infertility	and	immunodeficiency.		
	
	The	 DDR	 protein	 most	 frequently	 mutated	 in	 cancers	 is	 p53.	 It	 is	 a	 transcription	
factor	 that	 stimulates	 transcription	 of	 the	 genes	 that	 promote	 cell	 cycle	 arrest,	
genomic	integrity	and	apoptosis	(Hanahan	and	Weinberg,	2011;	Jackson	and	Bartek,	
2009;	Kastan,	2008).	p53	mediates	apoptosis	mainly	by	stimulating	the	transcription	
of	various	proapoptotic	genes,	 including	members	of	 the	Bcl-2	 family,	 such	as	Bax,	
Noxa,	and	Puma;	although	p53	is	also	implicated	in	the	repression	of	anti-apoptotic	
genes,	 such	 as	 survivin	 (Kang	 et	 al.,	 2005;	 Zilfou	 and	 Lowe,	 2009).	 Loss	 of	 p53	
function,	through	mutations	in	p53	itself	or	alterations	in	pathways	signaling	to	p53	
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is	frequently	observed	in	many	human	cancers.	The	Li-Fraumeni	syndrome	is	caused	
by	inheritance	of	mutations	in	the	p53	gene	and	the	afflicted	individuals	have	a	very	
high	risk,	almost	100%	of	developing	many	different	cancers	in	their	lifetime	(Kastan,	
2008).	
	
	
1.2.				Sources	of	DNA	damage	
	
1.2.1.			Endogenous	DNA	damage	sources	
	
Genotoxic	 stress	 can	 either	 be	 endogenous	 or	 result	 from	 exogenous	 sources.	
Endogenous	sources	are	mainly	hydrolytic	spontaneous	reactions	and	metabolic	by-
products	that	leads	to	the	generation	of	reactive	oxygen	species	(ROS)	and	nitrogen	
species,	 lipid	 peroxidation	 products,	 endogenous	 alkylating	 agents,	 estrogen	 and	
cholesterol	 derived	 reactive	 species,	 and	 reactive	 carbonyl	 species.	 Of	 all	 the	
endogenous	 agents	 that	 attack	 DNA,	 ROS	 are	 the	 most	 predominant	 source	 of	
endogenous	 DNA	 damage.	 ROS	 include	 hydrogen	 peroxide,	 hydroxyl	 radicals,	
superoxide,	and	singlet	oxygen.	All	 these	highly	 reactive	molecules	cause	oxidative	
stress	 when	 the	 production	 of	 ROS	 exceeds	 the	 natural	 limit	 of	 the	 body	 to	
counterbalance	the	oxidative	load.	Under	these	conditions	the	three	major	biological	
macromolecules	 DNA,	 proteins	 and	 lipids	 are	 oxidized.	 In	 DNA	 ROS	 can	 lead	 to	
oxidized	bases	as	well	as	single	and	double-strand	breaks.	Among	the	oxidized	bases,	
8-oxo-deoxyguanosine	 (8-oxo-dG)	 is	 the	 most	 abundant	 one.	 8-oxo-dG	 base	
preferentially	pairs	with	adenine	rather	than	cytosine	and	thus	generates	GC	to	TA	
transversion	after	DNA	replication,	 leading	to	point	mutations	(De	Bont,	2004).	The	
polyunsaturated	fatty	acid	residues	of	phospholipids	are	also	targeted	by	ROS,	which	
leads	 to	 the	 production	 of	 intermediate	 products	 lipid	 hydroperoxides	 that	 are	
converted	 to	 unreactive	 fatty	 acid	 alcohols,	 epoxides	 and	 aldehydes.	
Malondialdehyde	(MDA)	is	the	most	mutagenic	product	of	lipid	peroxidation.	Direct	
oxidation	of	DNA	by	agents	that	extract	the	4’-hydrogen	atom	of	the	sugar	backbone	
leads	 to	 the	 formation	 of	 base	 propenals	 through	 a	 series	 of	 reactions.	 Base	
propenals	 are	more	 potent	 than	MDA	 in	 formation	 of	 exocyclic	 adducts	 (De	Bont,	
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2004).	 DNA	 bases	 are	 also	 susceptible	 to	 hydrolytic	 deamination.	 Cytosine	 and	 its	
homologue	5-methylcytosine	are	the	main	targets	of	deamination	(Lindahl,	1993).	It	
was	estimated	that	around	100	to	500	cytosines	are	deaminated	to	uracil	in	a	single	
cell	per	day	(Lindahl,	1993)	and	this	could	lead	to	GC	to	AT	transitions,	eventually.	
	
	
1.2.2.			Programmed	DNA	damage	
	
Although	most	of	the	DNA	damage	is	harmful	to	the	cells,	there	are	instances	where	
a	cell	deliberately	induces	DNA	lesions	to	induce	genetic	variations.	Two	examples	of	
cells	 that	 undergo	programmed	 induction	of	DNA	double-strand	breaks	 (DSBs)	 are	
lymphocytes	 and	 developing	 germ	 cells.	 Developing	 lymphocytes	 have	 evolved	
genetic	 mechanisms	 to	 enable	 the	 adaptive	 immune	 systems	 to	 generate	 a	 vast	
repertoire	of	immunoglobulin	and	T-cell	receptor	(TCR)	diversity	to	deal	with	almost	
any	kind	of	antigen.	Unlike	any	other	genes	in	metazoans,	 immunoglobulin	(Ig)	and	
TCR	 genes	 encoded	 in	 segments	 that	 must	 be	 recombined	 with	 flanking	
recombination	signal	sequence	 (RSS)	during	B-	and	T-cell	development	to	generate	
complete	 genes.	 Two	 RAG	 proteins	 encoded	 by	 RAG1	 and	 RAG2	 genes	 introduce	
DSBs	 precisely	 between	 the	 gene	 segments	 to	 be	 joined	 and	 their	 flanking	
recombination	 signal	 sequences	 (Schlissel	 et	 al.,	 2006).	 RAG	 proteins	 then	 initiate	
rejoining	of	DSBs	by	recruiting	enzymes	involved	in	DSB	repair	in	all	cells	and	also	by	
holding	the	ends	of	cleaved	DNA	in	close	proximity	(Bassing	and	Alt,	2004).		The	cells	
switch	generation	of	membrane-bound	IgM	and	IgD	to	IgG,	IgA,	or	IgE	antibodies	via	
a	 recombination	 based	 process,	 called	 as	 Class-switch	 recombination	 (CSR).	 CSR	
differs	from	V(D)J	recombination	in	many	ways,	but	the	one	that	is	most	significant	
from	DNA	repair	point	of	view	is	different	mechanism	for	the	induction	programmed	
DSBs	 and	differential	 requirement	of	 components	of	 the	 cellular	DSB	 response	 for	
site	 specific	 recombination.	 For	 instance,	 CSR	 is	 highly	 dependent	 on	 p53-binding	
protein	1	 (53BP1),	while	 the	role	of	53BP1	 in	V(D)J	 recombination	 is	 rather	 limited	
(Schlissel	et	al.,	2006).	
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Programmed	DSBs	are	also	crucial	for	the	meiotic	recombination	step	in	the	process	
of	gametogenesis,	known	as	meiosis.	Meiosis	produces	gametes	with	half	as	many	
chromosomes	as	their	diploid	precursor	cells.	Meiotic	recombination	begins	after	the	
pairing	of	 the	homologous	chromosomes,	with	 the	 induction	of	programmed	DSBs	
by	 a	 conserved	 protein	 called	 as	 Spo11.	 Spo11	 breaks	 both	 strands	 of	 the	 DNA	
double	 helix	 in	 one	 of	 the	 homologous	 chromosomes	 via	 a	 topoisomerase-like	
reaction	to	generate	transient,	covalent	protein-DNA	intermediates	at	the	5’	ends	of	
the	 (Keeney,	 2008;	 Neale	 et	 al.,	 2005).	 After	 DSBs	 are	 formed,	 Spo11	 is	 removed	
from	the	5ʹ	end	of	DNA	in	a	two-step	process.	In	the	first	step	MRE11	endonuclease	
activity	introduces	a	nick	on	the	DNA	duplex	as	far	as	300	nt	from	DSB	end	(Garcia	et	
al.,	 2012),	 which	 triggers	 Exo1-dependent	 5’-3’	 resection	 and	MRE11	 exonuclease	
dependent	3’-5’	degradation	of	 the	nicked	 strand	 toward	 the	break.	 In	 the	 second	
step	generation	of	3’	DNA	tails	via	DSB	resection,	promotes	recombination	with	the	
homologous	 chromosome.	 The	 recombination	 of	 meiotic	 DSBs	 with	 homologous	
chromosomes	 can	 either	 result	 in	 reciprocal	 exchange	 of	 the	 chromosome	 arms	
flanking	 the	break	 (a	 crossover)	or	no	exchange	of	 flanking	arms	 (a	noncrossover).	
The	reshuffling	of	genes	by	the	process	of	meiotic	recombination	between	maternal	
and	paternal	chromosomes	increases	the	genetic	diversity	of	the	population.	
	
	
1.2.3.			Exogenous	DNA	damage	sources	
	
DNA	 is	also	damaged	by	an	array	of	exogenous	physical	and	chemical	agents.	Two	
notable	 examples	 of	 physical	 genotoxic	 agents	 are	 ionizing	 radiation	 (IR)	 and	
ultraviolet	 (UV).	 IR	 (from	 natural	 cosmic	 and	 earth	 radiation,	 medical	 treatments	
employing	X-rays	or	radiotherapy)	can	induce	oxidation	of	DNA	bases	and	generates	
single-strand	 breaks	 (SSBs)	 and	 DSBs	 (Hoeijmakers,	 2009).	 Some	 IR	 results	 from	
radioactive	 decay	 of	 naturally	 occurring	 radioactive	 compounds.	 For	 example	 an	
important	 source	of	 IR	 is	 the	natural	 occurrence	of	 radioactive	 isotopes	 in	 the	air,	
most	notably	Radon,	which	is	generated	by	the	decay	of	naturally	occurring	Uranium	
in	 the	soil.	The	most	pervasive	environmental	DNA-damaging	agent	 is	UV	 light.	UV	
light	has	a	wavelength	ranging	from	200	to	300	nm	and	is	found	in	natural	sunlight.		
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Although	 the	ozone	 layer	 largely	 absorbs	 the	most	 dangerous	part	 of	 the	UV	 light	
(UV-C),	residual	UV-A	and	UV-B	in	sunlight	can	 induce	105	DNA	lesions	per	cell	per	
day	(Hoeijmakers,	2009;	Lindahl	and	Barnes,	2000).	UV	radiation	causes	two	classes	
of	DNA	 lesions:	 cyclobutane	 pyrimidine	 dimers	 (CPDs)	 and	 6-4	 photoproducts	 (6-4	
PPs).	Both	CPDs	and	6-4	PPs	cause	conformational	perturbations	in	DNA	in	the	form	
of	primary	lesions,	mainly	kinks	or	bends.	Primary	lesions	can	then	be	converted	to	
secondary	 lesions	 when	 DNA	 replication	 or	 RNA	 transcription	 associated	 protein	
complexes	hit	primary	lesions,	leading	to	formation	of	DSBs.	
Two	major	ways	to	treat	cancer	are	chemotherapy	and	radiotherapy;	both	of	these	
mostly	 depend	 on	 exogenous	 DNA	 damaging	 agents.	 DNA	 damage	 is	 normally	
recognized	and	repaired	by	the	intrinsic	DNA	damage	response	(DDR)	machinery.	If	
the	damaged	lesions	are	successfully	repaired,	the	cells	will	survive.	An	unsuccessful	
DNA	repair	might	result	in	cell	death.	Cancer	cells	have	evolved	capabilities	to	ignore	
DNA	damage	and	notably,	they	are	also	often	incapable	of	temporarily	halting	cell-
cycle	 progression	 in	 response	 to	 DNA	 damage.	 This	 means	 that	 they	 basically	
continue	 to	divide	 in	 the	presence	of	DNA	damage.	Given	 the	 fact	 that	one	of	 the	
hallmarks	 of	 cancer	 is	 high	 proliferation	 rates;	 treating	 cancer	 cells	 with	 DNA	
damaging	agents	often	have	lethal	consequences,	for	example	catastrophic	levels	of	
chromosomal	 loss	 and/or	 gross	 chromosomal	 rearrangements	 that	 occurs	when	 a	
cancer	cell	divides	despite	the	presence	of	chromosome	breaks.		
	
DNA	 crosslinking	 agents	 such	 as	 mitomycin	 C	 (MMC),	 cisplatin,	 psoralen,	 and	
cyclophosphamide	introduce	covalent	 links	between	bases	of	the	same	DNA	strand	
(intrastrand	 crosslinks)	 or	 of	 opposite	 DNA	 strands	 (interstrand	 crosslinks	 or	 ICLs).	
ICLs	represent	the	most	deleterious	lesions	produced	by	chemotherapeutic	agent	as	
they	 block	 DNA	 strand	 separation,	 thus	 interrupting	 essential	 processes	 such	 as	
replication	 and	 transcription	 (Deans	 and	West,	 2011).	 ICL-inducing	 drugs	 including	
melphalan	and	cisplatin	are	among	the	most	widely	used	chemotherapeutic	agents.	
Chemical	 modifications	 of	 nitrogen	 mustards	 such	 as	 cyclophosphamide	 and	
melphalan	are	widely	used	as	chemotherapeutic	agents	until	now	in	the	treatment	
of	leukemia	and	solid	tumors	(Deans	and	West,	2011).	Topoisomerases	are	a	class	of	
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enzymes	responsible	for	releasing	the	torsional	strain	in	front	of	the	DNA	replication	
and	 transcription	machineries.	A	DNA	 topoisomerase	 can	be	 viewed	as	 a	 nuclease	
that	 breaks	 a	 phosphodiester	 bond,	 reversibly	 in	 a	 DNA	 strand	 by	 attaching	
covalently	 to	 the	 phosphate	 of	 the	 DNA	 backbone.	 	 Topoisomerase	 I	 allow	 the	
passage	of	a	single	DNA	strand	through	a	transient	single-strand	break	created	in	the	
complementary	strand	of	the	double	helix.	Topoisomerase	II	cuts	both	strands	of	the	
double	 helix	 to	 allow	 the	 passage	 of	 an	 intact	 helix	 to	 unwind	 supercoiled	 DNA.	
Topoisomerase	 inhibitors	 are	 used	 to	 treat	 certain	 leukemias,	 as	 well	 as	 lung,	
ovarian,	 gastrointestinal,	 and	 other	 solid	 cancers.	 Topoisomerase	 inhibitors	
camptothecin	 (CPT)	 and	 etoposide	 (ETOP)	 inhibit	 topoisomerase	 I	 and	 II,	
respectively.	 Topoisomerase	 poisons	 trap	 the	 DNA-enzyme	 intermediate	 complex	
and	 this	 impedes	 replication	 fork	 progression	 resulting	 in	 the	 formation	 of	 DSBs	
(Nitiss,	 2009).	 Another	 class	 of	 drugs	 that	 is	 widely	 used	 to	 treat	 cancer	 is	
anthracyclines.	 Doxorubicin	 and	 Epirubicin,	 are	 among	 the	 most	 frequently	 used	
anthracyclines.	Anthracyclines	contain	an	amino	sugar	linked	by	a	O-glycosidic	bond	
to	 the	quinone	group	of	a	polyaromatic	 ring	 (Minotti,	 2004).	 For	many	years	now,	
mechanism	of	action	of	anthracyclines	is	under	active	investigation	and	it	seems	that	
in	 addition	 to	 acting	 as	 Topoisomerase	 II	 poisons,	 anthracyclines	 also	 act	 as	
intercalating	agents,	oxidizing	agents,	DNA	alkylating	agents	and	crosslinking	agents.	
They	 also	 interfere	 with	 helicase	 activity	 of	 DNA	 helicases	 and	 induce	 apoptosis	
(Minotti,	 2004).	 Alkylating	 agents	 such	 as	 methyl	 methanesulfonate	 (MMS)	 and	
temozolomide	attach	alkyl	groups	to	DNA	bases.	Most	reactive	groups	that	can	draw	
up	 covalent	 bonds	 with	 alkylating	 agents	 are	 present	 in	 guanine.	 These	 covalent	
modifications	disturb	replication	and	transcription,	eventually	resulting	in	cell	death.	
Alkylating	 agents	 are	more	 effective	 in	 treating	 slow-growing	 cancers	 (Ralhan	 and	
Kaur,	2007).		
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Figure	 2.	 Sources	 of	 DNA	 damage.	Natural	 sources	 such	as	X-Rays	 are	 the	most	 common	
sources	of	exogenous	DNA	damage.	UV	light	induces	the	formation	of	6–4	photoproduct	(6–
4	PP)	 and	 cyclobutane	pyrimidine	dimer	 (CPD).	Anti-cancer	drugs	 like	 cisplatin	 (cis-Pt)	 and	
mitomycin	 C	 (MMC)	 are	 DNA-crosslinking	 agents	 that	 generate	 interstrand	 cross-links.	
Topoisomerase	poisons	such	as	camptothecin	(CPT)	irreversibly	bind	to	DNA-topoisomerase	
complexes	thus	physically	impede	progression	of	replication	forks,	which	often	results	in	the	
formation	 of	 DSBs.	 Doxirubicin	 and	 Epirubicin	 belong	 to	 a	 group	 of	 drugs	 known	 as	
anthracyclines,	 which	 can	 act	 as	 intercalating	 agents,	 topoisomerase	 II	 poisons,	 oxidizing	
agents	 and	 crosslinking	 agents	 Endogenous	 sources	 are	 mainly	 hydrolytic	 spontaneous	
reactions	and	metabolic	by-products	that	lead	to	the	generation	of	reactive	oxygen	species	
(ROS)	and	nitrogen	species,	lipid	peroxidation	products	and	reactive	carbonyl	species,	all	of	
which	 damage	 DNA.	 Most	 of	 the	 programmed	 DNA	 damage	 in	 the	 cell	 leads	 to	 the	
formation	 of	 DSBs.	 Programmed	 DSB’s	 are	 important	 for	 genetic	 diversity	 and	
immunological	responses.	Adapted	and	modified	from	(Hoeijmakers,	2001).	
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1.3.			DNA	damage	response	-	A	broad	overview	
	
The	DNA	damage	 response	 (DDR)	 is	 a	 collection	of	biological	 processes,	which	are	
highly	conserved	throughout	evolution	and	exist	both	in	prokaryotes	and	eukaryotes	
to	 counteract	 the	 deleterious	 effects	 of	 DNA	 damage.	 The	 importance	 of	 genome	
maintenance	 is	 evident	 from	 the	 large	 repertoire	 of	 proteins	 that	 has	 evolved	 to	
ensure	 that	 the	 information	 encoded	 by	 the	 DNA	 is	 not	 corrupted.	 These	
investments	 include	the	double-helical	structure	of	DNA	that	provides	a	back-up	of	
the	 information	 in	 case	 one	 strand	 of	 the	 double-helix	 is	 damaged,	multiple	 DNA	
damage	 recognition,	 signaling	 and	 repair	 systems;	 programmed	 cell	 death	 if	 DNA	
damage	is	beyond	repair	and	proofreading	activities	employed	at	multiple	levels	for	
faithful	replication	of	the	genome.	The	DDR	is	a	biological	signaling	network	by	which	
cells	have	 integrated	DNA	repair	pathway	choice	and	coordination	of	that	pathway	
with	 transcription,	 cell	 cycle	 progression,	 replication	 and	 apoptosis.	 The	 DDR	 is	
controlled	 by	 three	 apical	 phosphatidylinositol	 3-kinase-like	 protein	 kinase	 (PIKKs),	
ataxia–telangiectasia	mutated	(ATM),	ataxia–telangiectasia	and	RAD3-	related	(ATR)	
and	DNA-dependent	protein	kinase	catalytic	subunit	(DNA-PKcs).	
	
ATM	and	DNA-PKcs	activation	 is	 induced	by	DSBs.	The	basic	structure	that	 leads	to	
ATM	activation	is	believed	to	be	free	DNA	ends	(You	et	al.,	2007).	Multiple	types	of	
DNA	 lesions	 activate	ATR,	 including	DSBs,	 base	 adducts,	 crosslinks,	 and	 replication	
stress.	 Many	 studies	 have	 shown	 that	 the	 basic	 structure	 that	 activates	 the	 ATR	
response	in	the	cell	 is	 long	stretches	of	single-stranded	DNA	(ssDNA)	(Cimprich	and	
Cortez,	 2008).	 Once	 activated,	 these	 kinases	 phosphorylate	 a	 multitude	 of	
downstream	targets	such	as	factors	of	the	DNA	repair	apparatus,	factors	of	the	cell-
cycle	machinery	and	factors	that	regulate	the	apoptotic	programs.	They	also	turn	on	
various	 transcriptional	programs.	Recruitment	of	 the	apical	PIKKs	 to	DNA	 lesions	 is	
important	 for	 their	 activation	 and	 occurs	 through	 direct	 interactions	 with	 specific	
adaptor	proteins	that	act	as	DNA	damage	sensors.	For	example,	Nijmegen	breakage	
syndrome	 1	 (NBS1)	 is	 an	 adaptor	 of	 ATM,	 ATR	 interacting	 protein	 (ATRIP)	 is	 an	
adaptor	of	ATR	and	KU70/80	heterodimer	acts	as	an	adaptor	for	DNA-PKcs	(Falck	et	
al.,	2005;	You	et	al.,	2005).	In	addition	to	DNA	repair	and	checkpoint	activation,	ATM	
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and	 ATR	 coordinate	 a	 wide	 spectrum	 of	 cellular	 activities	 ranging	 from	 DNA	
replication	to	transcription,	metabolic	signaling,	and	RNA	splicing	(Ciccia	and	Elledge,	
2010).	Many	 effector	 pathways	 of	 the	DDR	are	 regulated	by	 the	 kinases	ATM	and	
ATR	 via	 phosphorylation	 and	 activation	 of	 the	 two	 transducer	 kinases	 checkpoint	
kinase	 1	 (Chk1)	 and	 checkpoint	 kinase	 2	 (Chk2).	 Downstream	 targets	 of	 Chk1	 and	
Chk2	are	known	as	effector	proteins	that	function	at	the	interface	between	the	cell	
cycle,	 DNA	 repair	 and	 apoptosis.	 Either	 ATM/ATR	 or	 Chk1/Chk2	 then	 targets	
different	 proteins	 alone	 or	 alternatively,	 ATM/ATR	 and	 Chk1/Chk2	 target	 distinct	
residues	of	the	same	effector	proteins,	respectively.	One	such	effector	protein	is	the	
transcription	 factor	p53,	which	 is	 implicated	 in	many	aspects	of	 the	DDR	 including	
cell-cycle	control,	DNA	repair,	apoptosis,	senescence,	and	organismal	aging	(Fei	and	
El-Deiry,	2003).		
	
	
	
	
Figure	3.	DNA	damage	Response	(DDR).		DNA	lesions	elicit	signal	transduction	pathways	that	involve	
a	set	of	proteins	categorized	as	sensors,	mediators,	transducers	and	effectors.	DNA	damage	is	sensed	
by	 sensors,	 which	 then	 transmit	 the	 signal	 to	 checkpoint	 transducers	 which	 in	 turn	 transmit	 and	
amplify	 the	DDR	 signal	 to	 downstream	 targets	 by	 influencing	 the	 activity	 or	 stability	 of	DNA-repair	
factors,	 cell-cycle	 control	 factors,	 chromatin	 remodeling	 enzymes	 and	 apoptotic	 control	 proteins.	
Adapted	from	(Jackson	and	Bartek,	2009).	
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1.3.1.	Cell	cycle	checkpoint	activation	
	
The	cell	cycle	is	an	ordered	sequence	of	events	that	ultimately	leads	to	duplication	of	
the	genetic	material.	The	eukaryotic	cell	cycle	is	divided	into	four	sequential	phases:		
G1	(first	gap	phase),	S	phase	(DNA	replication	phase),	G2	(second	gap	phase)	and	M	
phase	 (cell	 division).	 Cyclin	 dependent	 protein	 kinases	 (CDKs)	 are	 the	 major	
regulators	of	the	cell	cycle.	CDKs	are	the	catalytic	subunits	that	dimerize	with	specific	
regulatory	 subunits	 to	 form	 Cyclin/CDK	 complexes.	 In	 humans,	 11	 genes	 encode	
different	CDKs	that	associate	with	specific	Cyclins	in	a	cell	cycle	dependent	manner	
(Malumbres	and	Barbacid,	2009).	The	Cyclin/CDK	complexes	are	phosphorylated	by	
a	CDK-activating	kinases	(CAKs)	to	form	active	complexes	(Morgan	1995).	In	order	to	
elicit	checkpoint	activation,	CDKs	are	inactivated	either	by	the	actions	of	kinases	or	
CDK	 inhibitors	 (CKI)	 (Malumbres	and	Barbacid,	2009).	To	ensure	that	the	structural	
integrity	 of	 the	 DNA	 is	 maintained,	 the	 cells	 have	 evolved	 different	 control	
mechanisms	 known	 as	 cell	 cycle	 checkpoints.	 The	 checkpoints	 have	 evolved	 to	
temporarily	 arrest	 cell	 cycle	 progression	 at	 different	 critical	 transitions	 of	 the	 cell	
cycle,	 upon	 the	 presence	 of	 genotoxic	 stress.	 The	 checkpoint	 activation	 can	
potentially	be	invoked	at	three	phases	of	the	cell	cycle.	The	first	checkpoint	is	in	late	
G1	(G1S	checkpoint),	where	either	the	cell	commits	to	enter	S-phase	or	draw	itself	
out	of	the	cell	cycle	by	entering	a	quiescence	state	(G0).	To	prevent	transmission	of	
corrupted	 genetic	 information	 to	 the	 daughter	 cells,	 cells	 in	 G1	 phase	 repair	 any	
damage	 that	 is	 generated	 by	 endogenous	 ROS	 species,	 chemical	 agents,	 UV	 or	 IR	
(Branzei	 and	 Foiani,	 2008).	 	Only	when	 the	DNA	 is	 free	of	 any	 lesion	 and	external	
factors	like	mitogens	are	adequate,	the	cell	makes	the	transition	to	the	S	phase.		
	
The	 next	 checkpoint	 is	 executed	 during	 S	 phase	 (intra-S	 phase	 checkpoint).	 The	
physical	 impediments	 to	 the	 elongating	 replication	 fork	 —	 such	 as	 DNA	 damage,	
DNA/protein	 adducts,	 non-B	 DNA	 structures	 and	 collisions	 with	 transcription	
machinery,	makes	S	phase	 the	most	 vulnerable	period	of	 the	 cell	 cycle	 (Ciccia	and	
Elledge,	2010;	Gaillard	et	al.,	2015;	Hoeijmakers,	2009;	Zeman	and	Cimprich,	2014).	
In	 response	 to	 DNA	 damage	 during	 S	 phase,	 the	 cells	 transiently	 delay	 the	
progression	 of	 the	 cell	 cycle	 in	 order	 to	 allow	 time	 for	 the	 repair	 of	 the	 damaged	
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DNA.	 If	damage	 is	not	 repaired	during	 this	delay	 the	 cell	 exits	 S	phase	and	arrests	
later	 when	 it	 reaches	 G2	 checkpoint	 (G2	 accumulation),	 which	 blocks	 cells	 from	
entering	mitosis	with	damaged	DNA.	If	there	are	problems	in	the	completion	of	DNA	
replication	 because	 of	 DNA	 damage,	 the	 cell	 stays	 arrested	 in	 G2	 until	 those	
problems	are	 resolved.	Replication	associated	 checkpoints	 (Replication	 checkpoint)	
is	different	from	the	DSB	induced	checkpoint	(intra-S	phase	checkpoint),	but	all	the	
S-phase	 checkpoints	 share	 some	 common	 apparatus	 and	 are	 well	 integrated	
mutually.	 Intra-S-phase	 checkpoint	 defect	 is	manifested	 in	 the	 form	 of	 inability	 of	
cells	 to	 transiently	 delay	 the	 cell	 cycle	 progression	 by	 inhibiting	 the	 initiation	 of	
replication	origin	 firing	and	 thereby	 slowing	down	DNA	 replication.	The	 IR	 induced	
DNA	damage	in	cells	leads	to	the	phosphorylation	of	CDC25A	by	Chk1,	activated	by	
ATR	(Mailand	et	al.,	2000;	Negrini	et	al.,	2010)	and	Chk2,	activated	by	ATM	(Dietlein	
et	 al.,	 2014;	 Falck	 et	 al.,	 2001).	 Phosphorylation	 of	 CDC25A	 triggers	 its	 ubiquitin	
dependent	 proteaosomal	 degradation;	 as	 a	 consequence	 CDC25A	 is	 no	 longer	
available	to	remove	the	inhibitory	phosphorylation	on	CDK2	(Bartek	and	Lukas,	2001;	
Bartek	et	al.,	2004).	This	eventually	results	 in	inhibition	of	CDK2-dependent	loading	
of	 initiator	 of	 DNA	 replication	 CDC45,	 onto	 chromatin	 associated	 prereplicative	
complex	 (Costanzo	 et	 al.,	 2000).	 Another	 important	 checkpoint,	 that	 elicits	 in	
response	 to	DNA	damage	 is	G2M	checkpoint,	which	 id	described	 separately	 in	 the	
next	section.	
	
	
1.3.2.		G2M	checkpoint	activation		
	
The	 third	 important	DNA	damage	 induced	cell	 cycle	 checkpoint	 is	 at	 the	 transition	
from	 G2	 to	 M	 phase,	 before	 the	 cell	 cycle	 control	 system	 allows	 the	 cell	 cycle	
progression	into	mitosis.		The	cell	has	linked	the	demand	for	accurate	repair	of	DNA	
lesions	 and	 the	 opportunity	 of	 having	 a	 sister	 chromatid	 by	 this	 time	 to	 the	most	
accurate	 and	 faithful	 recombination	 based	 pathways	 of	 DNA	 repair	 (HR),	 that	 are	
elicited	 during	 the	 activation	 of	 G2M	 checkpoint.	 IR	 induces	 two	 temporarily	 and	
mechanistically	 different	 checkpoints	 in	 G2	 (Figure	 4).	 The	 first	 one	 is	 activated	
immediately	 after	 IR	 exposure	 and	 it	 stops	 the	 progression	 of	 cells	 that	 are	 in	G2	
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phase	to	enter	M	phase.	This	checkpoint	is	ATM	dependent	and	is	generally	known	
as	 G2M	 checkpoint.	 The	 other	 is	 known	 as	 G2	 accumulation	 checkpoint.	 G2	
accumulation	checkpoint	is	ATR	dependent	and	it	is	actually	enhanced	by	the	lack	of	
ATM,	as	well	as	NBS1.	The	activation	of	this	checkpoint	is	typically	assessed	several	
hours	after	IR.	The	activation	of	this	checkpoint	leads	to	the	accumulation	of	the	cells	
that	had	been	in	earlier	phases	of	the	cell	cycle	at	the	time	of	irradiation	in	G2.	G2	
accumulation	 is	 more	 pronounced	 in	 cells	 that	 are	 defective	 in	 IR-induced	 intra-S	
phase	checkpoint,	such	as	BRCA1	deficient	cells	(Xu	et	al.,	2002).		
	
	Central	 to	 the	 regulation	 of	 the	 G2M	 checkpoint	 is	 the	 inhibition	 of	 the	 CDC25C	
phosphatase,	 a	 protein	 that	 removes	 the	 inhibitory	 phosphorylations	 from	 cyclin	
B/CDK1	 kinase.	 CDC25C	dependent	 dephosphorylation	of	 cyclin	 B/CDK1	 is	 vital	 for	
the	activation	of	M-CDK	at	the	beginning	of	mitosis.	This	happens	via	different	ways;	
in	 one	 pathway	 activated	 Chk2	 phosphorylates	 CDC25C	 at	 Ser216	 to	 block	 its	
function.	 In	 a	 parallel	 pathway	 activated	 Chk1,	 negatively	 regulates	 CDC25C	 by	
phosphorylating	it	at	Ser216	(Lammer	et	al.,	1998;	Matsuoka	et	al.,	1998;	Peng	et	al.,	
1997).	Other	upstream	regulators	of	CDC25C	and/or	cyclin	B/CDK1	that	can	also	be	
targeted	by	DNA-damage-induced	mechanisms	are	Polo-like	kinases	PLK3	and	PLK1	
(Ando	et	al.,	2004).	Interestingly,	CDC25A	and	CDC25B	have	also	been	implicated	in	
the	activation	of	G2M	checkpoint	and	it	is	now	becoming	more	and	more	clear	that	
CDC	 phosphatases	 play	 a	 more	 redundant	 role	 in	 the	 activation	 of	 cell	 cycle	
checkpoints	(Ferguson	et	al.,	2005;	 Iliakis	et	al.,	2003;	Kastan,	2008;	Lammer	et	al.,	
1998;	Melixetian	et	al.,	2009;	Niida,	2005).	The	G2M	checkpoint	also	depends	on	the	
transcriptional	programs	initiated	by	BRCA1	and	p53,	leading	to	the	upregulation	of	
cell-cycle	inhibitors	such	as	p21	(Fei	and	El-Deiry,	2003;	Kang	et	al.,	2005;	Zilfou	and	
Lowe,	2009).	
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Figure	4.	Two	molecularly	distinct	checkpoints	are	elicited	at	 the	G2	to	M	phase	transition.	These	
checkpoints	 prevent	 the	 progression	 of	 cells	 into	 the	M	 phase	 in	 the	 presence	 of	 unrepaired	 DNA	
damage.	 (A)	 G2M	 checkpoint	 is	 activated	 in	 the	 cells	 that	 are	 in	 the	 G2	 phase	 at	 the	 time	 of	
irradiation.	 This	 checkpoint	 is	 ATM	 dependent	 and	 it	 is	 activated	 as	 soon	 as	 30	 minutes	 after	
irradiation.	(B)	G2M	accumulation	checkpoint	is	activated	in	the	cells	that	are	in	S	phase	at	the	time	of	
irradiation.	This	checkpoint	is	ATR	dependent	and	its	activation	can	be	monitored	at	later	time	points	
after	irradiation.		
	
	
1.3.3.			DNA	repair	mechanisms		
	
Cells	 have	 evolved	 diverse	 sophisticated	 repair	mechanisms	 to	 deal	 with	 different	
types	of	lesions.	DNA	repair	pathways	are	highly	conserved	and	most	types	of	DNA	
repair	depends	on	the	presence	of	a	separate	copy	of	the	genetic	information	in	the	
undamaged	 strand	 of	 the	DNA	double	 helix.	 At	 least	 five	main,	 partly	 overlapping	
damage	 repair	 pathways	 operate	 in	mammals	—	 nucleotide-excision	 repair	 (NER),	
base-excision	 repair	 (BER),	 mismatch	 repair	 (MMR),	 non-homologous	 end-joining	
(NHEJ),	 and	 homologous	 recombination	 (HR).	 More	 subtle	 changes	 to	 DNA	 like	
oxidized	 bases,	 alkylation	 bases	 and	 SSBs,	 are	 repaired	 by	 BER.	 Relatively	 bulkier	
base	 adducts	 that	 distort	 the	DNA	helical	 structure	 like	 pyrimidine	 dimers	 such	 as	
those	 caused	by	ultraviolet	 light,	 are	processed	by	NER.	 The	MMR	 repair	 pathway	
repairs	post-replication	mismatched	bases,	which	are	escaped	by	 the	proofreading	
activity	of	the	DNA	polymerases	and	incorporated	during	replication.	 In	addition	to	
mismatched	bases,	MMR	proteins	also	correct	small	 insertions/deletions	generated	
at	 repetitive	 DNA	 sequences	 due	 to	 polymerase	 slippage	 during	 replication.	 DSBs	
generated	either	by	endogenous	or	exogenous	sources	are	repaired	by	NHEJ	or	HR.	
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1.4.			Repair	of	DNA	double	strand	breaks	(DSB’s)	
DSBs	are	the	most	lethal	kind	of	damage	and	research	has	shown	that	even	a	single	
DSB	 is	 sufficient	 to	 kill	 a	 cell	 (Bassing	 and	 Alt,	 2004;	 De	 Bont,	 2004;	 Lettier	 et	 al.,	
2006).	 	 The	 cell	 has	 evolved	 multiple	 pathways	 that	 repair	 DSBs	 in	 contexts	 of	
complexity	of	DSBs,	 their	 location	with	 respect	 to	DNA	as	well	 as	nucleus	 and	 cell	
cycle	 phase.	 	 Various	 studies	 using	 different	 experimental	 systems	 has	 led	 to	 the	
conclusion	 that	 DSB	 repair	 is	 essentially	 categorized	 into	 two	 broadly	 distinct	 and	
complementary	 pathways:	 homologous	 recombination	 (HR)	 and	 non-homologous	
end-joining	 (NHEJ),	 although	 there	 could	 be	 several	 variations	 in	 the	 precise	
mechanisms	of	NHEJ/HR	(Chapman	et	al.,	2012b).	NHEJ	 is	extremely	fast,	 functions	
throughout	 the	 cell	 cycle,	 operates	 with	 high	 efficiency	 and	 can	 result	 in	 small	
sequence	alterations	and	occasional	translocations.	Whereas	NHEJ	does	not	require	
extensive	resection	of	the	break,	HR	depends	on	the	generation	of	extensive	ssDNA	
tracts	by	DNA	end	resection.	HR	is	the	only	accurate	pathway	of	DNA	DSB	repair,	but	
it	operates	with	slow	kinetics	and	it	is	restricted	to	S	and	G2	phases	of	the	cell	cycle.	
Both	 these	 two	major	 pathways	 of	 DSB	 repair	 are	 described	 in	 detail	 later	 in	 this	
chapter.	 	 In	 addition,	 there	 are	 pathways	 of	 DSB	 repair	 machinery	 that	 have	
harnessed	components	both	from	HR	and	NHEJ.	DNA	end	resection	is	an	important	
initial	 step	 of	 these	 pathways	 that	 are	 dependent	 of	microhomologies.	 In	 case	 of	
alternative	 NHEJ	 (alt-NHEJ),	 DNA	 end	 resection	 reveals	 short	 regions	 of	
microhomology	(5-25	bp),	while	in	single-strand	annealing	(SSA),	longer	stretches	of	
microhomology	are	revealed	(Chiruvella	et	al.,	2013;	Jasin	and	Rothstein,	2013).		
	
1.4.1.			Non-homologous	end	joining	(NHEJ)	
NHEJ	 is	 the	 predominant	DSB	 repair	 pathway	 in	 higher	 eukaryotes	 and	 it	 is	 active	
throughout	the	cell-	cycle.	This	well-characterized	DSB	repair	pathway	operates	with	
high	speed,	with	a	half	 time	of	10-30	min	and	 it	efficiently	removes	DSBs	from	the	
genome.	 Genetic	 defects	 in	 its	 core	 components	 are	 associated	 with	 increased	
radiosensitivity.	 NHEJ	 is	 a	 mechanism	 where	 the	 broken	 ends	 are	 ligated	 after	
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limited	modification.	DSB	repair	by	NHEJ	often	results	in	nucleotide	deletions	and/or	
insertions	 at	 repair	 junctions,	which	makes	 it	more	 liable	 to	 errors.	DSB	 repair	 via	
NHEJ	can	operate	via	two	pathways:	c-NHEJ	(Classical	NHEJ)	or	alt-NHEJ	(alternative,	
microhomology	 mediated	 end	 joining	 or	 MMEJ).	 C-NHEJ	 appears	 to	 be	 the	
predominant	DSB	repair	pathway	used	in	mammalian	cells	and	is	active	throughout	
the	cell	cycle,	prominently	in	G0/G1.	In	c-NHEJ	broken	DNA	ends	are	recognized	by	
the	KU70	and	KU80	heterodimer,	which	 form	a	 symmetrical	 ring	by	direct	 contact	
with	the	DNA	backbone	or	bases	 (Deriano	and	Roth,	2013).	Association	of	KU	with	
DNA	ends	 serves	both	as	a	 scaffold	 for	 the	assembly	of	 the	NHEJ	apparatus	and	a	
physical	barrier	to	DNA	end	resection	(Decottignies,	2013).	KU	heterodimer	recruits	
DNA-PKcs	and	by	 interacting	with	KU-bound	DNA	ends,	 the	kinase	activity	of	DNA-
PKcs	 is	 stimulated.	 The	 complex	 of	 KU	 and	 DNA-PKcs	 at	 the	 broken	 DNA	 ends	
protects	 the	 DNA	 from	 nuclease	 attack	 and	 the	 KU	 component	 of	 the	 DNA-PK	
complex	contributes	to	the	recruitment	at	the	break	site	of	the	ligase	complex	(DNA	
LigaseIV/	XRCC4/XLF4).	Compatible	DNA	termini	that	possess	a	5ʹ	phosphate	and	a	3ʹ	
hydroxyl	 group	 can	 be	 directly	 ligated	 by	 the	 c-NHEJ	 factors	 described	 above.	
However,	 in	 order	 to	 repair	 more	 complex	 DNA	 ends,	 DNA-PKcs	 recruits	 and	
regulates	the	activity	of	ARTEMIS,	a	nuclease	involved	in	the	processing	of	the	DNA	
ends.	Endonucleolytic	activity	of	ARTEMIS/DNA-PKcs	can	resect	a	wide	range	of	DNA	
end	configurations,	which	could	 lead	to	small	deletions.	DNA	polymerases	 (such	as	
Polμ	or	Polλ)	 fill	 small	 gaps	by	misincorporation	of	nucleotides	at	 the	broken	DNA	
ends,	which	could	lead	to	small	additions,	contributing	to	heterogeneity	at	the	DSB	
repair	site	(Lieber,	2010).	The	net	result	of	the	action	of	DNA	processing	enzymes	at	
the	 site	of	NHEJ	 repair	 is	 the	generation	of	 compatible	ends,	which	are	eventually	
sealed	by	the	ligase	complex	(Figure	5).		
Alt-NHEJ	was	discovered	as	a	back	up	DSB	 repair	mechanism	 in	absence	of	 c-NHEJ	
and	 it	 is	 less	efficient	 than	c-NHEJ.	Alt-NHEJ	 is	more	error	prone	than	c-NHEJ,	as	 it	
can	even	 facilitate	 the	 joining	of	unrelated	DSBs,	 leading	 to	extensive	variations	at	
DSB	 joining	 sites	 and	 even	 to	 chromosome	 translocations	 (Decottignies,	 2013;	
Deriano	and	Roth)	 .	 In	alt-NHEJ,	Poly	 (ADP-ribose)	polymerase	1	 (PARP1)	has	been	
implicated	in	DSB	end	sensing	and	it	competes	with	the	KU	heterodimer	(c-NHEJ)	for	
		INTRODUCTION		
	 27	
free	DNA	ends.	As	with	NHEJ,	Alt-NHEJ	is	also	proposed	to	be	the	back	up	pathway	of	
HR	(Deans	and	West,	2011;	Deriano	and	Roth,	2013)	and	some	of	the	protein	factors	
implicated	in	alt-NHEJ	are	the	key	HR	proteins	like	MRN	complex	(Dinkelmann	et	al.,	
2009;	Xie	et	al.,	2009)	and	CtBP	 interacting	protein	 (CtIP)	 (Lee-Theilen	et	al.,	2011;	
Zhang	and	Jasin,	2011).	
	
	
	
Figure	 5.	 Classical	 and	 alternative	 NHEJ	 pathways.	 The	 DSBs	 are	 recognized	 and	 processed	 using	
different	repair	enzyme	complexes	in	c-NHEJ	and	alt-NHEJ	pathway.	C-NHEJ	is	typically	sensed	by	the	
KU70/80	complex,	which	then	recruits	DNA-PKcs.	KU70/80	heterodimer	and	DNA-PKcs	in	conjunction	
with	nucleases	such	as	the	MRN	complex	and	ARTEMIS	bring	about	the	limited	processing	of	the	DNA	
broken	ends,	which	are	eventually	ligated	by	a	DNA	ligase	complex	(XRCC4/Ligase	IV	and	XLF).	In	alt-
NHEJ	broken	ends	are	sensed	by	PARP1,	which	are	then	modified	by	the	combined	action	of	the	MRN	
complex	and	CtIP.	The	clean	ends	generated	are	finally	sealed	by	a	ligase.		Adapted	from	(Deriano	and	
Roth,	2013).	
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1.4.2.			Homologous	recombination	(HR)	
HR	is	the	most	accurate	pathway	of	DSB	repair	and	it	happens	in	the	S	and	G2	phases	
of	the	cell	cycle.	The	cell	cycle	dependent	execution	of	HR	is	linked	to	the	presence	
of	an	intact	sister	chromatid	as	a	template	for	HR	directed	repair,	which	ensures	that	
no	essential	sequence	information	is	lost	and	that	the	repair	does	not	lead	to	loss	of	
heterozygosity.	HR-mediated	 repair	 is	 initiated	with	 the	 recognition	and	binding	of	
DSB	ends	by	the	MRN	complex	and	CtIP.	MRN	complex	is	recruited	to	the	break	ends	
and	together	with	the	cohesin	complex	SMC5/6,	it	helps	in	stabilizing	the	DNA	ends	
and	hold	them	together	in	close	proximity	(Feeney	et	al.,	2010;	Hopfner	et	al.,	2002;	
Williams	et	al.,	2007).	MRN	complex	is	also	involved	in	recruitment	and	activation	of	
ATM	(Falck	et	al.,	2005;	Lee	and	Paull,	2005;	Williams	et	al.,	2007;	You	et	al.,	2005).		
The	 repair	of	DSBs	 is	mainly	 regulated	at	 the	 level	of	HR	via	DNA	end	 resection;	a	
process	 that	 generates	 3ʹ	 single-strand	 overhangs.	 DNA	 end	 resection	 is	 a	 key	
determinant	 of	 DSB	 repair	 pathway	 choice,	which	 commits	 cells	 to	HR	 and	 is	 also	
required	 for	 activation	 of	 the	 ATR-mediated	 checkpoint	 response	 (Jazayeri	 et	 al.,	
2006).	DNA	end	resection	is	a	highly	regulated	process	and	once	initiated,	the	DNA	
ends	 become	 poor	 substrates	 for	 binding	 by	 NHEJ	 proteins	 like	 KU	 and	 cells	 are	
committed	 to	 HR.	 Two	 key	 players	 that	 initiate	 DNA	 end	 resection	 are	 the	 MRN	
complex	 and	 CtIP.	 In	 S.pombe	MRN	 recruits	 CtIP	 and	 together	 they	 collaborate	 to	
initiate	resection,	leading	to	the	generation	of	3’	ssDNA	overhangs	that	subsequently	
are	coated	by	a	single	strand	binding	Replication	protein	A	(RPA).		All	sub-pathways	
of	 HR	 share	 the	 same	 initial	 steps	 including	 processing	 the	 DSB	 to	 3ʹ	 overhanging	
tails,	on	which	 the	RAD51	 filament	 is	assembled.	RAD51	coated	ssDNA	presynaptic	
filament,	mediates	 the	 homology	 search	 and	 DNA	 strand	 invasion.	 The	 loading	 of	
RAD51	onto	ssDNA	 is	a	critical	step	 in	HR,	as	 it	generates	a	nucleoprotein	 filament	
that	searches	for	homology	by	invading	a	nearby	homologous	duplex	DNA	template.	
BRCA2	 facilitates	 the	 loading	 of	 RAD51	 onto	 ssDNA	 by	 overcoming	 the	 inhibitory	
effect	 of	 RPA,	 while	 BRCA1	 plays	 a	 modulatory	 role	 in	 the	 PALB2	 and	 BRCA2	
dependent	 loading	 of	 RAD51	 repair	 at	 ssDNA	 tails	 (Liu	 et	 al.,	 2014).	 RAD54	 is	 a	
bidirectional	motor	protein	that	uses	ATP	to	translocate	on	dsDNA.	RAD54	associates	
with	 and	 stabilizes	 the	 RAD51	 presynaptic	 filament.	 The	 motor	 activity	 of	 RAD54	
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stimulates	strand	invasion	into	a	homologous	DNA	template,	which	involves	pairing	
with	the	complementary	strand	and	displacement	of	the	other	strand,	leading	to	the	
formation	 of	 a	 triple-stranded	 DNA	 structure	 also	 known	 as	 D-loop.	 RAD54	 then	
directs	 the	 transition	 from	 DNA-strand	 invasion	 to	 DNA	 synthesis	 by	 dissociating	
RAD51	from	heteroduplex	DNA	and	by	recruiting	DNA	polymerase	to	the	invading	3’	
end	of	the	D-loop	(Heyer	et	al.,	2006).	To	avoid	lethal	consequences	of	unrestrained	
HR	 activity	 cells	 have	 evolved	 anti-recombinases,	 typical	 examples	 are	 Srs2	 (S.	
cervisiae)	and	PARI	(vertebrates).	Both	of	these	anti-recombinogenic	helicases	have	
been	shown	to	bind	RAD51	and	to	disrupt	RAD51-ssDNA	filaments	in	vitro	(Chapman	
et	al.,	2012b).		
After	DNA	 synthesis	 is	primed	by	 the	 invading	 strand	 repair	 can	proceed	via	 three	
main	sub-pathways	referred	to	as	the	canonical	double	strand	break	repair	(DSBR),	
synthesis-dependent	 strand	 annealing	 (SDSA)	 and	 break-induced	 replication	 (BIR)	
(Figure	6).	During	SDSA	the	elongated	newly	synthesized	part	of	the	invading	strand	
pairs	 again	 with	 the	 resected	 strand	 of	 the	 second	 DSB	 end,	 to	 form	 DNA	 joint	
molecules	 (JMs).	RTEL1	promotes	SDSA	over	DSBR	 to	avoid	 crossover	 formation	 in	
mitotic	 and	 meiotic	 cells	 (Youds	 et	 al.,	 2010).	 RTEL1	 is	 also	 implicated	 in	 the	
disassociation	of	JMs,	at	an	early	stage	before	 initiation	of	repair	synthesis	by	anti-
recombinase	 helicases	 (Chapman	 et	 al.,	 2012b).	 Since	 this	 process	 only	 produces	
non-crossovers,	 SDSA	 is	 the	preferred	 recombination-mediated	DSB	 repair	 in	post-
mitotic	 cells	 in	 order	 to	 prevent	 loss	 of	 heterozygosity	 (LOH)	 or	 other	 genetic	
rearrangements.	Alternatively,	in	DSBR	pathway,	the	second	DNA	end	is	captured	by	
the	 D-loop	 to	 form	 an	 intermediate	 with	 two	 Holliday	 junctions,	 referred	 to	 as	
double	Holliday	junction	(dHJ).	These	joint	DNA	molecules	can	either	be	resolved	by	
specialized	 endonucleases	 into	 crossover	 (CO)	 or	 non-	 crossover	 (NCO)	 products.	
Yen1/GEN1,	 SlLX1-SLX4	 and	MUS81-MMS4/EME1,	 all	 have	 been	 implicated	 in	 dHJ	
resolution	 that	 can	 yield	 both	 COs	 and	 NCOs,	 depending	 on	 the	 orientation	 of	
cleavage.	 However,	 nicked	 HJs	 (precursors	 of	 dHJ)	 might	 be	 the	 preferred	 DNA	
substrates	 of	 MUS81-MMS4/EME1	 (Matos	 and	 West,	 2014);	 which	 leads	 to	 the	
formation	of	COs	(Chapman	et	al.,	2012b).	Another	protein	complex	that	exclusively	
leads	to	the	formation	of	NCOs	is	BLM-TopoIIIα-RMI1-RMI2	complex	(BTR).	In	mitotic	
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cells,	BTR	complex	(STR	in	yeast)	has	been	shown	to	migrate	and	decatenate	dHJs,	a	
process	 known	 as	 ‘dissolution’.	 However	 in	 meiotic	 cells,	 MLH1,	 MLH3	 and	 EXO1	
have	been	implicated	in	resolution	of	dHJs,	which	primarily	leads	to	the	formation	of	
COs	(Matos	and	West,	2014).	
Collapsed	 replication	 forks	 result	 in	 the	 formation	 of	 one-ended	 DSBs,	 which	 are	
predominantly	 repaired	by	break-induced	 replication	 (BIR)	 (Strumberg	et	al,	2000).	
The	presence	of	RPA	bound	ssDNA	adjacent	to	the	stalled	newly	replicated	double-
stranded	DNA	and	primer–template	junction,	act	as	a	signal	for	the	activation	of	the	
replication	 stress	 response	 (Cimprich	 and	 Cortez,	 2008;	 Malkova	 and	 Ira,	 2013;	
Zeman	 and	Cimprich,	 2014).	 The	ATR	pathway	 is	 activated	 in	 response	 to	 BIR	 and	
replication	stress	and	leads	to	the	inhibition	of	cell-cycle	progression,	suppression	of	
late	 origin	 firing	 (global	 effects)	 and	 stabilization	 of	 stalled	 fork,	 restart	 of	 stalled	
fork,	suppression	of	recombination	(local	effects).	In	this	pathway,	invasion	of	the	3’-
stranded	 end	 into	 homologous	 duplex	 DNA	 generates	 a	 replication	 fork	 that	
replicates	 the	 template	 to	 the	 chromosome	 end.	 This	 process	 is	 potentially	
mutagenic	because	repair	happens	in	a	way	that	ensues	LOH.		
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Figure	6:	Mechanism	of	Homologous	recombination	(HR).	Both	two-ended	and	one-ended	DSBs	can	
be	repaired	by	HR.	Formation	of	3’	ssDNA	tails	by	DNA	end	resection	commits	the	cell	to	HR.	In	all	the	
sub	pathways	of	HR	repair,	RAD51	presynaptic	filament	invades	the	homologous	duplex	DNA	and	the	
broken	DNA	is	extended	followed	either	by	second	end	capture	to	promote	dHJ	formation	as	in	DSBR	
or	disruption	of	D-loop	as	in	SDSA.	In	BIR,	Rad51	filament	strand	invasion	reestablishes	a	replication	
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fork	and	the	3'-end	is	extended	till	the	end	of	the	chromosome	template.	Adapted	from	(Chapman	et	
al.,	2012b)	
	
1.4.3.			DNA	end	resection		
DNA	end	resection	is	a	crucial	deterministic	process	for	the	fate	of	a	DSB	repair	and	
it	is	believed	to	happen	in	two	phases.	In	S.	cerevisiae,	this	first	step	is	dependent	on	
the	 Mre11-Rad50-Xrs2	 (MRX)	 complex	 (Symington,	 2014).	 MRX/N	 complex	 and	
Sae2/CtIP	are	essential	in	all	the	pathways	that	require	the	processing	of	DNA	ends	
like	HR,	alt-NHEJ	and	SSA	(Bennardo	et	al.	2008;	Simsek	et	al.	2011;	Zhang	and	Jasin	
2011).	 The	 precise	 role	 of	 MRX/N	 and	 Sae2/CtIP	 in	 DNA	 end	 resection	 is	 only	
beginning	to	be	understood.		It	was	unclear	for	a	very	long	time	as	to	how	the	MRN	
complex	catalyzes	5ʹ-3ʹ	nucleolytic	degradation	of	DNA	ends,	as	MRN	exhibits	3ʹ-5ʹ	
exonuclease	 activity	 in	 vitro,	 which	 is	 opposite	 to	 the	 5ʹ-3ʹ	 exonuclease	 activity	
required	 to	 produce	 3’	 ssDNA	 overhangs.	 A	 general	 view	 now	 is	 that	 DNA-end	
resection	occurs	with	bidirectional	polarity,	whereby	the	MRN	complex	incises	DNA	
ends	endonucleolytically	and	 then	uses	 its	3ʹ-5ʹ	exonuclease	activity	 to	generate	3’	
DNA	tails	(Garcia	et	al.,	2012;	Shibata	et	al.,	2013).	It	has	been	shown	both	in	yeast	
and	humans	that	Sae2/CtIP	promotes	nuclease	activity	of	the	MRX/MRN	complex	in	
vitro	(Cannavo	and	Cejka,	2015;	Sartori	et	al.,	2007).	Interestingly,	the	endonuclease	
activities	 have	 also	 been	 reported	 both	 for	 budding	 yeast	 Sae2	 (Lengsfeld	 et	 al.,	
2007)	and	its	human	counterpart	CtIP	(Makharashvili	et	al.,	2014).	Although	its	still	
not	clear	if	Sae2/CtIP	acts	as	a	regulator	of	MRE11	nuclease	activity	or	as	a	nuclease	
itself,	nevertheless	the	concerted	actions	of	MRX/N	and	Sae2/CtIP	are	important	to	
initiate	resection.	
	The	endonucleolytic	incision	of	the	5’	strand	mediated	by	the	actions	of	MRX/N	and	
Sae2/CtIP	 leads	 to	 formation	 of	 short	 3ʹ	 ssDNA	 overhangs.	 Although	 this	
endonucleolytic	cleavage	step	is	not	absolutely	required	to	resect	DSBs	with	“clean”	
ends,	 it	 is	 essential	 for	 the	 resection	 of	 DSBs	 with	 “dirty”	 ends,	 which	 are	 either	
blocked	 by	 covalently	 linked	 proteins	 or	 chemical	 adducts.	 Notably,	 the	 DSBs	
generated	by	 IR	have	also	 “dirty”	ends,	due	 to	oxidative	damage	of	 the	DNA	ends	
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(Nickjoo	et	al.,	 2001).	 	 In	 yeast,	processing	of	 clean	and	dirty	ends	 is	mediated	via	
two	 separate	 pathways	 dependent	 on	 either	 the	 Sgs1/Dna2	 (helicase/nuclease	
complex)	or	exonuclease	1	(Exo1)	(Figure	7).	Many	studies	have	shown	that	mutants	
lacking	Sae2	or	the	MRE11	nuclease	activity	were	impaired	only	partially	in	DNA	end	
resection,	when	the	DSBs	were	generated	by	endonucleases,	which	generate	“clean”	
ends	(Clerici	et	al.,	2005;	Llorente	and	Symington,	2004).	However,	the	DSBs,	which	
have	 “blocked/dirty	 ends”	 such	 as	 those	 generated	 by	 IR	 treatment,	 methylating	
agents,	 camptothecin,	 etoposide	 or	 meiotic	 DSBs	 require	 MRX/N	 and	 Sae2/CtIP	
activity	 to	 initiate	 DNA	 end	 resection	 (Hartsuiker	 et	 al.,	 2009a;	 2009b).	 All	 these	
observations	 have	 lead	 to	 the	model,	which	 proposes	 that	MRX/N	 complex	 is	 not	
required	for	processing	of	“clean”	DSBs,	but	it	is	absolutely	essential	for	resection	of	
non-canonical	DNA	ends	(Figure	6).	
MRX/N	 and	 Sae2/CtIP	 mediated	 endonucleolytic	 incision,	 create	 entry	 site	 sgs1–
DNA2	 and/or	 EXO1	 (Huertas,	 2010),	 but	 how	 these	 exonucleases	 carry	 out	 long-
range	 resection	 in	 the	 5ʹ-3ʹ	 direction	 remained	 unclear	 for	 a	 very	 long	 time.	 The	
MRN/X	complex	and	CtIP/Sae2	are	required	both	for	EXO1	dependent	resection	(Eid	
et	al.,	2010;	Nicolette	et	al.,	2010;	Shim	et	al.,	2010)	and	DNA2-BLM/Sgs1	complex	
dependent	resection	(Nimonkar	et	al.,	2011;	Shim	et	al.,	2010).	However,	it	has	also	
been	shown	in	yeast	that	Exo1	and	Sgs1-Dna2	can	resect	clean	DNA	ends	in	an	MRX	
independent	 manner	 (Cejka	 et	 al.,	 2010;	 Nicolette	 et	 al.,	 2010;	 Zhu	 et	 al.,	 2008),	
highlighting	that	MRN/X	complex	(first	step	of	resection)	is	important	for	the	repair	
of	dirty	or	blocked	ends.	Major	resection	defects	were	only	revealed	when	both	Exo1	
and	 Sgs1	 were	 inactivated	 simultaneously,	 which	 indicates	 that	 EXO1	 and	 DNA2-
BLM/Sgs1	 pathways	 play	 redundant	 roles	 during	DNA-end	 resection	 (Gravel	 et	 al.,	
2008;	Mimitou	 and	 Symington,	 2008;	Nimonkar	 et	 al.,	 2011).	 In	 contrast	 to	 yeast,	
MRN	 and	 CtIP	 are	 absolutely	 essential	 for	 DNA	 end	 resection,	 irrespective	 of	 the	
nature	of	the	breaks	(Cejka,	2015;	Sartori	et	al.,	2007).	
Recent	 studies	 have	 indicated	 that	 processing	 of	 “blocked	 ends”	 is	 a	 bidirectional	
process	 (Figure	6).	 In	 the	 first	 step,	concerted	efforts	of	Mre11	and	Sae2	 initiate	a	
nick	in	DNA	strand	up	to	300	nucleotides	upstream	of	5'-	terminus	of	the	DSB.	In	the	
second	 step,	 Mre11	 exonuclease	 activity	 provides	 the	 nicks	 in	 the	 3’–5’direction	
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towards	the	DSB	end	and	the	Exo1	or	Dna2-Sgs1	exonuclease	activity	in	the	opposing	
5’-3’	 direction	 generate	 long	 stretches	 of	 3’	 ssDNA	 tails/overhangs	 consisting	 of	
more	than	50,000	nucleotides	(Zhu	et	al.,	2008).		
	
FIGURE	7.	DNA	end	resection	of	free	and	blocked	DNA	ends.	(A)	The	nuclease	activity	of	Mre11	is	not	
required	for	resection	of	free/clean	DSBs.	MRX	complex	is	mainly	required	to	recruit	components	of	
the	 long	resection	that	 include	either	Sgs1-Dna2	or	Exo1.	However,	 the	role	of	 the	MRX	complex	 in	
recruitment	of	Sgs1-Dna2	or	Exo1	 is	not	absolutely	essential	(B)	 In	case	of	blocked	ends,	MRN/Sae2	
complex	 is	essential	to	 initiate	an	endonucleolytic	cut	and	to	recruit	Sgs1-Dna2	or	Exo1,	which	then	
perform	long	range	resection.		
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defect in vegetative cells (30–50% reduction) (9, 38). Therefore,
long-range resection is largely dispensable for recombination in
meiosis and not strictly required for repair in vegetative cells,
although it may be necessary for proper DNA damage check-
point and maintenance. In gene targeting, elimination of the
long-range resection pathways increased efficiency up to 600-
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1.4.4.			DNA	end	resection	-	determinant	of	DNA	DSBR	pathway	choice	
The	 default	 pathway	 of	 DSB	 repair	 in	 cells	 is	 NHEJ	 and	HR	 is	 favored	 in	 S	 and	G2	
phases	 of	 the	 cell	 cycle	 when	 a	 sister	 chromatid	 is	 available	 as	 a	 repair	 template	
(Brandsma	and	Gent,	2012;	Rothkamm	et	al.,	2003).	The	default	preference	of	 the	
cell	towards	NHEJ	is	also	evident	from	the	fact	that	the	Ku	heterodimer	can	bind	to	
the	DSB	much	faster	than	HR	factors	(Kim,	2005).	Even	during	S	and	G2	phases	of	cell	
cycle,	 NHEJ	 is	 the	 prominent	 DSB	 repair	 pathway	 and	 HR	 is	 only	 involved	 in	 the	
repair	 of	 few	 breaks.	 The	 choice	 between	 different	 DSBs	 repair	 pathways	 is	 thus	
highly	 regulated	and	DNA	end	 resection	 is	a	 crucial	process	 in	DSB	 repair	pathway	
choice	(Figure	8).		DNA	end	resection	is	a	critical	regulatory	step	of	HR.	Two	key	NHEJ	
proteins	KU	and	53BP1	that	subvert	HR	act	primarily	by	blocking	DNA	end	resection.	
KU	binds	DNA	ends;	it	presumably	physically	blocks	access	of	the	DNA	end	resection	
machinery	(Brandsma	and	Gent,	2012;	Heyer	et	al.,	2010;	Jasin	and	Rothstein,	2013;	
Kass	and	 Jasin,	2010;	Mimitou	and	Symington,	2010;	Pierce	et	al.,	2001).	DNA	end	
resection	machinery	competes	with	KU	and	channels	the	repair	of	DSBs	to	HR	in	the	
S	and	G2	phases	of	the	cell	cycle.	Not	only	HR,	but	also	other	pathways	of	DSB	repair	
that	involve	resection	like	alt-NHEJ	and	SSA,	are	suppressed	by	KU	(Weinstock	et	al.	
2007;	Simsek	and	Jasin	2010;	Simsek	et	al.	2011;	Escribano-Diaz	et	al.	2013).		
53BP1	 is	 another	 factor	 that	 protects	 DSB	 ends	 from	 processing	 by	 the	DNA	 end-
resection	machinery	during	the	G1	phase	of	the	cell	cycle.	Stable	binding	of	53BP1	to	
DNA	ends	channels	DSB	repair	into	NHEJ	in	part	by	suppressing	end	resection.	It	has	
also	 been	 proposed	 that	 BRCA1	 and	 CtIP	 collaborate	 to	 exclude	 53BP1	 and	 its	
cofactors,	RIF1	and	PTIP	from	the	chromatin	that	is	present	around	DSBs	specifically	
in	S	and	G2.	Presence	of	53BP1	and	its	cofactor	RIF1	in	the	chromatin	around	DSBs	in	
G1,	blocks	DNA	end	resection,	while	exclusion	of	53BP1	from	chromatin	surrounding	
DSBs,	 lead	 to	 extensive	 end	 resection	 in	 S	 and	G2	 phases	 (Bouwman	 et	 al.,	 2010;	
Bunting	 et	 al.,	 2010;	 Callen	 et	 al.,	 2013;	 Chapman	 et	 al.,	 2012a;	 Di	 Virgilio	 et	 al.,	
2013;	 Escribano-Díaz	 et	 al.,	 2013).	 Such	 a	 cell	 cycle	 poised	 regulation	 of	 DNA	 end	
resection	 ensures	 that	 HR	 is	maximally	 activated	 only	 when	 sister	 chromatids	 are	
available	to	guide	faithful	repair.	The	importance	of	this	cell	cycle	restricted	balance	
between	 HR	 and	 NHEJ	 is	 evident	 in	 the	 absence	 of	 functional	 BRCA1,	 when	 DNA	
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lesions	 occurring	 in	 S-phase	 that	 are	 normally	 repaired	 through	 HR	 are	 instead	
channeled	 into	 NHEJ.	 This	 results	 in	 the	 formation	 of	 highly	 aberrant	 DNA	 repair	
products	 such	 as	 chromosomal	 radials,	 leading	 to	 lethal	 consequences	 to	 the	 cell	
(Chapman	et	al.,	2012a).	
	
	
	
Figure	 8.	 DNA	 end	 resection	 as	 a	 regulator	 of	 DNA	 repairs	 pathway	 choice.	 In	 G1	 phase,	 NHEJ	
physically	 blocks	 DNA	 end	 processing	 via	 KU	 and	 prevents	 MMEJ	 or	 HR.	 In	 contrast,	 in	 S	 and	 G2	
phases	 of	 the	 cell	 cycle	 MRX/N	 and	 Sae2/CtIP	 collaborate	 to	 initiate	 DNA	 end	 resection,	 which	
displaces	KU	 from	DNA	ends	and	 thus	 inhibits	NHEJ.	 In	case	of	HR	 there	 is	extensive	 resection	 that	
results	in	RAD51	filament	formation	and	inhibition	of	MMEJ.	MMEJ	is	active	throughout	the	cell	cycle.	
Chemically	 modified	 or	 damaged	 ends	 (stars)	 cannot	 be	 repaired	 by	 NHEJ	 and	 require	 DNA	 end	
resection	to	be	processed	by	MMEJ	or	HR.	Adapted	from	(Symington	&	Gautier,	2011).	
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Apart	from	the	tussle	between	the	factors	of	HR	and	NHEJ,	another	important	level	
of	control	that	ensures	that	HR	is	maximally	activated	during	the	S	and	G2	phases	of	
the	cell	cycle	is	exerted	by	CDKs.	The	CDK	mediated	phosphorylation	of	S/T-P	motif	
at	the	Sae2-S267/CtIP-T847	is	essential	for	DNA	end	resection	(Huertas	and	Jackson,	
2009;	 Huertas	 et	 al.,	 2008).	 	 MRN	 mediated	 phosphorylation	 of	 CtIP	 by	 CDK2,	
interferes	 with	 its	 proteaosomal	 degradation	 in	 S	 and	 G2	 phases	 of	 the	 cell	 cycle	
(Buis	 et	 al.,	 2012;	 Ira	 et	 al.,	 2004).	 A	 recent	 study	 showed	 that	 phosphorylation-
specific	 prolyl	 isomerase	PIN1,	upon	phosphorylation	by	CDK	by	 a	proline-directed	
kinase	 PIN1	 and	 CDK2,	 binds	 to	 CtIP	 and	 triggers	 its	 conformational	 change	 that	
results	in	ubiquitination	and	subsequent	proteasomal	degradation	of	CtIP	(Steger	et	
al.,	2013).	The	degradation	of	CtIP	is	important,	as	the	persistence	of	CtIP	could	lead	
to	extensive	DNA-end	resection	(Bonetti	et	al.,	2015;	Chen	et	al.,	2015;	Lafranchi	et	
al.,	 2014;	 Nicolette	 et	 al.,	 2010;	 Puddu	 et	 al.,	 2015;	 Steger	 et	 al.,	 2013).	 CDK	
mediated	 phosphorylation	 of	 CtIP	 in	 S/G2	 promotes	 its	 interaction	with	 the	 other	
proteins	of	HR	like	MRN	complex	and	BRCA1	(Chen	et	al.,	2008;	Yu	and	Chen,	2004).	
CDKs	promote	resection,	both	in	yeast	and	vertebrates,	and	inhibition	of	CDK	activity	
in	 G2	 prevents	 extensive	 resection,	 Rad51	 filament	 formation	 and	 Mec1/ATR	
activation	 (Ira	et	al.,	2004;	 Jazayeri	et	al.,	2006).	DNA	end	resection	 is	 regulated	at	
various	levels,	and	in	addition	to	cell	cycle	phase	as	described	above,	its	regulation	is	
also	 linked	 to	 chromatin	 structure	 and	 damage	 complexity	 (Clouaire	 and	 Legube,	
2015;	Symington,	2014).		
	
1.4.5.			Impact	of	DNA	end	resection	on	DNA	damage	signaling	
	DNA	end	 resection	 generates	 long	 3’	 RPA	 coated	 ssDNA	 tails	 to	which	ATR/ATRIP	
binds	 and	 is	 subsequently	 activated	 by	 Rad17	 and	 TopBP1	 around	 ssDNA/dsDNA	
junctions.	 A	 critical	 target	 of	 ATR	 is	 the	 Chk1	 kinase,	 which	 is	 required	 both	 for	
replication	 stress	 response	 and	DNA	damage	 induced	 checkpoint	 activation	 (Liu	 et	
al.,	 2006;	MacDougall	 et	 al.,	 2007;	Van	et	 al.,	 2010;	 Zou	and	Elledge,	 2003;	 2003).	
Chk1	activity	is	regulated	by	its	phosphorylation	on	S317	and	S345	by	ATR	(Cimprich	
and	Cortez,	 2008).	A	 recent	 study	 showed	 that	Chk1	 is	 activated	 rapidly	 after	DSB	
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induction,	 in	a	manner	 independent	of	DNA	end	resection.	This	 study	also	showed	
that	 DNA	 end	 resection	 is	 crucial	 for	 checkpoint	 maintenance,	 suggesting	 that	
resection	 is	 linked	 to	 prolonged	 cell	 cycle	 arrest	 to	 allow	 sufficient	 time	 for	 HR	
mediated	DNA	repair.	The	initial	activation	of	the	G2M	checkpoint	happens	at	a	time	
point	that	precedes	the	 initiation	of	DNA	end	resection.	Once	HR	repair	 is	 initiated	
by	 DNA	 end	 resection,	 the	 resection	 dependent	 checkpoint	maintenance	 pathway	
takes	over	and	restricts	mitotic	entry	until	DNA	is	repaired	completely	(Kousholt	et	
al.,	2012).	Thus,	DNA	end	resection	plays	an	important	role	not	only	in	determining	
the	DNA	repair	pathway	but	also	 in	checkpoint	maintenance,	undermining	the	role	
of	DNA	end	resection	in	eliciting	an	efficient	overall	DNA	damage	response.	
	
1.5.			The	MRE11-RAD50-NBS1	(MRN)	complex	
	
The	MRN	 complex	 is	 an	 important	 player	 in	 the	DDR	 that	 is	 involved	 both	 in	DSB	
repair	 and	 in	 the	 activation	 of	 DNA	 damage-induced	 signaling	 cascades.	 (Huertas,	
2010;	 van	 der	 Linden	 et	 al.,	 2009).	 The	 MR	 complex	 is	 a	 heterodimer	 complex	
consisting	 of	 the	 two	 catalytic	 subunits,	 each	 of	 MRE11	 and	 RAD50.	 This	 core	
complex	is	conserved	from	bacteria	to	archaea	to	eukaryotes	and	it	is	even	found	in	
some	 viruses	 like	 the	 bacteriophage	 T4	 (Herdendorf	 et	 al.,	 2011;	 Hopfner	 et	 al.,	
2000b).	 The	 importance	 of	 MRN	 complex	 is	 reflected	 from	 the	 fact	 that	 the	 null	
mutations	 in	 any	 of	 the	 three	 components	 of	 MRN	 complex	 leads	 to	 embryonic	
lethality	in	mice	(Williams	et	al.,	2007).	Hypomorphic	mutations	in	any	of	the	three	
components	of	MRN	complex,	 lead	 to	 rare	 genetic	diseases.	 	Mutations	 in	MRE11	
gene	 lead	 to	 ataxia-telangiectasia-like	 disorder	 (ATLD).	 These	 patients	 have	 very	
similar	phenotypes	as	ATM	patients	like	ataxia	and	neurodegeneration	(Taylor	et	al.,	
2004).	 Hypomorphic	 mutations	 in	 NBS1	 in	 humans	 cause	 Nijmegen	 breakage	
syndrome	(NBS),	a	rare	autosomal	recessive	disorder	characterized	by	microcephaly,	
immunodeficiency	and	cancer	predisposition	(Maser	et	al.,	2001;	Varon	et	al.,	1998).	
It	 has	 also	 been	 reported	 that	 hypomorphic	mutations	 in	 RAD50	 lead	 to	 NBS-like	
disorder	(NBSLD)	(Waltes	et	al.,	2009).		
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In	 eukaryotic	 cells,	 the	 MRN	 complex	 is	 comprised	 of	 a	 MRE112RAD502	 	 (M2R2)	
heterodimeric	core	that	further	associates	with	NBS1,	via	interactions	with	MRE11	to	
give	an	overall	stoichiometry	of	MRE112RAD502NBS2;	although	there	is	some	dispute	
over	 the	 number	 of	 NBS1	 protein	 subunits	 bound	 to	 each	 M2R2	 heterotetramer	
(Trujillo	et	al.,	1998;	van	der	Linden	et	al.,	2009).	The	unusual	structural	architecture	
of	 the	MRN	 complex	 is	mainly	 characterized	 by	 RAD50	 that	 features	 an	 extended	
rod-like	 shape	 (Figure	 9A).	 The	 N-terminal	 and	 a	 C-terminal	 domain	 of	 RAD50	
consists	 of	 walker	 A	 and	 Walker	 B	 domains	 that	 together	 form	 a	 bipartite	 ATP-
binding	cassette	-	ATPase	(ABC-ATPase)	(Hopfner	et	al.,	2001;	2000a).	A	large	helical	
region,	which	links	the	N-	and	C-terminal	Walker	domains	of	RAD50,	folds	into	a	long	
coiled	 coil	 tail	 that	protrudes	 from	 the	 catalytic	head	 region	 (Hopfner	et	al.,	 2002;	
Moreno-Herrero	et	al.,	2005).	The	central	part	of	RAD50	contains	a	highly	conserved	
Cys-X-X-Cys	sequence	in	the	center	of	the	coiled-coil	region.	This	sequence	between	
two	RAD50	molecules	can	coordinate	a	zinc	ion,	to	form	a	Zn-hook	domain	that	leads	
to	 the	 formation	an	MRN	 intermolecular	 complex	 structure	 (Hopfner	et	 al.,	 2002).	
RAD50	also	contains	MRE11	binding	sites,	 located	at	the	 intersection	of	the	coiled-
coil	and	ATPase	domains	(de	Jager	et	al.,	2001;	Hopfner	et	al.,	2001).	MRE11	further	
interacts	with	NBS1,	via	the	MRE11	interaction	sites	present	towards	the	C-terminus	
of	 NBS1	 (Mirzoeva	 and	 Petrini,	 2001;	 Petrini,	 2003;	 Varon	 et	 al.,	 1998).	 The	MRN	
complex	thus	consists	of	a	globular	head	region,	which	mainly	harbors	the	catalytic	
functions	of	 the	 complex.	 It	 contains	 the	MRE11	nuclease,	 the	Walker	A/B	ATPase	
domain	of	RAD50.	The	other	part	 is	a	 large	helical	region	that	harbors	a	coiled–coil	
region	 and	 an	 apical	 zinc-hook	 dimerization	motif	 that	 allows	 the	 interaction	with	
other	MRN	complex	(Figure	9B).	
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Figure9.	 (A)	 Structural	 architecture	 of	 the	MRN	 complex.	 The	 head	 domain	 of	 the	MRN	
complex	 consists	 of	 the	 ATPase	 domains	 of	 RAD50,	 together	 with	MRE11	molecules.	 The	
coiled	coil	domain	consists	of	the	central	regions	of	RAD50	and	the	Zn	hook	domain.	The	Zn	
hook	domain	connects	two	MRN	complexes.	NBS1	is	connected	via	its	C-terminal	to	MRE11.	
(B)	 The	 structure	of	RAD50.	RAD50	 contains	Walker	A	 and	B	motifs	 in	N-	 and	C-terminus,	
respectively,	 that	 are	 responsible	 for	 the	 ATPase	 activity	 of	 RAD50.	 The	 central	 part	 of	
RAD50	consists	of	two	coiled-coil	regions	that	are	linked	by	a	zinc-	hook	motif	in	the	middle.	
MRE11	 interacts	with	RAD50	via	two	regions	 localized	at	the	 intersection	of	the	coiled-coil	
and	ATPase	domains.	Adapted	from	(Williams	et	al.,	2010).	
	
	
1.6.			NBS1:	structure,	function	and	link	to	diseases	
NBS1	is	the	least	conserved	component	of	the	MRN	complex	and	it	is	present	only	in	
eukaryotes.	 Although	 the	 NBS1	 gene	 is	 widely	 conserved	 in	 function	 in	 higher	
eukaryotes,	 it	 shows	 a	weak	 homology	 to	 the	 S.	 cerevisiae	 gene	 encoding	 Xrs2	 at	
both	the	N-	terminus	and	C-terminus	and	moderate	homology	to	the	S.	pombe	gene	
encoding	NBS1	(Symington	and	Gautier,	2011).	NBS1	is	a	regulatory	subunit	of	MRN	
component	and	it	mediates	nuclear	localization	of	MRE11	and	RAD50	(Mirzoeva	and	
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Petrini,	 2001).	 Mutations	 in	 the	 MRE11	 interaction	 motifs	 of	 NBS1	 results	 in	 the	
cytoplasmic	 retention	 and	degradation	of	MR	 (Desai-Mehta	 et	 al.,	 2001;	 Tauchi	 et	
al.,	2001).	NBS1	contains	several	 functional	domains,	mainly	 in	the	N-terminus	and	
the	 C-terminus.	 The	 N-terminus	 region	 of	 NBS1	 includes	 two	 phospho-interaction	
domains,	of	which	one	 is	a	 forkhead-associated	 (FHA)	domain	and	the	other	 is	 the	
combined	 tandem	 2	 BRCA1	 C-terminus	 (BRCT)	 domain.	 The	 C-terminal	 region	 of	
NBS1	harbors	a	MRE11	interaction	motif,	which	is	essential	for	the	for	direct	binding	
to	MRN	complex	and	its	nuclear	transportation	(Tauchi	et	al.,	2001).	Additionally,	an	
ATM	 interaction	 site	 is	 also	 present	 at	 the	 very	 C-terminus	 of	 NBS1,	 which	 is	
essential	for	the	recruitment	of	ATM	to	DSB	sites	and	its	activation	(Difilippantonio	
et	al.,	2005;	Falck	et	al.,	2005;	Lee	and	Paull,	2005;	You	et	al.,	2005.,	Shiotani	et	al.,	
2014).	 NBS1	 mediated	 ATM	 phosphorylation	 events	 have	 been	 implicated	 in	
checkpoint	activation	(Buscemi	et	al.,	2001;	Girard	et	al.,	2002).	
The	presence	of	FHA	and	BRCT	domains,	endows	adaptor/mediator	function	to	NBS1	
(Figure	10).	NBS1	does	not	possess	any	enzymatic	activity	and	act	as	a	adaptor	 for	
MR	 by	 mediating	 the	 sustained	 interaction	 of	 of	 MR	 with	 other	 proteins	 such	 as	
MDC1	 in	 the	 DSB-flanking	 chromatin	 (Chapman	 &	 Jackson,	 2008;	 Spycher	 et	 al.,	
(Melander	et	al.,	2008).	In	fission	yeast,	Nbs1	interacts	with	Ctp1	and	this	interaction	
is	critical	 for	promoting	DNA	damage	resistance	 (Lloyd	et	al.,	2009;	Williams	et	al.,	
2009).	In	contrast,	the	physical	and	functional	interaction	between	NBS1	and	CtIP	in	
human	cells	 is	much	 less	 clear.	NBS1	 is	 important	 in	mediating	phosphorylation	of	
nuclear	proteins	by	ATM	(Buscemi	et	al.,	2001;	Gatei	et	al.,	2003;	Girard	et	al.,	2002;	
2002)	and	ATR	(Stiff	et	al.,	2005).	NBS1	has	also	been	implicated	in	the	activation	of	
ATR	during	replication	stress	(Duursma	et	al.,	2013;	Lee	and	Dunphy,	2013;	Shiotani	
et	al.,	2014).		
	NBS1	 belongs	 to	 the	 haploinsufficient	 tumor	 suppressor	 genes	 cohort,	 which	
includes	 several	 genes	 including	many	 genes	 involved	 in	 DNA	 repair	 (Demuth	 and	
Digweed,	 2007;	 Santarosa	 and	 Ashworth,	 2004).	 The	 hypomorphic	 mutations	 in	
NBS1	gene	 lead	 to	a	 rare	autosomal	 recessive	 genetic	disorder	 called	as	Nijmegen	
breakage	syndrome	(NBS).	The	most	common	mutation	in	NBS1	syndrome	found	in	
90%	of	the	patients	(Varon	et	al.,	1998)	is	deletion	of	5	nucleotides	in	exon	6	of	NSB1	
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(657del5).	This	mutation	determines	the	synthesis	of	two	proteins	fragments	p26	(26	
kDa)	 and	 p70	 (70	 kDa).	 The	 p26	 fragment	 includes	 1-218	 aa	 of	 the	 NBS	 protein,	
consisting	of	FHA	and	the	BRCT1	domains.	The	p70	includes	the	second	BRCT	domain	
and	Mre11	and	ATM	interaction	sites	(Krüger	et	al.,	2007;	Maser	et	al.,	2001).	NBS	
patients	 with	 defective	 NBS1	 share	 many	 phenotypical	 features	 with	 AT	 patients,	
defective	 in	 ATM	 and	 ATR-Seckel	 patients,	 defective	 in	 ATR.	 For	 example	 NBS	
patients	exhibit	checkpoint	activation	defects,	a	feature	shared	by	both	AT	and	ATR-
Seckel	 patients.	 However,	 immunodeficiency,	 chromosomal	 aberrations,	 genomic	
instability,	 cancer	 predisposition,	 heightened	 radiosensitivity,	 and	 developmental	
defects	 are	observed	only	 in	AT	and	NBS	patients.	Whereas,	microcephaly,	mental	
retardation,	 dysmorphic	 facial	 features	 are	 observed	 only	 in	 ATR-Seckel	 and	 NBS	
patients.	 The	 risk	 of	 developing	 cancer	 in	 NBS	 patients	 is	 very	 high,	 with	 50%	 of	
patients	suffering	for	NBS	developing	lymphomas	soon	after	the	first	decade	of	 life	
(Demuth	 and	 Digweed,	 2007).	 Increased	 cases	 of	 stomach	 and	 colorectal	 cancer	
have	also	been	reported	in	NBS	patients	(di	Masi	and	Antoccia,	2008).	In	comparison	
to	 decreased	 levels	 of	 NBS1	 being	 implicated	 in	 most	 of	 the	 cancers	 observed	 in	
NBS1	patients,	 there	are	 incidents	where	 increased	expression	of	NBS1	 is	 linked	to	
the	development	of	several	types	of	cancer,	such	as	non-small	 lung	cell	cancer	and	
uveal	 melanoma	 (Ehlers	 and	 Harbour,	 2005).	 Increased	 NBS1	 expression	 has	 also	
been	 suggested	 as	 a	 Marker	 of	 aggressive	 form	 of	 Head	 and	 Neck	 Cancer	 and	
Overexpression	(Yang	et	al.,	2006).	
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Figure	 10.	Structure	 and	major	 interaction	 partners	 of	 human	 NBS1.	 FHA	domain	 at	 the	
very	 N-terminal	 interacts	 with	 Treacle	 and	 WRN.	 Both	 FHA	 and	 BRCT	 domains	 of	 NBS1	
interact	with	MDC1	and	TopBP1.	Several	 interaction	domains	at	the	C-terminus	of	NBS1	C-
terminal	are	critical	for	binding	to	MRE11,	ATM,	Rad18,	and	RNF20.	Adapted	from	(Saito	et	
al.,	2013).	
	
1.6.1.					FHA	domains	
The	 FHA	 domain	 was	 first	 discovered	 in	 forkhead	 family	 transcription	 factors	 and	
since	then,	it	has	been	identified	in	more	than	2000	proteins	both	in	prokaryotes	and	
eukaryotes	 (Mahajan	 et	 al.,	 2008).	 FHA	 domains	 can	 be	 found	 in	many	 regulatory	
proteins,	 kinases,	 phosphatases	 and	 transcription	 factors,	 kinesin-like	 motors	 and	
regulators	 of	 small	 G	 proteins	 and	 have	 been	 implicated	 in	 diverse	 biological	
processes	such	as	cell	cycle	control,	cell	growth,	signal	transduction	and	transcription	
and	 in	 DNA	 damage	 signaling.	 NMR	 or	 X-Ray	 crystallography	 has	 elucidated	 the	
structures	 of	many	 FHA	 domains	 and	 some	 notable	 DDR	 examples	 include	MDC1,	
NBS1,	 RNF8	 and	 Chk2.	 The	 FHA	 domain	 spans	 approximately	 80-120	 amino	 acids,	
which	 form	around	11	β-strands.	These	β-strands	 form	 two	 large	 intertwined	anti-
parallel	β-sheets,	which	 fold	 into	a	β-sandwich	structure.	Although	 the	known	FHA	
domains	 share	 low	 sequence	 homology	 but	 still	 adopt	 a	 similar	 fold,	 a	 structural	
featured	attributed	to	the	preservation	of	hydrophobicity	in	the	β	strands.	The	FHA	
domain	 specifically	 recognizes	 phosphothreonine	 residue	 and	 not	 phosphoserine	
residue.	 Combinatorial	 peptide	 library	 screening	 was	 used	 to	 identify	 ligand	
specificities	for	the	different	FHA	domains	(Durocher	et	al,	2000)	and	these	studies	
elucidated	that	the	highly	conserved	pThr	and	pThr+3	residue	form	the	primary	and	
secondary	 recognition	 site	 for	 binding	 to	 FHA	 domains.	 The	 pThr+3	 residue	 could	
either	be	an	Asp	or	 Ile/Leu.	However,	there	are	exceptions	to	this	pattern,	e.g.	the	
RNF8	FHA	domain	has	a	preference	for	Tyr	or	Phe	at	the	pThr+3	position	(Durocher	
et	al,	2000;	Huen	et	al,	2007)	and	the	FHA	domain	found	in	yeast	Dun1	has	a	unique	
preference	 for	phosphorylated	substrates	 including	 two	consecutive	pThr	 residues.	
The	specificity	of	binding	to	phosphopeptides	is	determined	by	the	loops	and	turns	
that	connect	the	β-strands,	which	vary	in	length	and	α-helical	insertions	between	the	
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different	FHA	domains.	 In	addition	to	the	role	of	FHA	domains	 in	kinase	activation,	
they	have	been	implicated	in	DNA	damage	dependent	oligomerization	processes	as	
well.	A	well	studied	example	is	the	FHA	domain	mediated	transient	dimerization	of	
Chk2	kinase,	that	leads	to	its	activation	(Ahn,	2002).	However,	Chk2	dimer	is	believed	
to	be	a	transient	structural	modification	that	places	the	kinase	active	sites	in	a	way	
that	facilitates	their	trans-phosphorylation,	ultimately	leading	to	their	activation	and	
then	 dissociation	 to	 active	 monomers.	 Lately,	 it	 has	 been	 shown	 that	 the	 FHA	
domain	 of	 MDC1	 mediates	 an	 intermolecular	 interaction	 with	 a	 previously	
uncharacterized	ATM	phosphorylation	site	(pThr4)	at	the	very	N-terminus	of	MDC1,	
which	leads	to	the	dimerization	of	MDC1	in	response	to	DNA	damage		
	
Like	 the	 characteristic	 FHA	domain	 structure,	 the	N-terminal	114	 residues	of	NBS1	
form	11	β-strands,	which	fold	into	a	β-sandwich.	As	speculated	from	the	sequence,	
analysis	 of	 the	 X-ray	 structure	 of	 the	 NBS1	 N-terminal	 fragment	 revealed	 two	
tandem	 BRCT	 domains.	 The	 FHA	 domain	 and	 first	 BRCT	 domain	 exist	 as	 a	 single	
globular	structure,	contrary	to	what	would	be	expected	from	two	distinct	domains.	
The	 FHA-BRCT1	 domains	 form	 a	 compact	 structural	 fold	 unit	 that	 is	 linked	 to	 the	
second	BRCT-repeat	motif	in	a	flexible	way.	The	FHA/	BRCT2	domain	composition	is	
conserved	in	all	eukaryotic	NBS1	proteins.	As	mentioned	before,	the	most	common	
mutation	found	in	NBS	patients	is	657del5	yields	two	protein	fragments	termed	p26	
and	p70.	 (Maser	et	al.,	2001)	 (Figure	9B).	The	underlying	reason	 for	 this	molecular	
scission	 is	 believed	 to	 be	 the	 instability	 of	 NBS1	 because	 of	 exposure	 of	 a	 large	
hydrophobic	 patch	 which	 is	 normally	 buried	 in	 the	 BRCT1-BRCT2	 Interface.	 The	
mutations	 in	FHA	domains	can	 lead	 to	 tumorigenesis,	as	 seen	 In	 the	case	of	Chk2.		
Two	 missense	 mutations	 (Ile157Thr	 and	 Arg145Trp)	 in	 the	 FHA	 domain	 of	 Chk2	
disrupt	 phosphorylation	 dependent	 protein-protein	 interactions	 and	 have	 been	
implicated	in	a	variant	form	of	the	Li-Fraumeni	cancer	syndrome.	
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Figure	9:		(A)	Structure	of	FHA/BRCT	domains	of	S.	pombe.	(B)	NBS1	657del5	frameshift	mutation	found	in	
majority	of	NBS	patients	causes	a	molecular	scission	of	the	protein	that	generates	two	protein	fragments	p26	and	
p70.	 The	 fragmentation	 of	 the	 protein	 leads	 to	 exposure	 of	 large	 patch	 of	 hydrophobic	 core,	 which	 leads	 to	
protein	instability.	Adapted	from	Lloyd	et	al.	2009	and	Williams	et	al.	2009	
	
	
1.6.2.			BRCT	domains	
BRCT	 repeats	 were	 first	 discovered	 in	 BRCA1	 (breast-cancer	 associated	 protein)		
(Bork	 et	 al.,	 1997)	 and	 since	 then	 have	 been	 shown	 to	 exist	 in	 a	 large	 number	 of	
proteins	involved	in	the	DDR	(Bork	et	al,	1997).	The	BRCT	domain	encompasses	90-
100	amino	acids	in	length	and	can	fold	independently.		The	phosphopeptide	binding	
activity	of	tandem	BRCT	domains	was	identified	in	BRCA1	and	PTIP	(PAX-interacting	
protein	 1),	 protein	 in	 a	 genome-wide	 proteomics	 screen.	 This	 screen	 identified	
domains	 that	 specifically	 binded	 to	 a	 library	 of	 peptides	 centered	 on	 the	 motifs	
generated	 by	 ATM	 and/or	 ATR	 (Manke	 et	 al.,	 2003).	 Notable	 examples	 from	DNA	
damage	 response	 that	 contain	 tandem	BRCT	 repeats	 include	BRCA1,	MDC1,	NBS1,	
53BP1,	PTIP,	DNA	ligase	IV	and	TopBP1.	
disconnect contributes to radio-sensitivity phenotypes and ulti-
mately to malignancies in NBS patients (Maser et al., 2001). At
the protein level, 657del5 causes molecular scission of hNbs1-
p95 into two halves: (1) an N-terminal (p26) fragment that fails
to interact with other members of the MRN complex and con-
tains the FHA-BRCT1 with an extended 15 amino acid C ter-
minus, and (2) a C-terminal (p70) fragment with intact Mre11-
ATM-binding motifs and an extended N-terminal peptide linked
to its BRCT2 domain (Figure 2D). Structurally, 657del5 physically
uncouples the Nbs1 FHA- and BRCT-mediated phosphoregula-
tory interactions of Nbs1 from its Mre11 and ATM/Tel1 interac-
tion regions. Besides split FHA and BRCT domains, we hypoth-
esize protein instability and decreased abundance of Nbs1-p70
underlying cancer incidence (Kruger et al., 2007) is caused by
solvent exposure of a larg hydrophobic patch on BRCT2 that
normally forms the BRCT1-BRCT2 interface (Figure 2D).
Nbs1 Missense Mutations
Two missense mutations (R215W and L150F) mapping to Nbs1-
fc are linked to NBS (Seemanova et al., 2006) and breast cancer
(Heikkinen et al., 2006). The R215W (643C/T) mutation occurs
with 657del5 in compound heterozygous individuals with NBS
presenting unusually severe neurological abnormities (Seema-
nova et al., 2006). Arg215 lies in the BRCT1-BRCT2 linker region,
and salt bridges with Asp205 and Glu206 in our hNbs1-fc
homology models (Figure 2E). Mutation of hNbs1-fc Arg215 to
Trp confers trypsin sensitivity, suggesting that R215Wdecreases
Nbs1 protein stability (Figure 2G). Conversely, the L150F
breast cancer associated mutation displays no measurable
stability defect. However, L150Fflanks theNbs1BRCTphospho-
serine interaction cleft (Figure 2F). By analogy to BRCA1 muta-
tions occluding phosphoprotein-binding pockets, L150F may
deform thepSer-bindingpocket via a relayof hydrophobic distor-
tion (Williams et al., 2004).Whereas patientswithNbs1mutations
decreasing protein stability and abundance present with clas-
sical NBS symptoms, a specific linkage of Nbs1 L150F to breast
cancers may reflect critical functional roles for the Nbs1 BRCT
interactions in tumor suppression. Thus, Nbs1 disease-causing
mutations may either directly impact phosphoprotein binding
as seen for BRCA1 (Williams et al., 2004), or global protein
stability as seen for BRCA1 (Williams et al., 2001), XPD (Fan
et al., 2008), and superoxide dismutase (DiDonato et al., 2003).
Figure 2. Structural Basis for NBS Muta-
tions
(A) Trypsin degradation produces a stable hNbs1
folded core (hNbs1-fc, residues 1–334).
(B) Comparison of calculated SAXS curves for
hNbs1 models (red) with experimental scattering
(black) shows hNbs1-fc architecture closely
matches the S. pombe structure.
(C) Superposition of 12 homology hNbs1 models
with SAXS scattering c2 fits better than 1.3. ATM
phosphorylation sites in hNbs1 map to surface
accessible loops with observed conformational
variability between models. Ser278 phosphoryla-
tion could mediate autoregulatory BRCT peptide
binding in cis through an interaction with the phos-
phoprotein-binding cleft.
(D) Nbs1 657del5 frameshift mutation found in
90% of NBS patients generates protein fragments
p26 and p70. Sequence in red, resulting from
657del5, shows extra C-terminal residues added
to the N-terminal (p26) and C-terminal (p70) frag-
ments.
(E) A homology model for Arg215 in hNbs1 based
on the spNbs1-fc structure suggests that Arg215
forms a salt bridge from the BRCT linker to
a BRCT1 helix. R215W is predicted to disrupt
protein folding.
(F) The Nbs1 L150F missense mutation likely
disrupts the BRCT pSer-binding pocket. Leu150
is found in the hydrophobic core directly contact-
ing pSer ligands, based on the structure of a
BRCA1-phosphopeptide complex, RCSB ID
1T2V.
(G) Protease sensitivity of Nbs1 missense muta-
tions. Mutant R215W destabilizes the protein fold
whereas L150F shows wild-type resistance to
trypsin digestion.
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residues is evident between spNbs1 and hNbs1, the nonpolar
character of amino acid r sidues that contribute core FHA-
BRCT1 interactions is conserved (Figure 2A). In addition, a strip
of conserved hydrophobic surface follows the path of the linker
extending from the BRCT1-FHA interface to BRCT2. Notably,
the N-terminal Met-Trp pair of spNbs1 is buried in the structure
and forms an intrinsic part of the non-polar FHA-BRCT1 interface
(Figure 2B). Trp-2 is highly conserved in animals and fungi, and,
because of its bulk, it presumably i sulates the initiator methio-
nine from cotranslational excision (Giglione et al., 2004). Plants,
however appear to have followed a different evolutionary path to
the same structural end point whereby an extra valine residue is
positioned to take the place ofMet-1 andmaintain the integrity of
the FHA-BRCT1 interface after more efficient methionine amino-
peptidase cleavage expected when small hydrophobic residues
are present in the second position (Martinez et al., 2008). Overall,
the importance of the structure around Met-1/Trp-2 is exempli-
fied by the insolubility/aggregation of recombinant Nbs1
expressed with either N-terminal GST or hexahistidine affinity
tags (data not shown). These observations, together with
the absence of any significant ‘‘linker’’ region between the
C terminus of the FHA domain and N terminus of BRCT1 in all
Nbs1 sequences (Becker et al., 2006) (Figure 2C), support our
contention that the structural coupling and precise spatial appo-
sition of the FHA and BRCT domains is likely to be crucial for
Nbs1 functions in all eukaryotes.
Structural Co text of Human Disease-Associate Nbs1
Mutations
The apparent structural conservation between Nbs1 orthologs
allows us to place in a molecular context various human
disease-associated Nbs1 mutations that are located within the
FHA/BRCT region. To date, around 90% of patients suffering
from NBS are homozygous or heterozygous for a founder muta-
tion,657del5, a 5bpdeletion in exon 6within thecoding region for
the BRCT1-BRCT2 linker that results in production of C- and
N-terminally truncated proteins termed p26 and p70, respec-
tively (Maser et al., 2001) (Figure S2A). In addition, a number of
FHA
BRCT 1
BRCT 2
Linker
N C
N
α0
A
C
β1
β2
β3
β4
β5
β6
β7
β8
β9
β10
β11
β1
β2
β3
β4
α1
α2
α3
α3’
β1
β2
β3β4
α1
α2α3
αc
αL1
αL2
αL3
Sp GFSCAMLNTS--SESHHLLELLGLRISTFMSLGDI-DKELISK-TD
Hs GKTFIFLNAKQHKKLSSAVVFGGGEARLITEENEEEHN-FFLAPG-
Xl DKVFLFLNAKQYKKLSPAVLFGGGKTDLLM--GELKDASVLDNPA-
Sp FVVLNNAVYDSE------------KISF--PE-GIFCLTIEQLWKIII
Hs TCVVDTGITNSQTLIPDCQKKWIQSIMDMLQRQGLRPIPEAEIGLAVI
Xl TCVIDVAMTESQLSESQSTQPWITSTLDLLQSKGLRTIPEAEIGLAVI
Ser 275
L3
SpNbs1 BRCT2
XlNbs1 BRCT2
BRCT1
FHA
D
FHA BRCT1 BRCT2
0
10
20
30
40
50
60
0 40 80 120 160 200 240 280 320
B
C
B
-fa
c
to
r C
α
 
(Å
2 )
Residue number
Figure 1. Structure of the S. pombe FHA/BRCT Region
(A) Ribbons representation of the spNbs1 FHA/BRCT region with b strands shown as arrows and a helices as tubes. The FHA, BRCT1, linker, and BRCT2 domains
are colored red, green, magenta, and blue, respectively, with the major secondary structural elements labeled. All structural representations were generated with
PyMOL (http://pymol.sourceforge.net/).
(B) Structural superposition (top) shows a remarkable similarity between the second BRCTmotif of spNbs1 and that of Xenopus laevis (PDBID: 2K2W) with a root
mean square deviation of 2.0 A˚ for 65 matched Ca atoms from each domain. The ‘‘L3’’ loop that contains a major site of ATM-phosphorylation corresponding to
Ser-278 in hNbs1 (Zhao et al., 2000) is replaced by a partially disordered helical loop in spNbs1. The resulting structure-based sequence comparison (bottom)
shows only a general conservation of non-polar residues that form the hydrophobic BRCT core.
(C) FHA- and BRCT1-domain interactions are shown in an ‘‘open book’’ representation. The contact areas of the FHA with BRCT1 (green) and BRCT1 with the
FHA (red) represent >2000A˚2 of total buried solvent-accessible surface.
(D) Top, least-squares superposition of the three crystallographically independent molecules from two crystal forms using the 114 Ca atoms from each FHA
domain shows that the relative arrangements of FHA and BRCT1 are nearly identical although some small displacements of BRCT2 are evident. Bottom, plot
of crystallographic B factors for Ca atoms in the selenomethionine spNbs1 structure. The positions of the FHA domain, BRCT repeatsn and linker region are
indicated by the horizontal bar with the same coloring as in (A). A similar distribution is seen in methylated spNbs1 structure (data not shown).
102 Cell 139, 100–111, October 2, 2009 ª2009 Elsevier Inc.
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The	phosphopeptide	binding	activity	of	BRCT	domains	is	stronger	for	phosphoserine	
than	for	phosphothreonine.	The	phosphopeptide	binding	activity	of	BRCT	domains	is	
restricted	 to	 tandem	 BRCT	 repeats	 (Manke	 et	 al.,	 2003;	 Rodriguez	 et	 al.,	 2003).	
Furthermore,	several	BRCT	domains	were	shown	to	strongly	select	 for	an	aromatic	
residue	in	the	pSer+3	position,	e.g.	BRCT	domains	of	BRCA1	(Clapperton	et	al.,	2004;	
Shiozaki	et	al.,	2004)	and	MDC1	(Stucki	et	al.,	2005).	Interestingly,	this	+3	position	is	
the	 site	where	many	 FHA	domains	 exhibit	 strongest	 binding	 specificity,	 suggesting	
that	 other	 sequence	 elements	 like	 binding	 surfaces	 and	 protein	 conformations	
determine	whether	a	given	phosphorylation	motif	 is	recognized	by	another	protein	
via	 FHA	or	 (BRCT)2	 domains	 (Reinhardt	 and	 Yaffe,	 2013).	 	Many	 structural	 studies	
revealed	 that	 the	 phosphopeptide-binding	 surface	 lies	 at	 the	 interface	 of	 the	 two	
BRCT	 domains,	 and	 each	 domain	 makes	 direct	 peptide	 contacts	 with	 the	
phosphopeptide	 ligand	 (Reinhardt	 and	 Yaffe,	 2013).	 For	 example	 in	 the	
phosphopeptide	from	BACH1,	the	phosphoserine	binds	to	a	pocket	in	the	N-terminal	
BRCT	domain,	whereas	the	Phe	at	the	pSer+3	position	binds	to	a	deep	groove	at	the	
interface	 between	 the	 two	BRCT	 domains	 of	 BRCA1	 (Clapperton	 et	 al.,	 2004).	 The	
γH2AX	 peptide	 also	 binds	 to	 a	 groove	 at	 the	 interface	 between	 the	 two	 BRCT	
domains	 of	 MDC1	 (Stucki	 et	 al.,	 2005).	 Although	 the	 BRCT	 domains	 frequently	
appear	as	 tandem	pairs,	which	are	 separated	by	 regions	of	different	 length;	 single	
BRCT	domains	are	also	found	in	DNA	damage	repair	enzymes,	such	as	REV1,	XRCC1	
and	PARP1.	MCPH1	carries	a	third	BRCT	domain	at	 its	N-terminus,	PTIP	has	6	BRCT	
domains	 and	 TopBP1	 contains	 8	 BRCT	 domains	 (Reinhardt	 and	 Yaffe,	 2013).	
However,	not	all	BRCT	domains	act	as	phosphopeptide	binding	modules.	Phospho-
independent	interactions	of	BRCT	domains	have	been	described	between	DNA	ligase	
IV	and	as	well	as	XRCC4,	53BP1	and	p53	(Derbyshire	et	al.,	2002;	Sibanda	et	al.,	2001)		
The	 importance	of	BRCT	domains	 in	genomic	 integrity	 is	highlighted	by	the	cancer-
associated	mutations	within	the	BRCT	domains.	For	example,	mutations	in	the	BRCT	
domains	 of	 BRCA1	 have	 been	 identified	 in	 familial	 breast	 and	 ovarian	 cancer	
syndrome	 and	 mutations	 within	 the	 BRCT	 domain	 of	 MCPH1	 are	 associated	 with	
autosomal	recessive	primary	microcephaly	(MCPH)	and	cancer	development	(di	Masi	
et	 al.,	 2011).	 Remarkably,	 the	 modular	 domains	 like	 FHA	 and	 BRCT	 domains,	 are	
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sometimes	considered	“promiscuous”	(Basu	et	al.,	2008;	Mesquita	et	al.,	2011).	This	
is	 because	 FHA	 and	 BRCT	 domains	 can	 interact	 with	 more	 than	 just	 one	
phosphorylated	 protein.	 A	 typical	 example	 is	 the	 BRCT	 domain	 of	 BRCA1,	 which	
forms	three	different	complexes	with	Abraxas,	BACH1	and	CtIP	(Huen	et	al.,	2010).
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2. Aims	
	
NBS1	 is	 the	 least	understood	component	of	 the	MRN	complex.	All	 the	studies	 that	
have	 been	 done	 on	 NBS1	 are	 primarily	 based	 on	 NBS1	 patient	 derived	 cell	 lines.	
Most	of	NBS	patients	harbor	a	657del5	(frame	shift	mutation)	that	causes	molecular	
scission	of	hNbs1-	p95	into	two	halves.	Structurally,	657del5	physically	uncouples	the	
FHA-	 and	BRCT-mediated	phosphoregulatory	 interactions	of	NBS1,	 from	 its	MRE11	
and	 ATM	 interaction	 regions.	 Such	 a	 genetic	 system	 is	 not	 well	 suited	 to	 study	
mutations,	as	complementing	such	a	system	essentially	mean	to	study	the	effects	of	
one	mutation	in	the	background	of	another	mutation.	Another	model	used	to	study	
NBS1	function	was	humanized	mouse	model,	but	this	is	again	not	a	perfect	system	as	
it	expresses	a	human	protein	in	mouse	cells.	Although	some	studies	have	suggested	
the	 involvement	of	NBS1	in	DNA	end	resection	the	precise	function	of	NBS1	in	this	
process	 in	mammalian	 cells	 has	 not	 been	 investigated	 in	 detail.	 Furthermore,	 the	
functional	relevance	and	contribution	made	by	the	FHA	and	BRCT	domains	of	NBS1	
in	DNA	end	 resection	are	not	known.	The	aim	of	 this	PhD	 thesis	was	 to	 rigorously	
test	the	role	of	NBS1	and	its	N-terminal	FHA	and	BRCT	domains	in	DNA	end	resection	
and	 G2M	 checkpoint	 activation	 and	 maintenance	 using	 a	 novel	 siRNA	 based	
complementation	system.	The	specific	aims	thus	were:	
	
2.1.	 To	 generate	 and	 characterize	 a	 siRNA	 based	 complementation	 system	 for	
NBS1:	
		
In	 an	 attempt	 to	 investigate	 the	 role	 of	NBS1	 in	 DNA	 end	 resection,	we	 aimed	 to	
generate	 C-terminally	 myc-tagged,	 siRNA	 resistant	 constructs	 of	 wild	 type	 (WT)	
NBS1,	R28A-NBS1	(FHA	domain	mutant),	K160M-NBS1	(BRCT	domain	mutant),	D.M.-
NBS1	 (FHA/BRCT	 domain	mutant).	 The	 final	 goal	 was	 to	 generate	 a	 system,	 using	
siRNA	resistant	NBS1myc	constructs	and	Flp-In	T-REx	system	(Invitrogen)	that	allows	
controlled	expression	of	the	recombinant	NBS1	and	 its	FHA/BRCT	mutants	from	an	
inducible	 promoter.	 We	 also	 intended	 to	 validate	 rigorously	 the	 NBS1	
complementation	 system,	 as	 the	 rest	 of	 the	 studies	 designed	 for	 this	 PhD	 project	
were	entirely	dependent	entirely	on	the	robustness	of	this	system.	
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2.2.	 	 To	 investigate	 the	 role	 of	 the	 FHA/BRCT	 domains	 of	 NBS1	 in	 DNA	 end	
resection:	
The	MRN	complex	 is	essential	 for	 the	sensing	and	signaling	of	DSBs,	and	 in	HR,	by	
promoting	 the	 resection	 of	 DSBs	 in	 collaboration	 with	 CtIP.	 NBS1	 was	 previously	
implicated	in	DSB	repair	by	homologous	recombination	(HR)	and	DNA	end	resection.	
Thus,	the	second	part	of	my	thesis	was	focused	on	the	analysis	of	human	NBS1	and	
its	 FHA/BRCT	mutants	 in	DNA	 end	 resection.	DNA	 resection	 is	 the	 first	 step	 in	HR	
repair	 and	 it	 generates	 3’	 ssDNA	 overhangs	 that	 are	 coated	 by	 RPA.	 The	 ssDNA	
overhangs	 can	 be	 visualized	 directly	 by	 neutral	 BrdU	 incorporation	 assay	 and	
indirectly	by	RPA	and	phospho	RPA	(S4/S8)	foci	formation.	Using	these	markers	as	a	
read-out	of	resection,	 I	 tried	to	find	out	how	NBS1	and	 its	FHA	and	BRCT	domains,	
contribute	to	I.R	induced	DNA	resection.		
	
2.3.			To	study	the	role	of	NBS1	in	DNA	damage	induced	checkpoint	maintenance:	
CtIP	mediated	DNA	end	 resection	has	 recently	been	 implicated	 in	G2M	checkpoint	
maintenance.		We	reasoned	that	NBS1	should	also	be	implicated	in	G2M	checkpoint	
maintenance	because	it	is	essential	for	efficient	DNA	end	resection	as	well.	The	aim	
of	 this	 study	was	 to	 test	 this	hypothesis	by	using	NBS1	knockout	cell	 line	 that	was	
recently	generated	in	our	laboratory	by	the	CRISPR/Cas9	technology.	
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3.	RESULTS	
	
	
3.1	Rational	 for	 the	development	of	a	novel	complementation	system	for	human	
NBS1	
	
The	function	of	NBS1	 in	many	aspects	of	the	DDR	has	 largely	remained	discordant.	
Conflicting	 findings	 have	 been	 reported	 regarding	 the	 role	 of	 NBS1	 in	 ATM	
activation,	cell	cycle	checkpoint	regulation	and	DSB	repair	pathways.		Elucidation	of	
many	 important	 aspects	 of	 NBS1	 has	 been	 obfuscated	 due	 to	many	 reasons.	 The	
most	 problematic	 issue	was	 the	 cell	 lines	 that	 have	been	used	 so	 far	 to	 study	 the	
cellular	 function	 of	 NBS1.	 These	 cell	 lines	 were	 derived	 from	 NBS	 patients.	
Approximately	 90%	 of	 NBS	 patients	 are	 homozygous	 for	 the	 657del5	 allele,	 a	
mutation	 that	 causes	 molecular	 scission	 of	 the	 NBS1	 protein.	 NBS	 cells	 express	
partially	functional	NBS1	in	the	form	of	N-terminal	NBS1	fragment	26-kD	(p26)	and	a	
C-terminal	 70-kD	 NBS1	 protein	 (p70)	 (Maser,	 2001).	 To	 use	 these	 cells	 for	 the	
functional	analysis	of	a	 specific	mutation	of	NBS1	would	essentially	mean	 to	 study	
one	 mutation	 in	 the	 genetic	 background	 of	 another	 mutation	 of	 NBS1.	 A	 second	
issue	 is	the	embryonic	 lethality	of	null	mutations	of	NBS1	 in	mammals	(Kang	et	al.,	
2002)	 and	 inviability	 of	 mouse	 Nbs1-null	 mutants	 (Zhu	 et	 al.,	 2001).	 Finally,	 the	
phenotype	of	mouse	models	that	have	been	used	to	study	the	role	of	NBS1	did	not	
closely	 resemble	 the	 phenotype	 of	 NBS	 patients.	 A	 humanized	mouse	model	 that	
expresses	 hNbs1	 657D5	 in	mNbs1-/-	background	 has	 also	 been	 used	 to	 investigate	
the	 functional	 aspects	 of	NBS1,	which	 is	 again	 not	 a	 clean	 system,	 as	NBS1	 is	 the	
least	 conserved	subunit	of	 the	MRN	complex.	Even	 though	 the	 functional	domains	
are	 shared	 across	 the	 species,	 the	 sequences	 of	 mouse	 and	 human	 NBS1	 are	
significantly	 different,	 so	drawing	direct	 parallels	 to	make	educated	 guesses	 about	
the	 role	 of	 functional	 domains	 has	 also	 remained	 a	 challenge.	 	 To	 understand	 the	
physiological	role	of	NBS1	in	the	DDR	and	to	assess	the	contribution	of	the	FHA	and	
BRCT	domains	of	NBS1	 for	 the	overall	 role	of	NBS1	 it	was	 important	 to	generate	a	
‘clean’	genetic	system.	This	is	the	reason	why	we	decided	to	develop	a	siRNA	based	
complementation	 system	 for	 NBS1,	 which	 allowed	 us	 to	 perform	 a	 detailed	
structure/function	analysis	of	the	FHA	and	BRCT	domains	of	NBS1	in	the	DDR.	
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3.1.1.	Generation	of	the	NBS1	complementation	system	
	
In	 order	 to	 study	 the	 physiological	 role	 of	 NBS1	 in	 a	 clean	 genetic	 system,	 we	
developed	 a	 siRNA-based	 cellular	 complementation	 system,	 using	 the	 Flp-In	 T-REx	
system	 from	 Invitrogen	 in	 the	human	osteosarcoma	 cell	 line	U2OS.	 The	 resistance	
against	 a	 siRNA	 targeting	 the	NBS1	mRNA	 (siNBS1	 #1),	was	 introduced	 by	making	
silent	mutations	in	the	NBS1	sequence,	targeted	by	siNBS1	#1.	The	siRNA	resistance	
of	 the	WT-NBS1myc	expression	construct	was	 tested	both	by	DNA	sequencing	and	
western	 blotting.	 To	 test	 the	 siRNA	 resistance	 against	 siNBS1	 #1,	 transient	 co-
transfection	of	HEK-293T	cells	with	an	expression	construct	for	wild	type	NBS1	(WT-
NBS1myc	expression	plasmid	 in	combination)	with	either	with	siNBS1	#1	or	siNBS1	
#2	 was	 performed	 (see	 materials	 and	 methods).	 As	 expected	 WTNBS1-myc	 was	
expressed	in	the	cells	transfected	with	siNBS1	#1	but	not	in	the	cells	with	siNBS1	#2,	
suggesting	 that	 WT-NBS1myc	 was	 resistant	 to	 siNBS1	 #1	 (Figure	 12A).	 Next,	 we	
asked	 if	 expression	 of	 WT-NBS1myc	 upon	 endogenous	 NBS1	 depletion	 had	 any	
influence	 on	 the	 expression	 levels	 of	 the	 other	 components	 of	 the	MRN	 complex,	
MRE11	and	RAD50.		Analyzing	the	expression	levels	of	proteins	by	western	blotting	
revealed	that	expression	of	WTNBS1-myc	had	no	effect	on	the	expression	 levels	of	
the	 other	 subunits	 of	 the	 MRN	 complex	 (Figure	 12B).	 Remarkably,	 it	 was	 also	
observed	 that	 the	 predominantly	 cytoplasmic	 localization	 of	 MRE11,	 which	 is	 a	
consequence	 of	 NBS1	 depletion	 (Mirzoeva	 and	 Petrini,	 2001),	 could	 be	 reversed	
upon	 expression	 of	 WTNBS1-myc,	 as	 revealed	 by	 immunofluorescence	 using	
antibodies	against	MRE11	(Figure	12C).	
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Figure	12.	 siRNA-based	complementation	system	for	NBS1.	 (A)	HEK-293T	cells	were	co-transfected	
with	 indicated	siRNAs	and	WT-NBS1myc	construct.	48	h	after	co-transfections,	 cells	were	 lysed	and	
whole	cell	extracts	were	analyzed	by	immunoblotting	with	the	indicated	antibodies.	(B)	Detection	of	
expression	 levels	of	MRE11,	RAD50	and	NBS1	 in	WT-NBS1myc	 cell	 line	72	h	after	 transfection	with	
siNBS1.	Expression	of	 recombinant	WT-NBS1myc	was	 induced	60	h	after	siNBS1	transfection	by	 the	
addition	of	1	μM	doxycycline	(DOX)	to	the	medium.	(C)	Immunofluorescence	of	the	same	cell	line	as	
in	(A).	Briefly,	U2OS	cell	lines	were	transfected	with	the	indicated	siRNAs	for	48	h	before	seeding	cells	
on	 coverslips,	 followed	 by	 doxycycline	 treatment	 (1μg/ml)	 for	 24	 h.	 Cells	 were	 fixed	 and	
immunostained	 using	 anti-NBS1	 antibodies	 (green)	 and	 anti-MRE11	 antibodies	 (red).	 Nuclei	 were	
stained	with	DAPI	(blue).	
	
	
	
	
	
3.1.2.	Validation	of	the	NBS1	complementation	system	
	
Next,	 as	 a	 part	 of	 the	 characterization	 of	 the	 NBS1	 complementation	 system,	 a	
colony	 formation	 assay	was	 employed	 to	 determine	 if	 expression	 of	WTNBS1-myc	
could	 rescue	 the	 increased	 IR	 sensitivity	 phenotype	 imposed	 by	 knockdown	 of	
endogenous	 NBS1.	 As	 expected,	 WT-NBS1myc	 rescued	 the	 radio	 sensitivity	
phenotype	of	NBS1	depleted	cells,	almost	to	the	control	levels	(Figure	13).		
	
C	
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Figure	 13.	 Expression	 of	 wild	 type	 recombinant	 NBS1	 rescues	 the	 radio-sensitivity	 phenotype	 of	
U2OS	cells	depleted	from	endogenous	NBS1	by	siRNA.	WT-NBS1myc	cell	line	was	transfected	for	72	
h	with	siNBS1	and	expression	of	 recombinant	WT-NBS1myc	was	 induced	by	 the	addition	of	DOX	 to	
the	medium	60	h	after	siNBS1	transfection.	Cell	survival	was	determined	after	12	days	of	irradiation	
with	the	indicated	X-Ray	doses,	by	colony-formation	assay.	Data	are	represented	as	mean	±	SEM	(n	=	
3	biological	replicas)	
	
	
	Another	important	function	of	NBS1	is	the	recruitment	of	MRN	complex	to	the	sites	
of	damage.	 Immunofluorescence	analysis	after	 laser	micro-irradiation	revealed	that	
the	 recruitment	 of	 MRE11	 to	 the	 DNA	 damage	 sites,	 which	 was	 abrogated	 on	
depletion	 of	 NBS1	 from	 the	 cells	 was	 rescued	 upon	 expression	 of	 WT-NBS1myc	
(Figure	14).	
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Figure	14.	Rescue	of	DNA	damage	induced	recruitment	of	the	MRN	complex	to	sites	of	DSBs	upon	
expression	 of	 WT-NBS1myc.	 Control	 and	 WT-NBS1myc	 cell	 lines	 were	 transfected	 for	 72	 h	 with	
siNBS1	 and	 expression	 of	 recombinant	 WT-NBS1myc	 was	 induced	 by	 the	 addition	 of	 DOX	 to	 the	
medium	 60	 h	 after	 siNBS1	 transfection.	 Immunofluorescence	 of	 these	 cells	 after	 laser	 micro-
irradiation	 revealed	 that	WT-NBS1myc	 could	 rescue	 the	 recruitment	 of	MRE11	 to	 the	 sites	 of	DNA	
damage.	
	
	
NBS1	is	phosphorylated	at	S343	by	ATM	in	response	to	DSBs	(Olson	et	al.,	2007)	and	
by	ATR	in	response	to	replication	stress	(Yang	et	al.,	2007).	NBS1	phosphorylation	at	
position	S343	has	been	implicated	in	intra-S	phase	checkpoint	activation	(Lim	et	al.,	
2000).	 To	ensure	 that	WT-NBS1myc	can	 take	over	all	 the	 functions	of	endogenous	
NBS1,	it	was	also	tested	if	the	WTNBS1-myc	is	phosphorylated	at	S343.		Western	blot	
analysis	 of	 the	 protein	 lysates	 from	 cells	 that	 exclusively	 expressed	WT-NBS1myc,	
using	 phospho-specific	 S343	 NBS1	 antibodies,	 revealed	 that	 WT-NBS1myc	 was	
indeed	phosphorylated	at	S343	position	(Figure	15).	To	test	if	the	recombinant	form	
of	 NBS1	 forms	 an	 intact	 MRN	 complex	 with	 RAD50	 and	 NBS1,	 co-
immunoprecipitations	(co-IPs)	for	the	myc-tag	of	WT-NBS1myc	were	performed.	WT-
NBS1myc	efficiently	co-IPd	with	the	other	two	components	of	MRN	complex,	MRE11	
and	RAD50	(Figure	16).		
	
	
	
Figure	 15.	WT-NBS1myc	was	phosphorylated	at	 position	 S343.	Control	and	WT-NBS1myc	cell	 lines	
were	transfected	for	72	h	with	siNBS1	and	expression	of	recombinant	WT-NBS1myc	was	induced	by	
the	addition	of	Doxycycline	 (DOX)	 to	 the	medium	60	h	after	 siNBS1	 transfection.	At	 this	 stage	cells	
were	irradiated	with	10	Gy	of	IR	and	1h	later	cells	were	harvested	and	lysed	with	SDS-lysis	buffer	for	
immunoblot	analysis	with	the	indicated	antibodies.	
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Figure	16.	Recombinant	WT-NBS1myc	is	 incorporated	in	the	MRN	complex.	NBS1-myc	IPs	in	NBS1-
myc	U2OS	Flp-In	T-Rex	cell	lines.	Briefly,	control	or	WT-NBS1myc	cells	were	treated	with	siNBS1	for	48	
h	and	then	induced	with	Doxycycline	for	24	h.	Cells	were	then	lysed	in	NP-40	buffer	and	NBS1myc	was	
immunoprecipitated	 from	 whole	 cell	 extracts	 using	 anti-myc	 antibody.	 The	 IPs	 were	 washed	 and	
analyzed	by	western	blotting	using	the	indicated	antibodies.		
	
When	exposed	to	IR,	mammalian	cells	arrest	in	G2	phase	that	occurs	within	an	hour	
of	exposure	to	ionizing	radiation.	This	arrest	is	transient,	with	cells	entering	mitosis	
after	a	time	that	depends	on	the	dose	of	 IR.	The	G2M	checkpoint	prevents	the	cell	
with	 damaged	 DNA	 from	 entering	 mitosis.	 Activation	 of	 G2M	 checkpoint	 is	
characterized	 by	 a	 rapid	 reduction	 of	 the	 number	 of	mitotic	 cells	 (Beamish	 et	 al.,	
1996;	Xu	et	al.,	2002)	following	treatment	with	IR.	The	activation	of	G2M	checkpoint	
in	cells	is	commonly	measured	by	immunostaining	with	antibodies	against	phospho-
Histone	H3	(P-H3)	that	marks	phosphorylation	of	histone	H3	at	serine	10,	present	in	
condensed	chromosomes	during	mitosis.	The	percentage	of	cells	in	mitosis	(termed	
the	mitotic	index)	was	measured	by	flow	cytometry.	It	was	observed	that	depletion	
of	NBS1	partially	alleviates	the	reduction	of	the	mitotic	index	upon	IR	treatment,	an	
indicator	of	 impaired	G2M	checkpoint	activation.	However,	expression	of	WTNBS1-
myc	 could	 rescue	 the	 defect	 in	 activation	 of	 G2M	 checkpoint	 at	 low	 doses	 of	
irradiation	(Figure	17).	Based	on	all	the	above	results,	we	concluded	that	most	of	the	
phenotypic	consequences	of	lack	of	endogenous	NBS1	are	reverted	by	expression	of	
WT-NBS1myc.	
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Figure	17.	Rescue	of	G2M	checkpoint	 activation	upon	expression	of	WT-NBS1myc.	U2OS	
cells	lines	stably	transfected	with	WT-NBS1myc,	were	treated	with	siNBS1	for	48	h	and	then	
induced	with	DOX	for	24	h.	Cells	were	harvested	1	h	after	0.5	Gy	of	 irradiation,	 fixed	with	
70%	ethanol	and	stained	with	propidium	iodide	(PI)	and	an	antibody	against	phosphorylated	
H3	(P-H3).	The	percentage	of	P-H3	positive	cells	was	determined	by	flow	cytometry.	In	this	
graph,	 three	 independent	 experiments	 are	 summarized.	 The	 bars	 represent	 the	 standard	
error	of	mean.	
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3.1.3.	Generation	and	characterization	of	FHA	and	BRCT	domain	mutant	cell-lines	
of	NBS1	
	
In	order	to	perform	structure/function	analysis	of	the	FHA	and	BRCT	domains	in	the	
N-terminal	region	of	NBS1,	WTNBS1-myc	construct	was	used	as	a	base	construct	to	
introduce	 different	 site-directed	 mutations	 in	 order	 to	 substitute	 two	 amino	 acid	
residues	 that	are	 conserved	 in	 the	FHA	and	BRCT	domains	of	NBS1.	 For	disrupting	
the	 function	of	 the	 FHA	domain,	Arg	at	position	28	was	mutated	 to	Ala	 (R28A)	by	
site-directed	mutagenesis.	The	x-ray	crystal	structure	of	the	Rad53	FHA1	domain	has	
revealed	 that	 this	 arginine	 is	 located	 in	 a	 peptide	 loop	 that	 binds	 phosphorylated	
Rad9	(Durocher	et	al.,	2000;	Durocher	and	Jackson,	2002).	R28A	mutation	in	the	FHA	
domain	 of	 NBS1	 is	 well	 characterized	 and	 has	 been	 used	 in	many	 studies	 for	 the	
disruption	 of	 the	 phospho-binding	 function	 of	 the	 FHA	 domain	 (Cerosaletti	 and	
Concannon,	 2003).	 To	 disrupt	 the	 BRCT	 domain	 of	 NBS1,	 Lys	 at	 position	 160	was	
mutated	to	Met	(K160M)	by	site	directed	mutagenesis.	K160M	mutation	in	the	BRCT	
domain	of	NBS1	is	also	well	characterized	and	it	effects	only	the	phospho-dependent	
interactions	without	impairing	the	solubility	or	structure	of	BRCT	domain	(Chapman	
and	Jackson,	2008;	Hari	et	al.,	2010;	Spycher	et	al.,	2008).	
	
Different	FHA	and	BRCT	domain	mutant	variants	(Figure	18A)	of	NBS1myc	were	then	
used	to	generate	inducible	stable	U2OS	cell	lines,	using	the	same	U2OS	Flp-In	T-REx	
system	 as	 described	 above.	 The	 expression	 of	 the	 doxycycline	 inducible	 NBS1myc	
forms:	WT-NBS1myc,	R28A-NBS1myc	(FHA	mutant),	K160M-NBS1myc	(BRCT	mutant)	
and	 D.M.-NBS1myc	 (combined	 R28A/K160M	 double	 mutant),	 respectively	 was	
tested	 both	 by	 western	 blotting	 (Figure	 18B)	 and	 by	 immunofluorescence	 (Figure	
18C).		
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Figure	 18.	 Expression	of	 FHA/BRCT	domain	mutants	 of	NBS1.	 (A)	Schematic	 representation	of	 the	
primary	structure	of	NBS1.	Location	of	mutations	in	the	FHA	domain	and	BRCT	tandem	domains	are	
indicated.	 (B)	 Control	 or	 NBS1myc	 cells	 were	 treated	with	 siNBS1	 for	 60	 h	 and	 then	 induced	with	
Doxycycline	for	12	h.	Cells	were	then	lysed	in	SDS-lysis	buffer.	50	μg	of	the	protein	extracts	from	the	
indicated	 samples	 were	 analyzed	 by	 western	 blotting	 using	 the	 indicated	 antibodies.	 Note	 that	
induction	of	expression	of	recombinant	myc-tagged	NBS1	by	DOX	leads	to	overexpression	of	NBS1.	(C)	
U2OS	cells	lines	were	seeded	cells	on	coverslips,	followed	by	doxycycline	treatment	(1	μg/ml)	for	24	
h.	Cells	were	fixed	and	immunostained	using	anti-NBS1	antibodies	(green),	anti-myc	antibodies	(red).	
Nuclei	 were	 stained	 with	 DAPI	 (blue).	 Induction	 of	 expression	 of	 recombinant	 myc-tagged	 NBS1,	
without	knock-down	of	endogenous	NBS1	by	DOX	leads	to	overexpression	of	NBS1.	
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Further	the	expression	levels	of	the	individual	MRN	subunits	in	the	stable	NBS1myc	
cell	 lines	 upon	 expression	 of	 R28A-NBS1myc,	 K160M-NBS1myc	 or	 D.M.-NBS1myc	
were	 tested.	 The	 levels	 of	 other	 subunits	 of	 MRN	 complex	 namely	 MRE11	 and	
RAD50,	 essentially	 remained	 unaltered	 as	 measured	 by	 western	 blotting	 (Figure	
19A).	 Next,	 it	 was	 tested	 if	 FHA	 and	 BRCT	 mutant	 forms	 of	 NBS1	 form	 are	
incorporated	 into	 the	MRN	 complex.	 To	 this	 end,	 co-IPs	 of	 the	 different	 FHA	 and	
BRCT	mutants	 forms	of	NBS1	was	performed	 in	 the	stable	cell	 lines	using	anti-myc	
beads	and	it	was	observed	that	R28A-NBS1myc,	K160M-NBS1myc	or	D.M.-NBS1myc,	
efficiently	 interacted	 with	 MRE11	 and	 Rad50	 and	 thus	 are	 incorporated	 into	 the	
MRN	complex	(Figure	19B).	
	
	
	
Figure	19.	(A)	Expression	of	the	recombinant	NBS1	mutant	proteins	does	not	 influence	expression	
of	RAD50	and	MRE11.	NBS1-myc	cell	lines	were	treated	with	siNBS1	for	48	h	and	then	induced	with	
doxycycline	for	24	h.	Cells	were	lysed	in	SDS-lysis	buffer	and	50	μg	of	the	protein	from	the	indicated	
samples	 was	 analyzed	 by	 western	 blotting	 using	 the	 indicated	 antibodies.	 (B)	 Recombinant	 myc-
tagged	NBS1	wild	 type	 and	mutants	 exist	 in	 a	 complex	with	MRE11	 and	RAD50.	NBS1-myc	 IPs	 in	
U2OS:	NBS1-myc	cell	lines.	Cells	were	treated	with	siNBS1	for	48	h	and	then	induced	with	doxycycline	
for	24	h.	After	harvesting,	 cells	were	 lysed	 in	NP-40	buffer	and	NBS1-myc	was	 immunoprecipitated	
from	 whole	 cell	 extracts	 using	 anti-myc	 antibody	 beads.	 The	 immunoprecipitated	 proteins	 were	
washed	and	analyzed	by	western	blotting	using	the	indicated	antibodies.	
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3.1.4.	 FHA	 and	 BRCT	 domain	 mutant	 forms	 of	 NBS1	 are	 defective	 for	
phosphorylation	at	S343	
	
As	 mentioned	 before,	 NBS1	 phosphorylation	 at	 S343	 in	 response	 to	 DSBs	 and	
replication	stress	is	important	for	the	function	of	NBS1	in	DNA	damage	signaling	and	
in	intra-S	phase	checkpoint	control	(Buscemi	et	al.,	2001).	To	test	a	potential	role	of	
FHA	 and	 BRCT	 domains	 on	 phosphorylation	 of	 NBS1	 at	 S343,	 the	 FHA	 and	 BRCT	
mutant	 forms	of	NBS1-myc	were	expressed	 in	 the	cell	 lines	and	endogenous	NBS1	
was	 down	 regulated	 at	 the	 same	 time.	 These	 cell	 lines	 were	 exposed	 to	 IR	 and	
western	 blot	 analysis	 with	 phospho-specific	 S343	 NBS1	 antibodies	 revealed	 that	
NBS1	S343	phosphorylation	was	partially	impaired	in	FHA	(R28A)	and	BRCT	(K160M)	
mutants,	while	the	FHA/BRCT	(D.M.)	mutant	of	NBS1	was	completely	defective	in	the	
phosphorylation	of	the	S343	residue	(Figure	20).	This	is	in	complete	agreement	with	
the	previous	studies	that	have	implicated	FHA	and	BRCT	domains	in	phosphorylation	
of	NBS1	 on	 S343	 (Zhao	 et	 al.,	 2002).	 Remarkably,	we	 also	 observed	 that	 FHA	 and	
BRCT	mutants	were	partially	defective,	while	 the	D.M.	was	completely	defective	 in	
the	in	the	phosphorylation	of	S343	residue	of	NBS1.	
	
																																																
	
Figure	20.	Defective	NSB1	S343	phosphorylation	in	FHA	and	BRCT	mutants.	NBS1myc	stable	cell	lines	
were	transfected	with	siNBS1	for	60	h,	after	which	they	were	induced	with	1	μM	DOX	for	12	h.	Cells	
were	then	exposed	to	10	Gy	of	IR,	recovered	for	1	h	and	then	lysed	in	SDS-Lysed	buffer.	50	μg	of	the	
protein	from	the	indicated	samples	was	analyzed	by	western	blotting	using	the	indicated	antibodies.	
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3.1.5.			The	NBS1	combined	FHA/BRCT	(D.M.)	mutant	is	hypersensitive	to	IR	
	
The	 very	 first	 studies	 that	 investigated	 the	 role	 of	 FHA	 and	 BRCT	 domains	 in	 cell	
survival	reported	that	the	BRCT	domain	of	NBS1	and	not	the	FHA	domain	of	NB1	has	
a	function	 in	cell	survival	after	 IR	(Zhao	et	al.,	2002).	To	 investigate	the	function	of	
these	domains	of	NBS1	in	cell	survival	upon	IR	treatment	in	a	clean	genetic	system,	
we	performed	clonogenic	survival	assays	in	our	U2OS	cell	lines.	By	measuring	colony	
formation	2	weeks	after	exposure	of	 cells	 to	a	 sub-lethal	 IR	dose,	a	 comparison	of	
the	 different	 mutants	 in	 terms	 of	 survival	 after	 IR	 was	 performed.	 This	 analysis	
revealed	that	the	 individual	FHA	and	BRCT	domain	mutants	had	 little	effect	on	cell	
survival	 after	 IR.	 However	 the	 combined	 FHA	 and	 BRCT	 mutant	 (D.M.-NBS1)	
expressing	cells	were	as	radiosensitive	as	the	NBS1	depleted	cells.		
	
	
	
	
	
Figure	 21.	 Combined	 FHA/BRCT	 domain	 mutant	 is	 radiosensitive.	 U2OS-NBS1myc	 cell	 lines	 were	
transfected	 for	 72	 h	with	 siNBS1	 and	 expression	 of	 recombinant	WT-NBS1myc	was	 induced	by	 the	
addition	of	DOX	60	h	after	siNBS1	transfection.	Cell	survival	was	determined	2	days	after	 irradiation	
with	 the	 IR	 doses,	 by	 the	 colony-formation	 assay.	 Plotted	 values	 represent	 average	 of	 3	 biological	
replicas.		
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3.2. Investigation	of	role	of	NBS1	in	DNA	end	resection	
	
The	very	first	hints	regarding	the	function	of	NBS1	in	DNA	end	resection	came	from	
studies	that	implicated	NBS1	in	DNA	repair	by	HR	(Jazayeri	et	al.,	2006;	Tauchi	et	al.,	
2002).	 In	 fission	 yeast	 the	 FHA	domain	of	Nbs1	 interacts	with	Ctp1,	 via	 the	motifs	
that	 are	 constitutively	 phosphorylated	 by	 CK2	 (Lloyd	 et	 al.,	 2009;	Williams	 et	 al.,	
2009).	 In	 mammalian	 cells,	 a	 recent	 study	 reported	 a	 similar	 mechanism,	 where	
NBS1	acts	as	a	mediator	of	CtIP	phosphorylation	at	T859	by	ATM.	However,	contrary	
to	 previous	 reports	 this	 study	 suggested	 that	 FHA	 and	 BRCT	 domains	 of	 NBS1	
interact	with	phosphorylated	CDK	sites	in	CtIP.	
		
Recent	work	has	also	suggested	that	NBS1’s	role	in	DNA	end	resection	is	controlled	
by	 CDK	 activity.	 NBS1	 S432	 is	 phosphorylated	 by	 CDK	 in	 a	 cell	 cycle	 dependent	
manner	 and	mutating	 this	 site	 in	NBS1	disrupted	 the	 formation	of	 IR-induced	RPA	
foci	 and	 the	 generation	 of	 ssDNA	 at	 sites	 of	 DSBs	 (Falck	 et	 al.,	 2012).	 In	 contrast,	
another	 study	 also	 found	 that	 S432	 in	 NBS1	 is	 phosphorylated	 in	 a	 cell	 cycle	
dependent	manner,	but	did	not	observe	defective	resection	in	the	absence	of	NBS1	
S432	phosphorylation	(Wohlbold	et	al.,	2012).	The	role	played	by	NBS1	in	DNA	end	
resection	is	thus	not	clear	yet	and	needs	to	be	studied	in	a	clean	genetic	system.	
	
3.2.1. NBS1	plays	an	important	role	in	DNA	end	resection	
	
To	 investigate	 in	 detail	 the	 role	 of	 NBS1	 in	 DNA	 end	 resection;	 U2OS,	 HEK-293T,	
MRC5	and	HeLa	cells	were	depleted	of	NBS1,	by	siNBS1	treatment	and	then	exposed	
to	 irradiation.	 An	 hour	 after	 irradiation,	 cells	 were	 harvested	 and	 analyzed	 by	
Western	 blotting	 for	 signs	 of	 defective	 DNA	 end	 resection.	 In	 particular,	
phosphorylation	of	RPA	at	S4/S8	that	is	generally	regarded	as	a	surrogate	marker	for	
the	generation	of	ssDNA	at	sites	of	DSBs	(Sartori	et	al.,	2007)	was	analyzed	(Figure	
22).	 Remarkably,	 knockdown	 of	 NBS1	 by	 siRNA	 strongly	 compromised	 RPA2	
phosphorylation	in	response	to	IR,	and	this	was	evident	in	all	the	cell	lines	that	were	
tested.	At	the	same	time,	cyclin	A	expression	levels	remained	unchanged	thus	ruling	
out	a	cell	cycle	distribution	effect	of	the	RPA2	S4/S8	phosphorylation.	
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											Figure	22.	Defective	phosphorylation	of	RPA	at	S4/S8	upon	NBS1	depletion.	U2OS,	MRC5	and	HeLa	
cells	 were	 transfected	 with	 indicated	 siRNAs	 and	 72	 h	 later,	 cells	 were	 treated	 with	 5	 Gy	 of	 IR,	
recovered	 for	 1	h	 and	 then	 lysed	 in	 SDS-lysis	 buffer.	 50	μg	of	 the	protein	 extracts	 of	 the	 indicated	
samples	was	then	analyzed	by	western	blotting	using	the	indicated	antibodies.		
	
	
	
Next,	DSB-induced	RPA	foci	formation	was	investigated	by	immunofluorescence.	For	
this,	 cells	 were	 grown	 on	 coverslips	 and	 irradiated	 with	 5	 Gy	 of	 IR.	 A	 mild	 pre-
extraction	protocol	was	applied	to	increase	the	signal/noise	ratio.	For	quantification,	
random	fields	were	recorded	and	the	number	of	 foci	per	cell	was	determined	with	
the	 help	 of	 a	 self-written	 ImageJ	macro	 (see	Materials	&	Methods	 for	 detail).	 The	
distribution	of	number	of	RPA	foci	per	cell	was	calculated	and	blotted	with	R	Studio	
(ggplot2	 library).	 As	 with	 CtIP	 depletion,	 NBS1	 depletion	 strongly	 impaired	 DNA	
damage	 induced	 RPA	 foci	 formation	 (Figure	 23).	 Cyclin	 A	 staining	 was	 used	 as	 a	
marker	 for	 S	 and	 G2	 phase	 cells	 and	 it	 was	 observed	 that	 RPA	 foci	 were	 mostly	
formed	in	cells	staining	positive	for	cyclin	A.	Thus,	in	the	quantitative	image	analysis	
(Figure	23B),	only	cyclin	A	positive	cells	were	included.		
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Figure	 23.	 Loss	 of	 RPA	 foci	 in	NBS1	 depleted	 cells.	 (A)	U2OS	cells	 lines	were	 transfected	with	 the	
indicated	 siRNAs	 for	 48	 h	 and	 seeded	 on	 coverslips.	 24	 h	 later,	 cells	 were	 exposed	 to	 5	 Gy	 of	 IR,	
recovered	 for	 3	 h,	 fixed	 and	 immunostained	 using	 anti-RPA32	 antibodies	 (red)	 and	 anti-cyclin	 A	
antibodies	 (green);	 nuclei	 were	 stained	 with	 DAPI	 (blue).	 (B)	 Quantification	 of	 RPA	 foci	 in	 NBS1-
depleted	 cells.	 At	 least	 100	 cells	 per	 condition	 were	 analyzed	 by	 semi-automated	 image	 analysis	
(ImageJ	macro).	Only	cyclin	A	positive	cells	were	scored	for	RPA	foci	counting.	Box	plots	represent	the	
inter-quartile	 range	 (IQR)	 of	 the	 data	 (box),	 from	 the	 25th	 percentile	 to	 the	 75th	 percentile.	 The	
whiskers	extend	over	1.5	times	the	IQR	in	both	directions.	Black	bar	indicates	the	median	and	white	
diamonds	indicates	the	mean	of	the	distributions.	Outliers	are	depicted	by	black	dots	(2	independent	
experiments,	1	representative	experiment	shown).	
	
	
	
Next,	RPA2	phosphorylation	in	response	to	IR	was	investigated	by	immunostaining	of	
cells	 with	 anti-pRPA2	 S4/S8	 antibodies.	 As	 pointed	 out	 above,	 RPA2	 S4/S8	
phosphorylation	 serves	 as	 a	 marker	 for	 ssDNA	 generation	 at	 sites	 of	 DSBs.	 	 As	
observed	with	RPA	foci,	pRPA2	S4/S8	foci	formation	was	also	significantly	reduced	in	
NBS1	depleted	cells	(Figure	24A).		Quantification	of	the	pRPA	pS4/S8	foci	was	done	
as	 described	 for	 RPA	 foci	 and	 the	 results	 revealed	 a	 very	 similar	 result:	 NBS1	
depleted	 cells	 were	 almost	 as	 defective	 for	 RPA	 pS4/S8	 foci	 formation	 as	 CtIP-
depleted	cells.	RPA	and	pRPA	foci	formation	are	indirect	markers	for	the	generation	
of	 ssDNA	 at	 sites	 of	 IR-induced	 DSBs,	 as	 both	 signals	 indicate	 RPA	 binding	 to	
stretches	of	ssDNA	and	do	not	detect	ssDNA	per	se.	The	ssDNA	overhangs	generated	
by	resection	can	be	visualized	by	incubating	cells	with	the	nucleotide	analogue	BrdU,	
which	 is	 incorporated	 into	 the	 DNA	 during	 normal	 DNA	 replication.	
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Immunofluorescence	 staining	 with	 a	 BrdU	 antibody	 under	 neutral	 conditions	
selectively	recognizes	BrdU	incorporated	in	DNA	only	when	the	DNA	is	in	the	single-
stranded	 form.	 Scoring	 ssDNA	 generation	 after	 IR	 treatment	 by	 a	 BrdU	 antibody	
again	yielded	very	similar	results	as	RPA	and	pRPA	staining:	namely	defective	ssDNA	
generation	at	sites	of	DSBs	in	NBS1	depleted	cells	very	similar	to	CtIP	depleted	cells	
(Figure	24B	and	D).	Taken	together,	by	employing	three	different	resection	markers	
in	quantitative	immunofluorescence	analysis	it	was	revealed	that	NBS1	plays	a	very	
important	 role	 in	DNA	end	 resection	 and	 that	 its	 depletion	by	 siRNA	 resulted	 in	 a	
resection	phenotype	that	was	almost	as	strong	as	the	one	caused	by	CtIP	depletion.	
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Figure	24.	(A)	Loss	of	pRPA	foci	in	NBS1	depleted	cells.	U2OS	cells	lines	were	transfected	with	the	indicated	
siRNAs	for	48	h	and	seeded	on	coverslips.	24	h	later,	cells	were	exposed	to	5	Gy	of	IR,	recovered	for	3	h,	
fixed	and	 immunostained	using	anti-pRPA	 (S4/S8)	antibodies	 (red);	nuclei	were	 stained	with	DAPI	 (blue).	
(B)	Loss	of	BrdU	foci	in	NBS1	depleted	cells.	U2OS	cells	lines	were	transfected	with	the	indicated	siRNAs	for	
48	h	and	seeded	on	coverslips,	followed	by	addition	of	BrdU	(10	µg/ml).	24	h	later,	cells	were	exposed	to	5	
Gy	of	IR,	recovered	for	3	h,	fixed	and	immunostained	with	anti-BrdU	antibodies	(red);	nuclei	were	stained	
with	DAPI	(blue).	(C)	Quantification	of	the	number	of	pRPA	foci	per	cell	in	NBS1-depleted	cells.	At	least	100	
cells	per	condition	were	scored	by	semi-automated	image	analysis	(ImageJ	macro).	Box	plots	represent	the	
inter-quartile	 range	 (IQR)	of	 the	data	 (box),	 from	 the	25th	percentile	 to	 the	75th	percentile.	The	whiskers	
extend	over	1.5	times	the	IQR	in	both	directions.	Black	bars	indicate	medians	and	white	diamonds	means	of	
the	distributions.	Outliers	are	depicted	by	black	dots.		(D)	Quantification	of	BrdU	foci	in	NBS1-depleted	cells	
as	in	B	(2	independent	experiments,	1	representative	experiment	shown).	
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3.2.2.		Role	of	FHA	and	BRCT	domains	of	NBS1	in	DSB	resection	
	
Based	on	the	observation	that	NBS1	depletion	leads	to	a	strong	resection	defect	(see	
above),	we	next	 asked	 if	 the	 FHA	and	BRCT	domains	of	NBS1	would	 contribute	 to	
NBS1’s	role	in	DNA	end	resection.	These	two	domains	control	localization	of	NBS1	in	
the	cell	and	connect	 it	 to	other	proteins	such	as	MDC1	and	TCOF1/Treacle	(Hari	et	
al.,	2010;	Larsen	et	al.,	2014).	Moreover,	it	was	recently	suggested	that	mutations	in	
the	FHA/BRCT	region	of	NBS1	lead	to	a	strong	HR	defect	(Wang	et	al.	2013).	In	a	first	
step	 it	 was	 important	 to	 know	 if	 expression	 of	 recombinant	 wild	 type	 NBS1	 can	
rescue	 the	 defect	 in	 DNA	 end	 resection	 observed	 upon	 depletion	 of	 endogenous	
NBS1	 by	 RNAi.	 Since	 a	 functioning	 complementation	 system	 for	NBS1	 had	 already	
been	generated	 (see	Section	1),	RPA,	pRPA	and	BrdU	 foci	 formation	was	 tested	by	
immunofluorescence	analysis	after	IR	treatment	in	NBS1-depleted	cells	in	which	the	
expression	 of	 recombinant	WT-NBS1myc	was	 induced	 by	 doxycyclin.	WT-NBS1myc	
could	rescue	the	ssDNA	generation	defect	imposed	by	depletion	of	NBS1,	thus	ruling	
out	the	possibility	that	the	defect	in	resection	observed	in	NBS1	depleted	cells	is	an	
artifact	 resulting	 from	 off-target	 effects	 of	 the	 siRNA	 used.	 Moreover,	 this	
observation	also	supported	our	notion	that	NBS1	has	a	very	specific	role	in	DSB	end	
resection.		
Next,	 we	 sought	 to	 investigate	 the	 contribution	 of	 the	 FHA	 and	 BRCT	 domains	 of	
NBS1	 in	 DNA	 end	 resection.	 For	 this,	 RPA	 foci	 and	 pRPA	 foci	 were	 assessed	 after	
irradiation,	in	NBS1-depleted	stable	cell	lines	that	inducibly	expressed	WT-NBS1myc,	
R28A-NBS1myc	 (FHA	mutant),	 K160M-NBS1myc	 (BRCT	mutant)	 and	D.M.-NBS1myc	
(combined	 R28A/K160M	 double	 mutant),	 respectively.	 In	 a	 similar	 manner,	 the	
contribution	 of	 the	 FHA	 and	 BRCT	 domains	 of	 NBS1	 in	 DNA	 end	 resection	 was	
analyzed	 by	 scoring	 ssDNA	 generation	 directly	 via	 BrdU	 staining.	 Remarkably,	 all	
three	different	 resection	based	markers	 -	 RPA,	 pRPA	 and	BrdU	 revealed	 that	 both	
the	 FHA	and	BRCT	domains	 of	NBS1	 contribute	 in	 an	 additive	manner	 to	DSB	 end	
resection	(Figure	25,	Figure	26,	Figure	27).	The	single	FHA	and	BRCT	domain	mutants	
R28A-NBS1myc	and	K160M-NBS1myc	were	partially	defective	in	resection,	while	the	
combined	FHA/BRCT	domain	mutant	(D.M.-NBS1myc)	exhibited	a	very	strong,	robust	
defect	in	the	generation	of	ssDNA	at	sites	of	DSBs.	In	all	the	assays	it	also	emerged	
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that	the	BRCT	domain	mutant	(K160M)	was	more	defective	in	resection	than	the	FHA	
domain	mutant	 (R28A).	 The	 combined	 FHA/BRCT	 domain	mutant	 (D.M.-NBS1myc)	
did	not	rescue	the	resection	phenotype	at	all,	suggesting	that	the	function	of	NBS1	in	
DNA	end	resection	is	dependent	on	its	N-terminal	phospho-interaction	modules.		
	
	
	
Figure	25.	Role	of	FHA	and	BRCT	domains	of	NBS1	in	RPA	foci	formation.	(A)	U2OS	Flp-In	T-REx	cell	
lines	were	transfected	with	the	indicated	siRNAs	for	48	h	before	seeding	cells	on	coverslips,	followed	
by	 doxycycline	 treatment	 (1	µg/ml)	 for	 24	 h	 to	 induce	 FHA	 and	BRCT	mutant	 forms	 of	NBS1.	 Cells	
were	 then	 exposed	 to	 5	 Gy	 of	 IR,	 fixed	 and	 immunostained	 for	 RPA	 (red)	 and	 cyclin	 A	 antibody	
(green);	nuclei	were	stained	with	DAPI	(blue).	Same	cells	as	in	(A)	were	 lysed	in	SDS-Lysis	buffer	and	
equal	amounts	of	protein	lysates	from	the	indicated	samples	was	then	analyzed	by	western	blotting	
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using	indicated	antibodies.	(B)	Quantification	of	RPA	foci	in	U2OS	Flp-In	T-REx	cells.	At	least	100	cells	
per	condition	were	analyzed	by	semi-automated	image	analysis	(ImageJ	macro).	Only	cyclin	A	positive	
cells	were	considered	for	RPA	foci	counting.	Box	plots	represent	the	inter-quartile	range	(IQR)	of	the	
data	(box),	from	the	25th	percentile	to	the	75th	percentile.	The	whiskers	extend	over	1.5	times	the	IQR	
in	 both	 directions.	 Black	 bar	 indicates	 the	 median	 and	 white	 diamonds	 the	 mean	 of	 the	 data	
distributions.	 Outliers	 are	 indicated	 by	 black	 dots.	 (2	 independent	 experiments,	 1	 representative	
experiment	shown).	
	
	
	
Figure	26.	Role	of	FHA	and	BRCT	domains	of	NBS1	in	pRPA	foci	formation.	(A)	U2OS	Flp-In	T-REx	cell	
lines	were	transfected	with	the	indicated	siRNAs	for	48	h	before	seeding	cells	on	coverslips,	followed	
by	doxycycline	treatment	(1	µg/ml)	for	24	h	to	induce	expression	of	FHA	and	BRCT	mutant	forms	of	
NBS1.	Cells	were	then	exposed	to	5	Gy	of	IR,	fixed,	pre-extracted	and	immunostained	for	pRPA	S4/S8	
(red);	nuclei	were	stained	with	DAPI	(blue).	(B)	Quantification	of	pRPA	foci	in	U2OS	Flp-In	T-REx	cells.	
CtIP	depleted	cells	served	as	a	positive	control.	At	least	100	cells	per	condition	were	analyzed	by	semi-
automated	 image	analysis	 (ImageJ	macro).	Box	plots	 represent	 the	 inter-quartile	 range	 (IQR)	of	 the	
data	(box),	from	the	25th	percentile	to	the	75th	percentile.	The	whiskers	extend	over	1.5	times	the	IQR	
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in	both	directions.	Black	bar	 indicates	the	median	and	white	diamond	the	mean	of	 the	distribution.	
Outliers	 are	 indicated	 by	 black	 dots	 (2	 independent	 experiments,	 1	 representative	 experiment	
shown).	
	
	
	
	
	
Figure	27.	Role	of	FHA	and	BRCT	domains	of	NBS1	in	BrdU	foci	formation.	(A)	U2OS	Flp-In	T-REx	cell	
lines	were	transfected	with	indicated	siRNAs	for	48	h	before	seeding	cells	on	coverslips,	followed	by	
addition	 of	 BrdU	 (10	µg/ml)	 and	 doxycycline	 (1	µg/ml)	 for	 24	 h	 to	 label	 the	 DNA	 and	 induce	 the	
expression	 of	 FHA	 and	 BRCT	 mutant	 forms	 of	 NBS1.	 Cells	 were	 then	 exposed	 to	 5	 Gy	 of	 IR	 pre-
extracted	and	immunostained	for	BrdU	(red);	nuclei	were	stained	with	DAPI	(blue).	(B)	Quantification	
of	 BrdU	 foci	 in	 U2OS	 Flp-In	 T-REx	 cells.	 At	 least	 100	 cells	 per	 condition	 were	 analyzed	 by	 semi-
automated	 image	analysis	 (ImageJ	macro).	Box	plots	 represent	 the	 inter-quartile	 range	 (IQR)	of	 the	
data	(box),	from	the	25th	percentile	to	the	75th	percentile.	The	whiskers	extend	over	1.5	times	the	IQR	
in	both	directions.	Black	bars	indicate	the	median	and	white	diamonds	the	mean	of	the	distribution.	
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Outliers	 are	 indicated	 by	 black	 dots	 (2	 independent	 experiments,	 1	 representative	 experiment	
shown).	
	
	
As	an	alternative	means	to	quantitatively	assess	the	generation	of	ssDNA	at	sites	of	
DSBs,	a	flow	cytometry-based	method	analogous	to	the	one	described	in	(Forment	et	
al.,	 2012)	 was	 adopted.	 The	 flow	 cytometry	 based	 quantification	 of	 ssDNA	
generation	 at	 sites	 of	 DNA	 damage	worked	 efficiently	 when	 CPT	was	 used	 as	 the	
DNA	damage	 agent;	 however,	 this	 assay	worked	with	 a	 limited	 efficiency	when	 IR	
was	used	as	source	of	DNA	damage	(Figure	28).	
	
		 	
	
Figure	28.	 Flow	 cytometry	 analyses	of	RPA	 levels	 in	U2OS	 cells	 upon	 treatment	with	CPT	and	 IR.	
Briefly,	U2OS	cells	were	either	treated	with	1	µM	CPT	or	with	10	Gy	IR.	After	2	h	of	exposure	to	DNA	
damage	 agents,	 cells	 were	 fixed,	 pre-extracted,	 permeabilized	 and	 then	 stained	 for	 RPA.	 It	 was	
observed	 that	 CPT	 treatment	 induced	much	 higher	 RPA	 levels	 when	 compared	 to	 IR	 treatment	 (2	
independent	experiments,	1	representative	experiment	shown).	
	
	
Despite	this	 low	efficiency	we	employed	the	cytometry-based	assay	to	confirm	our	
findings	of	the	role	of	FHA	and	BRCT	domains	of	NBS1	 in	DNA	end	resection	by	an	
alternative	 assay.	 EdU	 staining	 was	 used	 to	 gate	 for	 S	 phase	 cells	 and	 then	 RPA	
fluorescence	 quantification	 was	 done	 in	 the	 cells	 staining	 positive	 for	 EdU.	
Remarkably,	 as	 with	 immunofluorescence	 based	 foci	 formation	 assays,	 the	 single	
FHA	(R28A)	and	BRCT	(K160M)	domain	mutants	of	NBS1	were	partially	defective	for	
DNA	 end	 resection.	 In	 addition,	 the	 double	 FHA	 and	 BRCT	 domain	mutant	 (D.M.)	
	 														RESULTS	
	 72	
exhibited	 a	 very	 strong,	 robust	 RPA	 staining	 defect	 (Figure	 29).	 In	 summary,	 the	
combined	fluorescence	microscopy	and	flow	cytometry	based	analysis	revealed	that	
the	FHA	and	BRCT	domains	of	NBS1	are	indispensible	for	DNA	end	resection	and	that	
they	contribute	in	additive	manner	to	the	overall	role	of	NBS1	in	DNA	end	resection.		
	
	
	
	
	
Figure	29.	Flow	cytometry	analyses	of	RPA	and	EdU	florescence	intensity	in	U2OS	Flp-In	T-REx	cell	
lines.	Briefly,	U2OS	Flp-In	T-REx	cell	lines	were	transfected	with	siRNA	for	48	h	before	inducing	them	
by	addition	of	doxycycline		(1	µg/ml)	for	expression	of	the	indicated	FHA	and	BRCT	mutant	forms	of	
NBS1.	Cells	were	then	pulse-labeled	with	10	µM	EdU	for	30	min	before	treating	them	with	10	Gy	of	IR.	
After	 2	 h	 cells	 were	 fixed,	 permeabilized	 and	 then	 stained	 with	 RPA	 antibodies.	 EdU	 detection	
reaction	 was	 carried	 out	 at	 this	 point,	 followed	 by	 DAPI	 staining.	 The	 red	 square	marks	 the	 gate,	
counting	 the	 percentage	 of	 RPA	 positive	 cells.	 (2	 independent	 experiments,	 1	 representative	
experiment	shown).	
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3.2.3.	Mechanistic	explanation	of	defective	DNA	end	resection	phenotype	 in	FHA	
and	BRCT	mutants	of	NBS1	
To	 understand	 the	 mechanism	 of	 defective	 end	 resection	 in	 NBS1	 mutants,	 we	
tested	a	couple	of	possibilities,	which	have	been	described	in	detail	in	the	following	
sections.	
	
3.2.3.1	Normal	nuclear	localization	of	MRN	complex	in	FHA	and	BRCT	mutants	
	
Since	it	was	shown	that	NBS1	is	crucial	for	both	nuclear	localization	and	formation	of	
IR-induced	 foci	 (IRIF)	 of	 RAD50	 and	MRE11	 (Zhao	 et	 al.,	 2002),	we	 considered	 the	
possibility	 that	 the	defect	 in	 resection	observed	upon	expression	of	NBS1	mutants	
might	be	an	indirect	effect,	caused	by	either	cytoplasmic	localization	of	MRE11	and	
RAD50	or	by	defective	IRIF	formation	of	MRE11	and	RAD50	at	sites	of	DSBs.	To	rule	
out	 the	 first	 possibility	 we	 examined	 the	 nuclear	 localization	 of	 MRE11	 in	 the	
NBS1myc	 Flp-In	 T-REx	 cell	 lines.	 	 We	 observed	 that	 depletion	 of	 NBS1	 by	 siRNA	
indeed	 resulted	 in	 predominantly	 cytoplasmic	 localization	 of	MRE11	 (Figure	 30A).	
However,	expression	of	a	combined	FHA/BRCT	domain	mutant	form	of	NBS1	(D.M.)	
fully	 restored	 the	 localization	 of	 MRE11	 to	 the	 nucleus.	 These	 results	 thus	
demonstrate	 that	 the	 resection	defects	of	FHA	and	BRCT	domain	mutants	of	NBS1	
are	not	caused	by	an	inability	to	bring	about	MRE11	nuclear	localization.	
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Figure	 30.	Normal	 nuclear	 localization	 of	MRE11	 upon	 expression	 of	 D.M.-NBS1myc.	 (A)	 Control,	
WT-NBS1myc	cell	 line	and	D.M.-NBS1myc	cell	 lines	were	transfected	with	siNBS1	for	60	h.	and	then	
the	 expression	 of	 indicated	 recombinant	 NBS1myc	 was	 induced	 by	 the	 addition	 of	 doxycycline	 (1	
µg/ml)	to	the	medium	for	12	h.	Immunofluorescence	of	these	cells	revealed	that	cytosolic	localization	
of	 MRE11	 in	 the	 absence	 of	 NBS1,	 could	 be	 rescued	 even	 on	 expression	 of	 recombinant	 D.M.	
NBS1myc.	(B)	Same	cells	as	in	(A)	were	lysed	in	SDS-Lysis	buffer	and	equal	amounts	of	protein	lysates	
from	 the	 indicated	 samples	 was	 then	 analyzed	 by	 western	 blotting	 using	 indicated	 antibodies	 (2	
independent	experiments,	1	representative	experiment	shown).	
	
	
3.2.3.2.			NBS1	functions	in	DNA	end	resection	independently	of	MDC1	
As	 a	 second	 possibility	 we	 reckoned	 that	 the	 resection	 defect	 of	 FHA	 and	 BRCT	
domain	 mutants	 of	 NBS1	 might	 be	 caused	 by	 the	 defect	 in	 MRN	 IRIF	 formation	
observed	with	 these	mutants	 (Zhao	et	al.,	2002).	The	MRN	complex	 is	 recruited	 to	
sites	of	DSBs	in	an	MDC1-independent	manner,	but	its	sustained	interaction	with	the	
DSB-flanking	chromatin	requires	the	interaction	of	FHA/BRCT	domains	of	NBS1	with	
MDC1	 (Chapman	 and	 Jackson,	 2008;	 Lukas	 et	 al.,	 2004a;	 Melander	 et	 al.,	 2008;	
Spycher	 et	 al.,	 2008;	 2008)	 Thus,	 we	 considered	 the	 possibility	 that	 may	 be	 the	
sustained	 interaction	 of	 NBS1	 with	 damaged	 chromatin	 is	 required	 for	 DNA	 end	
resection.	 Should	 this	 be	 the	 case	 we	 would	 expect	 to	 see	 an	 equally	 strong	
resection	 defect	 in	MDC1	 depleted	 cells	 as	 we	 see	 in	 NBS1	 and/or	 CtIP	 depleted	
cells.	However,	quantitative	analysis	of	RPA	and	pRPA	 foci	 formation	revealed	 that	
DNA	end	resection	 is	normal	 in	MDC1	depleted	cells	 (Figure	31).	This	also	suggests	
that	 the	 role	 of	 NBS1	 in	 DNA	 end	 resection	 is	 actuated	 by	 a	 different	mechanism	
when	compared	to	accumulation	in	IRIF	at	sites	of	DSBs	and	although	this	function	of	
NBS1	relies	on	the	FHA	and	BRCT	domains;	 it	 is	not	dependent	on	the	presence	of	
MDC1	and	on	the	phenomenon	of	MRN	IRIF	formation.	
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Figure	 31.	 NBS1’s	 role	 in	 DNA	 end	 resection	 is	 independent	 of	 MDC1.	 (A)	 No	 effect	 of	 MDC1	
depletion	on	RPA	and	pRPA	foci	formation.	U2OS	cells	were	transfected	with	the	indicated	siRNAs	for	
48	h	and	then	seeded	on	coverslips.	24	h	 later,	cells	were	exposed	to	5	Gy	of	 IR,	recovered	for	3	h,	
fixed	and	stained	with	anti-RPA	(red)	and	anti-pRPA	S4/S8	antibody	(green);	nuclei	were	stained	with	
DAPI	 (blue).	 (B)	 Normal	 phosphorylation	 of	 RPA	 at	 S4/S8	 upon	MDC1	 depletion.	 U2OS	 cells	 were	
transfected	with	indicated	siRNAs	and	72	h	later,	cells	were	treated	with	5	Gy	of	IR,	recovered	for	1hr	
and	then	lysed	in	SDS-Lysed	buffer.	50	μg	of	the	protein	from	the	indicated	samples	was	analyzed	by	
western	blotting	using	the	indicated	antibodies.	 (C)	Quantification	of	RPA	foci	in	U2OS	cells.	At	least	
100	control	siRNA	or	siMDC1	treated	cells	were	analyzed	by	semi-automated	image	analysis	(ImageJ	
macro).	Box	plots	represent	the	inter-quartile	range	(IQR)	of	the	data	(box),	from	the	25th	percentile	
to	 the	 75th	 percentile.	 The	 whiskers	 extend	 over	 1.5	 times	 the	 IQR	 in	 both	 directions.	 Black	 bar	
indicates	 the	 median	 and	 white	 diamonds	 indicate	 the	 mean	 of	 the	 distributions.	 Outliers	 are	
indicated	by	black	dots	(2	independent	experiments,	1	representative	experiment	shown).	
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3.2.3.3.	Rad17	is	not	involved	in	DNA	end	resection	
A	 recent	 study	 suggested	 that	 the	 checkpoint	 factor	 Rad17	 may	 facilitate	 MRN	
recruitment	via	the	FHA/BRCT	domains	of	NBS1	in	the	proximity	of	DSBs	at	an	early	
time	points	after	DNA	damage	infliction,	which	would	impact	DNA	end	resection	and	
HR	 (Wang	 et	 al.,	 2014b).	 If	 that	 was	 indeed	 the	 case	 we	 would	 expect	 to	 see	 a	
resection	defect	in	Rad17	depleted	cells	similar	to	the	one	observed	upon	expression	
of	 FHA	and	BRCT	mutant	 forms	of	NBS1.	 To	 test	 the	effect	of	Rad17	depletion	on	
DNA	 end	 resection,	 we	 first	 analyzed	 RPA2	 phosphorylation	 at	 S4/S8	
phosphorylation	in	a	western	blot	analysis,	which	revealed	that	there	was	no	effect	
of	Rad17	depletion	on	RPA2	phosphorylation	(Figure	32).	A	quantitative	analysis	of	
BrdU	and	RPA	foci	upon	IR	treatment	was	also	performed	in	cells	depleted	of	Rad17	
and	it	revealed	no	DNA	end	resection	defect	(Figure	33).	
		
	
	
	
	
	
	
													
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 32.	 Normal	 phosphorylation	 of	 RPA	 at	 S4/S8	 upon	 Rad17	 depletion.	U2OS,	MRC5	or	HeLa	
cells	 were	 transfected	 with	 indicated	 siRNAs	 and	 72	 h	 later,	 cells	 were	 treated	 with	 5	 Gy	 of	 IR,	
recovered	for	1hr	and	then	lysed	in	SDS-Lysis	buffer.	50	μg	of	the	protein	from	the	indicated	samples	
was	then	analyzed	by	western	blotting	using	the	indicated	antibodies.	
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Figure	33.	Rad17	is	not	involved	in	DNA	end	resection.	(A)	No	effect	of	Rad17	depletion	on	BrdU	foci	
formation.	In	short,	U2OS	cells	were	transfected	with	the	indicated	siRNAs	for	48	h	and	then	seeded	
on	coverslips.	24	h	later,	cells	were	exposed	to	5Gy	of	IR,	recovered	for	3	h,	fixed	and	immunostained	
using	 anti-BrdU	 antibodies	 (green);	 nuclei	 were	 stained	 with	 DAPI	 (blue).	 (B)	 No	 effect	 of	 Rad17	
depletion	on	RPA	and	pRPA	foci	formation.	U2OS	cells	were	transfected	with	the	indicated	siRNAs	for	
48	h	and	seeded	on	coverslips.	24	h	 later,	cells	were	exposed	to	5	Gy	of	 IR,	recovered	for	3	h,	fixed	
and	 immunostained	 using	 anti-RPA	 (red)	 anti-pRPA	 (S4/S8)	 antibodies	 (green);	 nuclei	 were	 stained	
with	DAPI	 (blue).	 (C)	Quantification	of	BrdU	 foci	 in	Rad17	depleted	U2OS	cells.	At	 least	100	control	
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siRNA	or	siRad17	treated	cells	were	analyzed	by	semi-automated	image	analysis	(ImageJ	macro).	Box	
plots	 represent	 the	 inter-quartile	 range	 (IQR)	of	 the	data	 (box),	 from	the	25th	percentile	 to	 the	75th	
percentile.	 The	 whiskers	 extend	 over	 1.5	 times	 the	 IQR	 in	 both	 directions.	 Black	 bars	 indicate	 the	
median	 and	white	 diamonds	 the	mean	 of	 the	 distributions.	Outliers	 are	 indicated	 by	 black	 dots	 (2	
independent	 experiments,	 1	 representative	 experiment	 shown).	 (D)	 Quantification	 of	 pRPA	 foci	 in	
Rad17	depleted	U2OS	cells	as	in	C.	
	
3.2.3.4.	NBS1	phosphorylation	at	S432	is	dispensable	for	DNA	end	resection		
	
As	mentioned	before,	 two	 studies	 recently	 suggested	a	 cell	 cycle	 regulated	 role	of	
NBS1	 in	 DNA	 end	 resection.	 In	 one	 of	 these	 studies	 it	 was	 shown	 that	 NBS1	 is	
phosphorylated	at	S432	residue	in	a	CDK	dependent	manner	in	the	S	and	G2	phases	
of	 the	 cell	 cycle.	Moreover,	mutating	 this	 amino	acid	 residue	 to	Alanine	disrupted	
the	 formation	of	 IR	 induced	RPA	foci	and	the	generation	of	ssDNA	at	sites	of	DSBs	
(Falck	 et	 al.,	 2012).	 In	 contrast,	 another	 study	 reported	 normal	 resection	 in	 the	
absence	 of	 NBS1-S432	 phosphorylation	 (Wohlbold	 et	 al.,	 2012).	 The	 role	 of	 NBS1	
phosphorylation	at	S432	in	DNA	end	resection	thus	remains	obscure.	We	speculated,	
if	 CDK	 dependent	 phosphorylation	 of	 NBS1	 at	 S432	 is	 implicated	 in	 DNA	 end	
resection	then,	FHA	and	BRCT	domains	of	NBS1	might	have	a	role	in	mediating	CDK	
dependent	 phosphorylation	 of	 NBS1	 at	 S432.	 Should	 this	 be	 the	 case,	 we	 would	
expect	 defective	 DNA	 end	 resection	 in	 cells	 that	 express	 a	 mutant	 form	 of	 NBS1	
where	Ser	at	position	432	has	been	changed	to	Ala	(S432A).	To	test	this	possibility,	
we	 generated	 a	 cell	 line	 that	 stably	 expressed	 S342A	 NBS1myc	 in	 an	 inducible	
manner;	using	the	U2OS	Flp-In	T-REx	system	in	a	similar	manner	as	described	before	
for	FHA	and	BRCT	mutants	of	NBS1.	We	then	tested	if	exclusive	expression	of	siNBS1	
resistant	S432A	NBS1myc	could	rescue	the	resection	defect	observed	 in	U2OS	cells	
depleted	 of	 endogenous	 NBS1.	 BrdU,	 pRPA	 and	 RPA	 foci	 formation	 upon	 IR	
treatment	 in	 cells	 that	 express	 S3432A-NBS1myc	 was	 normal,	 thus	 revealing	 that	
phosphorylation	of	NBS1	at	S432	is	dispensable	for	DNA	end	resection	in	U2OS	cells	
(Figure	34).		
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Figure	 34.	 NBS1	 pS342	 is	 dispensable	 for	 DNA	 end	 resection.	 (A)	 Normal	 RPA	 and	 pRPA	 foci	
formation	upon	expression	of	 S432A	NBS1myc.	U2OS	 Flp-In	 T-REx	 cells	 lines	were	 transfected	with	
the	 indicated	 siRNAs	 for	 48	 h	 and	 seeded	 on	 coverslips.	 24	 h	 later,	 cells	 were	 exposed	 to	 5	 Gy,	
recovered	 for	3	h,	 fixed	and	 immunostained	using	anti-RPA	 (green)	and	anti-pRPA	S4/S8	antibodies	
(red);	nuclei	were	stained	with	DAPI	(blue).	(B)	Normal	RPA	phosphorylation	at	S4/S8	upon	expression	
of	 S432A	 NBS1.	 Briefly,	 U2OS	 Flp-In	 T-REx	 cell	 lines	 were	 transfected	with	 siNBS1	 for	 48	 h	 before	
inducing	the	expression	of	indicated	mutant	forms	of	NBS1	by	addition	of	doxycyclin.	Cells	were	then	
exposed	to	5	Gy	of	IR,	recovered	for	1hr	and	lysed	in	SDS-lysis	buffer.	50	μg	of	the	protein	from	the	
indicated	 samples	was	 analyzed	 by	western	 blotting	 using	 the	 indicated	 antibodies	 (2	 independent	
siLuc
siCtIP
siNBS1
siNBS1 + WT
siNBS1 + K160M
.
5 
 G
y,
 3
 h
  r
ec
ov
er
y
DAPI      RPA        pRPA
NBS1
CtIP
MCM7
pRPA S4/S8
RPA32
pChk1 317
si
Lu
c
si
Lu
c
si
N
B
S
1
si
C
tIP
W
T 
N
B
S
1
D
.M
.- 
N
B
S
1
K
16
0M
 -N
B
S
1
R
28
A
-N
B
S
1
S
43
2A
- N
B
S
1
siNBS1
+ Dox
DAPI      BrdU
siLuc
siCtIP
siNBS1
siNBS1 + WT
siNBS1 + S342A
5 
G
y,
 3
 h
 re
co
ve
ry
 siNBS1 + R28A
siNBS1 + D.M.
siNBS1 + S342A
A B
C
	 														RESULTS	
	 80	
experiments,	1	representative	experiment	shown)	(C)	Normal	BrdU	foci	formation	upon	expression	of	
S432A	NBS1.	U2OS	Flp-In	T-REx	 cells	 lines	were	 transfected	with	 the	 indicated	 siRNAs	 for	48	h	and	
seeded	 on	 coverslips.	 24	 h	 later,	 cells	 were	 exposed	 to	 5	 Gy	 of	 IR,	 recovered	 for	 3	 h,	 fixed	 and	
immunostained	 with	 anti-BrdU	 antibodies	 (green);	 nuclei	 were	 stained	 with	 DAPI	 (blue);	 (2	
independent	experiments,	1	representative	experiment	shown).	
	
	
	3.2.3.5.	NBS1	interacts	with	CtIP	via	FHA	and	BRCT	domains	
	
In	a	further	quest	to	find	a	possible	mechanistic	explanation	of	the	effect	of	FHA	and	
BRCT	domains	of	NBS1,	we	speculated	that	defective	end	resection	in	NBS1	mutants	
might	 be	 the	 outcome	 of	 loss	 of	 interaction	 with	 some	 key	 player	 of	 DNA	 end	
resection.	 	Many	studies	have	reported	that	CtIP	 interacts	with	MRN,	although	the	
mechanism	of	 this	 interaction	 is	not	clear.	However,	a	more	direct	 role	of	NBS1	 in	
DNA	end	resection	was	 implied	when	 it	was	shown	that	 interaction	between	NBS1	
and	CtIP	is	 implicated	in	DNA	damage	resistance	(Lloyd	et	al.,	2009;	Williams	et	al.,	
2009).	However,	 it	 remained	unknown	 if	 a	 similar	mechanism	of	 interaction	 exists	
between	CtIP	and	NBS1,	exists	 in	mammalian	cells	also	and	if	this	 interaction	has	a	
role	 in	DNA	damage	 response.	Another	 important	question	 that	also	has	not	been	
addressed	so	far	is	whether	the	interaction	between	CtIP	and	NSB1	has	a	role	in	DNA	
end	resection.		
	
Although	multiple	point	of	interaction	have	been	suggested	between	NBS1	and	CtIP	
(Wang	 et	 al.,	 2013a;	 Yuan	 and	 Chen,	 2009),	 we	 were	 particularly	 interested	 in	
dissecting	the	mode	of	interaction	between	NBS1	and	CtIP;	and	to	understand	if	this	
interaction	 is	 implicated	 in	DNA	end	resection.	To	specifically	 investigate	the	direct	
interaction	 between	 NBS1	 and	 CtIP	 and	 to	 separate	 this	 interaction	 from	 the	
interaction	between	RAD50	or	MRE11	and	CtIP	we	overexpressed	different	FHA	and	
BRCT	domain	mutants	of	 Flag-tagged	N-terminal	 fragment	 (1-382	aa)	of	NBS1	 that	
lacked	any	MRE11	interaction	site	in	HEK	293T	cell	lines	and	performed	Flag-tag	pull	
downs.	Analysis	of	pulled	down	fractions	by	western	blotting	revealed	no	traces	of	
CtIP	 (Figure	 35),	 even	 in	 WT-NBS1	 (N-terminal)	 pull-down	 fraction.	 However,	 we	
observed	 that	 WT-NBS1	 N-terminal	 fragment	 interacted	 in	 a	 DNA	 damage	
dependent	manner	with	BRCA1	and	 this	 interaction	was	 lost	 in	 the	 FHA	and	BRCT	
domain	mutants	 of	 NBS1.	 Based	 on	 these	 results	 and	 the	 previous	 studies,	which	
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implied	that	in	vivo	interaction	of	NBS1	with	CtIP	is	strengthened	when	NBS1	forms	a	
complex	 with	 MRE11	 and	 Rad50	 (Chen	 et	 al.,	 2008);	 we	 concluded	 that	 the	
interaction	between	N-terminal	part	of	NBS1	with	CtIP	was	not	strong	enough	to	be	
captured	by	immunoprecipitation.		
	
	
												
													Figure	 35.	 An	 N-terminal	 fragment	 of	 NBS1	 (1-382	 aa)	 does	 not	 interact	 with	 CtIP.	 293-T	 cells	
transfected	with	Flag	tagged	N-terminal	NBS1	fragments	(wild	type	and	R28A,	K160M	or	R28A/K160M	
(D.M.)	were	lysed	and	Flag-NBS1	fragments	were	immunoprecipitated	from	whole	cell	extracts	using	
anti-Flag	 antibody	 beads	 (M2).	 The	 immunoprecipitated	 proteins	 were	 then	 analyzed	 by	 western	
blotting	using	indicated	antibodies.		
	
Because	 no	 interaction	 between	 an	 N-terminal	 fragment	 of	 NBS1	 (containing	 the	
FHA/BRCT	 region)	 and	 CtIP	 could	 be	 detected,	 we	 performed	 co-
immunoprecipitation	 experiments	 with	 overexpressed	 full-length	 NBS-myc	 in	 the	
U2OS	 Flp-In	 T-REx	 cell	 lines.	 A	 very	 weak	 interaction	 between	 WT-NBS1myc	 and	
endogenous	CtIP	was	observed	(Figure	36).	A	very	faint	band	in	control	myc	IP	was	
present,	which	implied	that	non-specific	interactions	between	endogenous	CtIP	and	
the	anti-myc	beads	take	place.	Based	on	these	results,	we	concluded	that	the	NBS1	
and	CtIP	 interaction	may	be	too	weak	 for	detection	with	endogenous	proteins	and	
that	 the	 overexpression	 of	 both	 NBS1	 and	 CtIP	 might	 be	 necessary	 to	 capture	 a	
specific	interaction	by	immunoprecipitation.	
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Figure	 36.	WT-NBS1myc	 interacts	with	 endogenous	 CtIP.	Briefly,	U2OS	Flp-In	T-REx	cell	 lines	were	
transfected	with	siNBS1	for	48	h	before	 inducing	recombinant	protein	expression	by	the	addition	of	
doxycycline	 	 (1	 µg/ml).	 Cells	 were	 lysed	 and	 NBS1-myc	 was	 immunoprecipitated	 from	 whole	 cell	
extracts	 using	 beads	 coated	 with	 anti-myc	 antibodies.	 The	 immunoprecipitated	 proteins	 were	
analyzed	 by	 western	 blotting	 using	 the	 indicated	 antibodies	 (2	 independent	 experiments,	 1	
representative	experiment	shown).	
	
In	order	 to	detect	 a	 robust	 interaction	between	NBS1	and	CtIP	we	over-expressed	
full	 length	 Flag-CtIP	 and	 different	 myc-tagged	 full-length	 FHA	 and	 BRCT	 domain	
mutants	 of	 NBS1	 in	 HEK-293T	 cell	 by	 co-transfection.	 Co-immunoprecipitaiton	
experiments	revealed	that	WT-NBS1myc	interacted	with	Flag-CtIP	but	single	FHA	and	
BRCT	domain	mutants	namely	R28A-NBS1myc	and	K160M-NBS1myc	as	well	as	D.M.-
NBS1myc	were	completely	defective	for	CtIP	interaction	(Figure	37).	Taken	together,	
these	 results	 suggest	 that	 CtIP	 and	NBS1	 interaction	 requires	 full-length	NBS1	 and	
this	 interaction	 is	dependent	on	 the	FHA	and	BRCT	domains	of	NBS1.	Remarkably,	
we	 also	 noticed	 an	 enhanced	 CtIP	 interaction	 with	 MRE11	 and	 RAD50	 in	 cells	
transfected	 with	 WT-NBS1myc	 but	 not	 in	 cells	 transfected	 with	 FHA	 and	 BRCT	
domain	mutants	of	NBS1.	This	again	confirms	that	FHA	and	BRCT	domains	of	NBS1	
are	important	for	strengthening	the	interaction	between	CtIP	and	MRN	complex.	
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											Figure	37.	CtIP	 and	NBS1	 interaction	 is	 dependent	on	 the	 FHA	and	BRCT	domains	of	NBS1.	293-T	
cells	were	 transiently	 co-transfected	with	 Flag-CtIP	 (wild	 type)	 and	NBS1-myc	 (wild	 type	 and	R28A,	
K160M	 and	 R28A/K160M	 mutants,	 respectively).	 Cells	 were	 lysed	 and	 Flag-CtIP	 was	
immunoprecipitated	 from	whole	 cell	 extracts	 using	 anti-Flag	 antibody	 beads.	 After	 washing	 of	 the	
beads,	 the	 immunoprecipitated	 proteins	 were	 analyzed	 by	 western	 blotting	 using	 the	 indicated	
antibodies	(3	independent	experiments,	1	representative	experiment	shown).	
	
	
										In	 order	 to	 examine	 if	 impairment	 in	 NBS1-CtIP	 interaction	 is	 the	 underlying	
mechanism	of	DNA	end	resection	defect	in	FHA	and	BRCT	domain	mutants	of	NBS1,	
we	 sought	 to	 identify	 the	NBS1	binding	motif	 in	CtIP.	A	detailed	protein	 sequence	
analysis	of	putative	CK2	sites	in	human	CtIP	revealed	a	cluster	of	potential	CK2	sites	
towards	the	C-terminus	(T671,	T687	and	T698)	(Figure	38A).	Sequence	alignment	of	
human	 CtIP	 with	 known	 NBS1-FHA	 interaction	 sequences	 revealed	 a	 	 “minimal	
consensus"	 region	 centered	 around	 T671	 with	 an	 acidic	 amino	 acid	 (or	
phosphorylated	 Ser	 residue)	 at	 the	 	 -2	 position	 relative	 to	 the	 central	 T671	 and	
another	 acidic	 amino	 acid	 at	 the	 +3	 position.	 To	 test	 the	 contribution	 of	 these	
putative	CK2	sites	towards	DNA	end	resection,	we	made	a	deletion	mutant	of	CtIP,	
lacking	 aa	 residues	 650	 –	 750.	 However,	 unfortunately	 this	 mutant	 was	 not	
expressed	 in	 293T	 cells	 indicating	 that	 it	 may	 be	 unstable	 or	 insoluble.	 We	 then	
introduced	point	mutations	to	destroy	potential	CK2	sites	towards	the	C-terminus	of	
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Flag-WT-CtIP	 and	 generated	 Flag-T671A-CtIP,	 Flag-T687A-CtIP	 and	 Flag-T698A-CtIP,	
respectively.		
	
											This	 was	 followed	 by	 co-transfection	 of	 the	 various	 CtIP	mutants	 with	 full	 length	
NBS1myc	in	HEK-293T	cell.	As	a	positive	control	Flag-CtIP-ΔC	was	used.	This	mutant	
derivative	of	CtIP	does	not	interact	with	MRN	complex	(Sartori	et	al.,	2007).	Flag-tag	
immunoprecipitations	were	performed	and	the	precipitated	proteins	were	analyzed	
by	 western	 blotting	 for	 the	 presence	 NBS1myc.	 It	 was	 observed	 that	 while	 WT-
NBS1myc	 was	 efficiently	 co-immunoprecipitated	 with	 wild	 type	 and	 T687A	 and	
T698A	 mutant	 Flag-CtIP;	 it	 was	 not	 efficiently	 co-immunoprecipitated	 with	 one	
putative	CK2	site	mutant	forms	of	Flag-T671A-CtIP	(Figure	38B).	This	 indicated	that	
T671	 could	be	a	potential	 site	 in	CtIP	 that	mediates	 the	 interaction	with	NBS1.	 To	
test	the	role	of	this	putative	interaction	site	in	DNA	end	resection,	currently	we	are	
adapting	 a	 siRNA	 based	 complementation	 system	 for	 CtIP	 (Reference	 from	 Sartori	
lab),	using	 the	 same	U2OS	based	Flp-In	T-Rex	 system	 from	 Invitrogen	as	described	
for	NBS1	complementation.		
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Figure	38.	(A)	Schematic	representation	of	the	primary	structure	of	human	CtIP.	Shown	is	coiled	coil	
region	at	the	N-terminus	and	a	cluster	of	potential	CK2	sites	towards	the	C-terminus	(T671,	T687	and	
T698).	 Furthermore,	 the	 red	 ΔC	 part	 is	 deleted	 in	 the	 C-terminal	 deletion	 mutant.	 Sequence	
alignment	 of	 T671	 of	 human	 CtIP	 with	 known	 NBS1-FHA	 interaction	 sequences.	 The	 "minimal	
consensus"	seems	to	be	an	acidic	amino	acid	(or	phosphorylated	Ser	residue)	at	-2	and	acidic	amino	
acid	 at	 +3.	 (B)	 Co-IP	 experiment	 with	 Flag-IP	 from	 extracts	 prepared	 from	 293T	 cells	 transiently	
transfected	with	Flag-CtIP	(WT,	T671A,	T687A,	T698A	and	ΔC	mutant)	and	NBS1-myc	(wild	type).	Note	
that	 T671A	 and	 ΔC	 mutant	 CtIP	 are	 unable	 to	 efficiently	 interact	 with	 NBS1	 (2	 independent	
experiments,	1	representative	experiment	shown).	
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3.2. Investigation	 of	 the	 role	 of	 NBS1	 in	 G2M	 checkpoint	 activation	 and	
checkpoint	maintenance	
	
An	 important	 aspect	 of	 the	 cellular	 responses	 to	 DNA	 damage	 induced	 by	 IR	 is	
activation	of	 cell	 cycle	 checkpoints	 that	 delay	 progression	of	 cells	 through	 the	 cell	
cycle.	IR-induced	checkpoints	are	active	at	the	transition	from	the	G1	phase	to	the	S	
phase	 (G1S),	 in	 the	 S	 phase	 (intra-S),	 and	 at	 the	 transition	 from	 the	 G2	 phase	 to	
mitosis	 (G2M).	 The	 activation	 of	 checkpoints	 facilitates	 maintenance	 of	 genomic	
integrity,	by	allowing	time	for	DNA	damage	repair	and	inhibiting	DNA	replication	or	
segregation	into	the	daughter	cells	until	DNA	is	completely	repaired.	NBS1	has	been	
implicated	as	an	essential	mediator	of	cell	cycle	checkpoint	control,	after	exposure	
to	IR	or	radiomimetic	drugs.	The	role	of	NBS1	in	S-phase	was	initially	studied	in	NBS	
cells,	which	exhibit	radio-resistant	DNA	synthesis	(RDS),	a	hallmark	of	 intra-S-phase	
checkpoint	 failure	 (Kobayashi	 et	 al.,	 2004;	 Zhang	et	 al.,	 2006).	 Later,	 it	was	 shown	
that	there	are	three	parallel	pathways	to	control	intra-S-	phase	checkpoint	and	NBS1	
has	 been	 implicated	 in	 all	 three	 of	 these	 pathways.	 The	 first	 branch	 is	 ATM-Chk2-
CDC25A	 pathway	 (Horejsí	 et	 al.,	 2004;	 Lee	 and	 Paull,	 2005),	 the	 second	 branch	
involves	 ATM-NBS1-SMC1	 pathway	 (Kim	 et	 al.,	 2002;	 2002)	 and	 the	 third	 is	 the	
ATM/FANCD2	pathway	 (Lim	et	 al.,	 2000).	 In	 contrast,	 the	 role	of	NBS1	 in	G1S	and	
G2M	checkpoint	 integrity	has	remained	controversial.	While	some	studies	reported	
that	in	NBS	fibroblast	cells,	G1	arrest	was	found	to	be	attenuated	(Lee	et	al.,	2003),	
others	reported	normal	G1	checkpoint	control	 in	the	same	cells	 (Gatei	et	al.,	2003;	
Girard	et	al.,	2002).	Inconsistent	findings	were	reported,	regarding	the	role	of	NBS1	
in	 G2M	 checkpoint	 activation	 also.	 While	 some	 studies	 reported	 that	 NBS	
lymphoblastoid	 cells,	 fail	 to	 elicit	 G2	 checkpoint	 activation	 upon	 IR	 treatment	 and	
this	defect	could	be	rescued	by	the	ectopic	expression	of	a	wild-type	NBS1	(Buscemi	
et	 al.,	 2001);	 others	 reported	 normal	 G2	 checkpoint	 activation	 in	 the	 same	 cells	
(Antoccia	et	al.,	1997;	Girard	et	al.,	2002).	
	Given	the	contradicting	findings	regarding	the	role	of	NBS1	in	checkpoint	activation;	
we	sought	to	investigate	the	same	in	a	clean	genetic	system,	which	is	a	novel	NBS1	
gene	 knockout	 in	U2OS	 cell	 line.	 In	 particular,	we	 focused	 on	G2M	 checkpoint;	 as	
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majority	 of	 cancer	 cells	 arrest	 in	G2,	 despite	 being	 impaired	 in	 P53	dependent	G1	
arrest	 (Löbrich	 and	 Jeggo,	 2007).	 We	 examined	 the	 role	 of	 NBS1	 both	 in	 G2M	
checkpoint	activation	and	G2M	checkpoint	maintenance.		
	
3.2.1. Characterization	of	NBS1	knockout	
	
In	order	 to	study	 the	role	of	NBS1	 in	G2M	checkpoint	activation	 in	a	clean	genetic	
system;	NBS1	 gene	 knockout	 in	 U2OS	 cell	 line	was	 generated,	 using	 CRISPR/Cas9-
mediated	gene-editing	approach	(Sander	and	Joung,	2014;	Wang	et	al.,	2014c).	First,	
we	 looked	 into	 the	 DNA	 damage	 signaling	 associated	 phosphorylation	 events	 in	
NBS1	knockout	cells.	Wild-type	and	NBS1	knockout	U2OS	cells	were	exposed	to	10	
Gy	IR	and	an	hour	after	IR	treatment,	cells	were	harvested	and	analyzed	by	Western	
blotting	for	DNA	damage	induced	phosphorylation	events	(Figure	40).		As	expected,	
NBS1	knockout	cells	were	defective	in	phosphorylation	of	RPA	at	S4/S8.	Remarkably,	
RPA	phosphorylation	at	S33	was	also	reduced	in	NBS1	knockout	cells,	in	response	to	
IR.	This	is	in	line	with	a	recent	study	that	implicated	NBS1	in	RPA32	phosphorylation	
at	S33	by	ATR	(Shiotani	et	al.,	2014).	This	study	also	reported	that	RPA	is	gradually	
phosphorylated	at	S33	by	ATR,	before	its	phosphorylated	at	S4/S8	by	DNA-Pkcs	and	
indicated	 that	 RPA32	 Ser33	 phosphorylation	 could	 be	 the	 initial	 phosphorylation	
driven	 by	 resection.	 However,	 this	 study	 used	 camptothecin,	 which	 induces	
replication-	 associated	 DSBs	 that	 are	 efficiently	 processed	 by	 DNA	 end	 resection.	
Taken	together,	defective	RPA32	S33	phosphorylation	in	NBS1	knockout	cells	implies	
a	role	of	NBS1	in	ATR	activation,	in	response	to	IR.	It	is	noteworthy	that	the	role	of	
NBS1	in	ATR	activation	reflects	a	post-resection	function	of	NBS1	and	given	the	role	
of	 NBS1	 in	 resection,	 it	 seems	 obvious	 that	 since	 the	 ATR	 activating	 structure	
(ssDNA)	is	not	generated	in	NBS1	knockout	cells,	these	cells	are	also	defective	in	ATR	
activation.	 As	 previously	 reported	 for	 NBS	 cells,	 NBS1	 knockout	 cells	 were	 also	
defective	in	phosphorylation	of	Smc1	at	S966	and	Chk1	at	S317.	Although	the	role	of	
NBS1	in	ATM	activation	is	important,	it	is	not	absolutely	required	(Difilippantonio	et	
al.,	2007;	2005;	Horejsí	et	al.,	2004).	 In	agreement	with	the	previous	studies,	NBS1	
knockout	cells	were	only	partially	defective	in	the	activation	of	ATM	as	revealed	by	
phospho	 specific	 ATM-S1981	 antibody.	 We	 observed	 that	 the	 effect	 of	 NBS1	
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depletion	on	ATM	activation	was	little,	but	it	was	visible	only	in	NBS1	knockout	cells	
and	 not	 in	 the	 cells,	 in	 which	 NBS1	 was	 depleted	 using	 siRNA.	 This	 observation	
emphasizes,	 that	 a	 complete	 depletion	 of	NBS1	 protein	 is	 necessary	 to	 visualize	 a	
very	marginal	effect	of	NBS1	upon	ATM	activation.	
		
	
	
Figure	40.	DNA	damage	induced	phosphorylation	events	in	NBS1	Knockout.	Wild-type	U2OS	or	NBS1	
Knockout	cells	were	exposed	to	10	Gy	of	IR,	recovered	for	1hr	and	then	lysed	in	SDS-lysis	buffer.	50μg	
of	the	protein	extracts	from	the	 indicated	samples	was	then	analyzed	by	western	blotting	using	the	
indicated	antibodies	(2	independent	experiments,	1	representative	experiment	shown).	
	
	
Next,	 as	 a	 part	 of	 the	 characterization	 of	 NBS1	 knockout	 and	 based	 on	 the	
observation	 that	 NBS1	 depletion	 leads	 to	 a	 strong	 resection	 defect	 (see	 section	
3.2.1),	RPA	foci	 formation	 in	response	to	 IR	was	 investigated	by	 immunostaining	of	
cells	in	NBS1	knockout	cells.	Immunostaining	and	quantification	of	the	RPA2	foci	was	
done	 as	 described	 before	 (section	 3.2.1).	 As	 seen	 in	 NBS1	 knockdown	 cells,	 NBS1	
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knockout	cells,	RPA	foci	 formation	was	also	significantly	reduced	 in	NBS1	knockout	
cells	(Figure	41).		
		
	
	
Figure	41.	Loss	of	RPA	foci	 in	NBS1	depleted	cells.	(A)	Wild-type	or	NBS1	knockout	U2OS	cells	lines	
were	seeded	on	coverslips.	24	h	later,	cells	were	exposed	to	10	Gy	of	IR,	recovered	for	3	h	fixed	and	
immunostained	 using	 anti-RPA32	 antibodies	 (red);	 nuclei	 were	 stained	 with	 DAPI	 (blue).	 (B)	
Quantification	of	RPA	 foci	 in	NBS1	knockout	cells.	Around	300	cells	per	condition	were	analyzed	by	
semi-automated	image	analysis	(ImageJ	macro).	Box	plots	represent	central	75%	percentiles	(box)	and	
95%	 percentiles	 (whiskers).	 Black	 bars	 indicate	 medians	 and	 white	 diamonds	 means	 of	 the	
distributions.	 Outliers	 are	 depicted	 by	 black	 dots	 (2	 independent	 experiments,	 1	 representative	
experiment	shown).	
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3.2.2. NBS1	is	required	for	G2M	checkpoint	activation	
	
Given	 the	 contradictory	 findings	 regarding	 the	 role	 of	 NBS1	 in	 G2M	 checkpoint	
activation,	we	employed	NBS1	knockout	U2OS	cells	as	a	“clean”	system	to	study	the	
same.	 Many	 studies	 also	 reported	 the	 requirement	 of	 NBS1	 In	 G2M	 checkpoint	
activation,	 but	 only	 when	 cells	 were	 exposed	 to	 low-doses	 of	 IR	 (Buscemi	 et	 al.,	
2001).	 To	 address	 if	 IR	 dose	 has	 any	 impact	 on	 the	 dependency	 of	 NBS1	 in	 G2M	
checkpoint	 activation,	 a	 range	 of	 IR	 doses	 (0.5,	 1,	 2	 and	 4	 Gy)	 were	 used	 to	
investigate	 the	 role	 of	 NBS1	 in	 the	 activation	 of	 G2M	 checkpoint.	 As	 described	
before,	co-staining	of	cells	with	propidium	 Iodide	 (PI)	and	anti-p-histone	H3	Ser	10	
antibodies	in	a	FACS	based	assay	was	employed	to	check	the	cell-cycle	profiles	and	
the	mitotic	 index.	 In	 these	 FACS	 based	 experiments	 it	 emerged	 that	 as	 previously	
reported,	NBS1	depletion	 indeed	 interfered	with	 the	activation	of	G2M	checkpoint	
and	this	was	evident	at	doses	as	low	as	1	Gy	(Figure	42).	Remarkably,	NBS1	knockout	
cells	were	also	defective	 in	G2M	checkpoint	activation,	at	 IR	dose	as	high	as	4	Gy.	
This	 was	 in	 contrast	 to	 previous	 studies	 that	 have	 implicated	 NBS1	 in	 G2M	
checkpoint,	only	at	low	IR	doses	of	less	than	3	Gy	(Girard	et	al.,	2002).	As	with	most	
of	the	studies	on	NBS1;	these	were	also	done	in	NBS	patient	derived	cell	lines,	which	
retains	some	NBS1	function	(Maser	et	al.,	2001).	Our	results	suggest	that	complete	
loss	of	NBS1	protein	is	important	to	visualize	its	effect	on	G2M	checkpoint	activation.	
This	is	accordance	with	some	of	the	results	described	later,	where	cells	depleted	of	
NBS1	with	siRNA	exhibited	a	defect	in	G2M	checkpoint,	but	only	at	very	low	IR	doses	
(0.5	Gy).	
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Figure	42.	NBS1	knockout	cells	are	impaired	in	G2M	checkpoint	activation.	(A)	U2OS	Wild-type	cells	
or	U2OS	NBS1	knockout	cells	were	exposed	to	1	Gy,	2	Gy,	3	Gy	or	4	Gy	of	IR.	Cells	were	harvested	1	h	
after	IR	treatment,	fixed	with	70%	ethanol	and	stained	with	antibodies	against	Histone	H3-Ser10p	(P-
H3)	 and	 propidium	 iodide	 (PI).	 The	 percentage	 of	 P-H3	 positive	 cells	 was	 determined	 by	 flow	
cytometric	analysis.	 (B)	 The	bar	chart	 represent	 the	percentage	of	Histone	H3-Ser10p–positive	cells	
measured	by	 flow	 cytometry.	All	 data	points	 represent	 an	 average	of	 at	 least	 three	 replicates	with	
error	bars	indicating	standard	error	of	mean.		
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3.3.3. FHA	 and	 BRCT	 domains	 of	 NBS1	 are	 important	 for	 G2M	 checkpoint	
activation	
	
Having	established	the	role	of	NBS1	in	G2M	checkpoint	activation,	we	next	asked	if	
the	 FHA	 and	 BRCT	 domains	 of	 NBS1	would	 contribute	 to	 the	 NBS1’s	 role	 in	 G2M	
checkpoint	activation.	As	mentioned	before,	NBS	patient	derived	cells	expressing	the	
common	 675del5	 mutation	 show	 an	 impaired	 G2M	 checkpoint	 response	 at	 low	
doses	 of	 IR	 (less	 than	 2Gy),	 but	 nearly	 normal	 G2/M	 checkpoint	 arrest	 following	
exposure	 to	 3	 Gy	 IR.	 This	 ‘leaky’	 phenotype	 of	 NBS1	 cells	 at	 higher	 IR	 doses	 is	
dependent	on	ATM,	whose	kinase	activity	 is	 largely	normal	 in	 these	cells.	This	was	
consistent	with	previous	 findings;	where	NBS	cells	when	complemented	with	NBS1	
fragment	 lacking	C-terminal	ATM	 interaction	motif	 remain	 impaired	 for	 IR-induced	
G2/M	 arrest	 (Girard	 et	 al.,	 2002;	 Stiff	 et	 al.,	 2008).	 Thus,	 NBS1’s	 C-terminal	
dependent	ATM	signaling	is	generally	considered	to	be	the	main	reason	for	impaired	
G2M	checkpoint	activation	in	NBS1	cells.	However,	a	role	of	FHA	and	BRCT	domains	
of	 NBS1	 has	 been	 implicated	 in	 ATR	 dependent	 but	 replication	 independent	 G2M	
checkpoint	 activation	 (Stiff	 et	 al.,	 2008).	 Since	 we	 had	 a	 functional	 siRNA	 based	
complementation	system	to	study	the	FHA	and	BRCT	domains	of	NBS1;	we	sought	to	
investigate	the	role	of	FHA	and	BRCT	domains	of	NBS1	in	G2M	checkpoint	activation	
in	this	complementation	system	for	NBS1.	
	
To	gain	 insight	 into	the	contribution	of	FHA	and	BRCT	domains	towards	the	overall	
function	 of	 NBS1	 in	 G2M	 checkpoint	 analysis;	 mitotic	 index	 was	 quantified	 after	
irradiation,	in	NBS1-depleted	stable	cell	lines	that	inducibly	expressed	WT-NBS1myc,	
R28A-NBS1myc	 (FHA	mutant),	 K160M-NBS1myc	 (BRCT	mutant)	 and	D.M.-NBS1myc	
(combined	R28A/K160M	double	mutant),	respectively.	We	observed	that	the	single	
FHA	 and	 BRCT	 domain	 mutants,	 R28A	 and	 K160M	 respectively	 were	 partially	
defective	in	activation	of	checkpoint,	while	the	combined	FHA/BRCT	domain	mutant	
(D.M.-NBS1)	 was	 largely	 as	 defective	 as	 NBS1	 depleted	 cells	 in	 the	 activation	 of	
checkpoint.	Strikingly	and	much	to	our	expectations,	from	these	data	it	also	emerged	
that	 as	 observed	 in	 DNA	 end	 resection,	 the	 ‘additive	 effect’	 in	 D.M.-NBS1myc	 cell	
line	 was	 prevalent	 in	 G2M	 checkpoint	 activation	 also.	 Again,	 as	 with	 DNA	 end	
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resection;	 BRCT	 domain	 mutant	 (K160M)	 was	 more	 defective	 in	 G2M	 checkpoint	
activation	as	compared	to	FHA	domain	mutant	(R28A)	and	the	combined	FHA/BRCT	
domain	 mutant	 (D.M.)	 did	 not	 rescue	 the	 resection	 phenotype	 at	 all	 (Figure	 43),	
emphasizing	that	the	function	of	NBS1	in	G2M	checkpoint	activation	is	dependent	on	
its	N-terminal	phospho-interaction	modules.	
	
	
	
Figure	43.	Role	of	FHA	and	BRCT	domains	of	NBS1	in	G2M	checkpoint	activation.	(A)	U2OS	cells	lines	
stably	 transfected	with	WT-NBS1myc	 or	with	 R28A-NBS1myc,	 K160M-NBS1myc	 and	D.M.-NBS1myc	
were	treated	with	siNBS1	for	48h	and	then	induced	with	doxycycline	for	24h.	Cells	were	harvested	1	h	
after	 0.5	 Gy	 of	 irradiation,	 fixed	 with	 70%	 ethanol	 and	 stained	 with	 an	 antibody	 against	
phosphorylated	 H3	 (P-H3)	 and	 propidium	 iodide	 (PI).	 The	 percentage	 of	 P-H3;	 positive	 cells	 was	
determined	by	flow	cytometric	analysis.	(B)	The	graph	represents	three	independent	experiments	and	
the	error	bars	represent	the	standard	error	of	mean.	
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3.3.4. NBS1	has	no	role	in	G2M	checkpoint	maintenance	
	
DNA	 end	 resection	 has	 been	 linked	 to	 G2M	 checkpoint	 maintenance	 in	 a	 recent	
study,	 where	 the	 authors	 have	 shown	 that	 the	 resection	 dependent	 checkpoint	
pathway	takes	over	and	maintains	the	HR	associated	G2M	checkpoint,	by	restricting	
mitotic	 entry	 until	 DNA	 is	 repaired	 completely	 (Kousholt	 et	 al.,	 2012).	 Having	
established	the	specific	role	of	NBS1	in	G2M	checkpoint	activation,	we	investigated	
the	role	of	NBS1	in	G2M	checkpoint	maintenance.	To	this	end	we	first	analyzed,	the	
effect	 of	 NBS1	 depletion	 on	 HR	 repair	 by	 U2OS	 based	 DR–GFP	 system,	 which	
contained	a	green	fluorescent	protein	(GFP)	based	HR	reporter	construct	bearing	a	
cleavage	 site	 for	 the	 I-SceI	 restriction	endonuclease.	 I-SceI	 expression	 in	 such	 cells	
induces	 a	 DSB	 that	 can	 be	 repaired	 by	HR-	mediated	 gene	 conversion	 to	 produce	
GFP-positive	 cells.	 U2OS/DR–GFP	 cells	 were	 treated	 with	 siNBS1	 and	 24h	 later	
transfected	 either	 with	 I-SceI	 expression	 plasmid.	 As	 expected,	 formation	 of	
functional	GFP	was	impaired	in	siNBS1	treated	cells,	emphasizing	the	role	of	NBS1	in	
HR-mediated	repair	(Figure	44).	
																							
	
		
Figure	44.		NBS1	promotes	HR	repair.	(A)	Scheme	of	the	DR-GFP	reporter	for	HR-mediated	DSB	repair.	The	
site-specific	DSB	in	the	reporter	cassette	is	generated	by	I-SceI	endonuclease.	Only	HR	events	give	rise	to	a	
functional	 GFP	 allele.	 (B)	 Western	 blot	 analysis	 of	 extracts	 from	 U2OS/DR-GFP	 cells	 transfected	 with	
indicated	 siRNAs.	Blots	were	probed	with	 indicated	antibodies.	 (C)	Efficiency	of	HR-mediated	 repair	of	 I-
SceI-induced	 DSB	 in	 U2OS/DR-GFP	 cells	 treated	 with	 indicated	 siRNAs.	 Cells	 were	 transfected	 with	
indicated	siRNAs	two	days	before	transfection	with	 I-SceI-expressing	plasmid.	Percentage	of	GFP	positive	
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Figure 19. Analysis of RAD50S mutants with respect to homology-directed repair. (A) 
Scheme of the DR-GFP reporter along with the homology-directed repair (HDR) product that 
results in GFP-positive cells. (B) HEK293 DR-GFP cells were co-transfected with the I-SceI 
expression plasmid together with indicated FLAG-RAD50 plasmids and harvested after 48 h for 
flow cytometry (left panel) and immunoblot analysis (right panel). Data is represented as mean ± 
SEM (N=3), p values were calculated using paired t-test: *p < 0.05, ns (not significant).  
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Nbs1 was shown to directly bind to phosphorylated Ctp1, the fission yeast ortholog of 
human CtIP, via its FHA domain, thereby promoting the recruitment of Ctp1 to DSBs 
and HR [66,70]. Remarkably, overexpression of Ctp1 rescued the DNA damage 
sensitivity of nsb1-s10 and nbs1 (R27A) mutant strains harboring the functionally 
disruptive mutations in the FHA domain of Nbs1, but not of an nbs1 null mutant [66,72]. 
These data suggested that overexpression of Ctp1 can circumvent the repair defects of 
Nbs1 mutant impaired in Ctp1 binding. Based on these observations, we hypothesized 
that overexpression of Ctp1 might also suppress the DNA damage sensitivity of a rad50S 
mutant strain. Therefore, we established collaboration with Dr. Edgar Hartsuiker and Dr.!
Rolf Kraehenbuehl (Bangor University, Wales, UK), experts in studying the role of the 
MRN complex in S. pombe. As expected, rad50S (K81I) mutant was hypersensitive to 
CPT, though to a lesser extent than ctp1Δ, rad50Δ or ctp1Δ rad50Δ strains [98] (Figure 
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cells	was	measured	by	flow	cytometry	two	days	after	DSB	induction	and	taken	as	a	measure	of	DSB	repair	
efficiency.	Values	plotted	 represent	absolute	 repair	efficiency.	All	data	points	 represent	an	average	of	at	
least	three	biological	replicates	with	error	bars	indicating	standard	error	of	mean.	
	
	
	
Next,	we	tested	if	NBS1	depletion	also	leads	to	a	defect	in	checkpoint	maintenance,	
as	 reported	 for	 the	 proteins	 involved	 in	 DNA	 end	 resection	 in	 a	 recent	 study	
(Kousholt	 et	 al.,	 2012).	 To	 analyze	 G2M	 checkpoint	 maintenance,	 cells	 were	 first	
exposed	 to	 IR	 and	 then	 trapped	 in	mitosis	 by	 adding	 nocodazole,	 2	 h	 after	 being	
exposed	to	 IR	 (referred	as	nocodazole	trap	experiment).	 	The	cells	 that	exhibited	a	
leaky	G2M	checkpoint	were	trapped	 in	mitosis	by	nocodazole	and	a	comparison	of	
the	mitotic	index	by	FACS	at	two	different	time	points,	2	h	after	IR	and	8	h	after	IR	(6	
h	 after	 Nocodazole	 addition)	 revealed	 differences	 in	 checkpoint	 activation	 and	
checkpoint	 maintenance	 respectively.	 Strikingly,	 NBS1	 knockout	 cells	 exhibited	 a	
very	little	defect	when	compared	to	CtIP	depleted	cells	in	the	maintenance	of	G2M	
checkpoint	 in	 this	assay.	Moreover,	NBS1	knockout	cells	depleted	of	CtIP	exhibited	
very	 little	 affect,	when	 compared	 to	wild-type	 cells	 depleted	of	 CtIP	 in	 checkpoint	
maintenance	(Figure	45).	These	findings	suggest	that	the	effect	of	CtIP	depletion	on	
checkpoint	maintenance	is	counteracted	in	the	cells	that	don’t	express	NBS1.	These	
results	were	totally	counterintuitive,	given	the	positive	role	of	both	NBS1	and	CtIP	in	
DNA	 end	 resection.	 To	 get	 a	 deeper	 insight	 into	 this,	 we	 treated	 U2OS	 NBS1	
knockout	 cells	 with	 IR	 and	 estimated	 checkpoint	 activation	 and	 maintenance	 by	
blotting	for	Chk1	phosphorylation.	As	reported	for	CtIP	(Kousholt	et	al.,	2012),	Chk1	
phosphorylation	as	measured	by	pS317	Chk1	and	pS345	Chk1	antibodies,	 revealed	
that	Chk1	was	phosphorylated	as	soon	as	15	minutes	after	IR	in	NBS1	knockout	cells.	
In	 contrast	 the	 levels	 of	 phosphorylated	 Chk1	 was	 substantially	 reduced	 at	 2-3	 h	
after	IR,	when	compared	to	Wild-type	cells	(Figure	46).		In	summary,	the	role	of	NBS1	
in	maintenance	of	Chk1	phosphorylation	was	revealed	in	the	western	blot	analysis,	
but	 role	 of	 NBS1	 in	 checkpoint	 maintenance	 was	 not	 discernible	 when	 NBS1	
knockout	cells	defective	in	G2M	checkpoint	maintenance	were	trapped	in	mitosis	by	
nocodazole.		
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Figure	45.	NBS1	knockout	cells	exhibit	different	response	when	compared	to	CtIP	depleted	cells	in	
IR-induced	 checkpoint	maintenance.	 (A)	U2OS	Wild-type	 cells	 or	U2OS	NBS1	 knockout	 cells	 (NBS1	
KO)	were	 transfected	with	 the	 siCtIP	 for	 72	 h	 and	 samples	were	 fixed	 at	 the	 indicated	 time	points	
after	 IR.	 Nocodazole	 was	 added	 2	 h	 after	 IR.	 The	 bar	 chart	 represents	 the	 percentage	 of	
phosphorylated	Histone	H3-Ser10p	(P-H3)	positive	cells	measured	by	flow	cytometry.	All	data	points	
represent	an	average	of	at	least	three	replicates	with	error	bars	indicating	standard	error	of	mean.		
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Figure	 46.	 NBS1	 is	 required	 for	 sustained	 checkpoint	 signaling.	 U2OS	 Wild-type	 or	 U2OS	 NBS1	
Knockout	cells	were	exposed	to	5	Gy	of	IR,	recovered	for	indicated	time	points	and	then	lysed	in	SDS-
lysis	buffer.	50	μg	of	the	protein	extracts	from	the	indicated	samples	was	then	analyzed	by	western	
blotting	 using	 the	 indicated	 antibodies	 (2	 independent	 experiments,	 1	 representative	 experiment	
shown).		
	
	
	
To	 move	 further,	 it	 was	 important	 to	 understand	 why	 NBS1	 knockout	 cells	 exhibit	
unrestrained	 checkpoint	 maintenance	 response	 in	 nocodazole	 trap	 experiments,	
despite	being	defective	in	DNA	end	resection.			We	considered	the	possibility	that	may	
be	checkpoint	maintenance	defect	in	NBS1	knockout	cells	is	not	evident	in	nocodazole	
trap	 experiments	 because	 these	 cells	 accumulate	 in	 G2	 upon	 IR	 treatment.	 G2	
accumulation	is	ATM	independent	(ATR	dependent)	and	it	 is	actually	enhanced	by	the	
lack	of	ATM,	as	well	as	NBS1	(Xu	et	al.,	2002).	Given	the	role	of	NBS1	in	intra-S	phase	
checkpoint,	 we	 reasoned	 that	 may	 be	 NBS1	 depleted	 cells	 don’t	 exhibit	 heightened	
mitotic	 Index	 in	nocodazole	trap	experiments	because	they	fail	 to	arrest	 in	S	phase	 in	
response	to	the	irradiation	and	later	exhibit	enhanced	G2	accumulation.	Should	this	be	
true,	one	would	expect	that	the	cells	that	get	trapped	in	mitosis	and	lead	to	heightened	
mitotic	 index	 in	CtIP	depleted	cells	were	 in	S-phase	at	 the	 time	of	 irradiation.	To	 test	
this	possibility,	cells	were	labeled	with	EdU	before	performing	FACS	based	Nocodazole	
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trap	 experiments.	 Remarkably,	we	observed	 that	 the	huge	mitotic	 population	of	 CtIP	
depleted	 cells	 was	 not	 coming	 from	 S-phase	 of	 the	 cell	 cycle	 as	 all	 these	 cells	 were	
negative	 for	 EdU	 (Figure	 47).	 This	 implies,	 that	 the	 unrestrained	 checkpoint	
maintenance	manifested	 in	 the	 form	 of	much	 lower	mitotic	 index	 in	 NBS1	 knockout	
cells	compared	to	CtIP	depleted	cells,	could	not	be	the	result	of	any	S-phase	checkpoint	
anomalies	 that	 could	 have	 resulted	 in	 enhanced	 G2	 accumulation	 of	 cells	 in	 NBS1	
knockout	 cells.	 Taken	 together	 it	 can	 be	 hypothesized	 that	 NBS1,	 is	 not	 required	 for	
checkpoint	maintenance.		
	
	
	
	
	
Figure	47.	The	huge	mitotic	population	of	CtIP	depleted	cells	comes	from	G2	phase.	U2OS	were	left	
transfected	with	siLuc	or	with	siCtIP	 for	65	h.	Cells	were	then	pulse-labeled	with	10	µM	EdU	for	30	
min	 before	 treating	 them	with	 X-Ray	 dose	 of	 4	 Gy.	 After	 2	 h	 of	 X-Ray	 exposure,	 Nocodazole	 was	
added	 to	 the	 cells	 and	 finally	 cells	 were	 fixed	 6	 h	 after	 IR	 exposure.	 	 The	 samples	 were	 then	
permeabilized	and	stained	with	antibodies	against	Histone	H3-Ser10p	(P-H3).	EdU	detection	reaction	
was	carried	out	at	this	point,	followed	by	DAPI	staining.	The	black	square	marks	the	gate,	 indicating	
the	 percentage	 of	 p-H3	 positive	 cells	 and	 EdU	 negative	 cells.	 (2	 indepenent	 experiments,	 1	
representative	experiment	shown).	
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4.			Discussion	
	
NBS1	 is	 the	 most	 enigmatic	 component	 of	 the	 MRN	 complex.	 Functionally,	 it	 is	
mainly	considered	to	act	as	a	regulatory	subunit	of	MRN	complex.	It	is	also	a	tumor	
suppressor	protein	and	hypomorphic	mutations	 in	NBS1	are	associated	with	a	 rare	
genetic	 disorder	 characterized	 by	 microcephaly,	 immunodeficiency,	 and	 cancer	
predisposition.	 In	higher	eukaryotes	NBS1	 is	essential	 for	radioresistance	and	sister	
chromatid	exchange,	suggesting	an	involvement	of	NBS1	in	HR	repair	(Sakamoto	et	
al.,	2007;	Tauchi	et	al.,	2002).	Since	NBS1	is	required	for	HR	and	given	the	fact	that	
HR	 is	mainly	 regulated	 at	 the	 level	 of	DNA	end	 resection,	we	 thought	 it	would	be	
interesting	 to	 investigate	 the	 role	 of	 NBS1	 in	 DNA	 end	 resection.	 In	 addition,	 this	
function	of	NBS1	has	not	yet	been	extensively	studied	in	mammalian	cells.	In	the	first	
part	of	this	work,	we	generated	a	novel	cellular	complementation	system	for	NBS1	in	
U2OS	cell	lines,	using	the	U2OS	Flp-In	T-REx	system.	In	the	next	phase	of	this	study,	
we	 employed	 this	 complementation	 system	 to	 investigate	 the	 function	 of	NBS1	 in	
DDR	and	discovered	that	NBS1	plays	an	important	role	in	DNA	end	resection	and	in	
the	G2M	checkpoint	activation,	which	 is	dependent	on	 its	FHA	and	BRCT	domains.	
Remarkably,	 we	 found	 that	 the	 FHA	 and	 BRCT	 domains	 contribute	 to	 the	 overall	
function	of	NBS1	in	an	additive	manner.	
	
	
4.1.			siRNA	based	complementation	system	for	NBS1	
	
Most	of	the	structure/function	studies	done	to	 investigate	the	physiological	role	of	
NBS1	and	to	understand	the	mechanisms	by	which	this	protein	 is	 implicated	 in	the	
DDR	 were	 performed	 in	 cell	 lines	 derived	 from	 NBS	 patients,	 harboring	 the	most	
common	657del5	mutation	 in	NBS1.	However,	657del5	 is	 a	hypomorphic	mutation	
that	determines	synthesis	of	two	truncated	protein	fragments	p26	and	p70	of	NBS1,	
albeit	in	very	low	levels	(Maser	et	al.,	2001).	While	several	NBS	patient	cell	lines	have	
been	 isolated,	one	of	 the	most	 frequently	used	 cell	 lines	 is	NBS1-iLB.	 This	 cell	 line	
was	derived	from	fibroblasts	of	a	Polish	patient	harboring	the	most	common	NBS1	
mutant	 form	675del5	 (Kraakman-van	 der	 Zwet	 et	 al.,	 1999;	Maser	 et	 al.,	 2001).	 It	
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was	then	subsequently	immortalized	by	SV40	transformation	which	gave	rise	to	the	
NBS1-iLB	 cell	 line	 that	 up	 until	 today	 is	 still	 the	most	 frequently	 used	 cell	 line	 for	
NBS1	 structure/function	 analysis	 in	 human	 cells.	 Both	 primary	 and	 immortalized	
NBS1-iLB	cell	lines	display	the	same	cellular	characteristics	and	hence	were	accepted	
as	a	good	model	to	study	NBS1.	However,	NBS1-iLB	synthesize	detectable	 levels	of	
p70	 fragment	 of	NBS1	 (Krüger	 et	 al.,	 2007;	 Lee	 et	 al.,	 2003)	 and	because	p70	 can	
form	a	complex	with	MRE11,	it	represents	a	partially	functional	form	of	NBS1	(Maser	
et	al.,	2001).	The	partial	 functionality	of	p70	 fragment	of	NBS1	 is	also	 reflected	by	
the	 fact	 that	 expression	 of	 the	 657del5	 human	NBS	 allele	 rescues	 the	 lethality	 of	
Nbs1-/-	mice	mutant	 (Difilippantonio	 et	 al.,	 2005).	 Several	murine	models	 to	 study	
NBS1	were	also	developed	by	targeted	disruption	of	the	exons	at	the	5’	end	(Kang	et	
al.,	2002;	Williams	et	al.,	2002).	However,	these	mice	also	expressed	low	levels	of	C-
terminal	NBS1	protein	and	didn’t	phenocopy	all	the	manifestations	of	NBS.	Efforts	to	
generate	NBS1	null	mutants	in	mice	largely	failed,	because	null	mutation	of	NBS1	is	
embryonic	 lethal	 (Zhu	 et	 al.,	 2001)	 In	 addition,	 a	 humanized	 mouse	 model	 was	
developed	 in	 which	 the	 human	 NBS1	 gene	 replaced	 the	 mouse	 NBS1	 gene	
(Difilippantonio	et	al.	Nat	Cell	Biol.,	2005;	Difilippantionio	et	al.	 J.	Exp.	Med.	2007).	
Some	 studies	 also	 applied	 Cre-loxP	 technology	 to	 conditionally	 knock	 out	 NBS1	 in	
certain	 tissues	 in	 order	 to	 overcome	 the	 embryonic	 lethality	 of	 NBS1	 deletion	
(Demuth	et	al.,	2004;	Frappart	et	al.,	2005;	Reina-San-Martin	et	al.,	2005).		
	
All	of	 the	 structure/function	 studies	on	NBS1	and	 its	 FHA	and	BRCT	domains	were	
done	 by	 functional	 complementation	 of	 either	 human	 immortalized	 NBS	 patient-
derived	 cell	 lines	 or	 by	 functional	 complementation	 of	 conditional	 mouse	 NBS1	
knockout	models	with	human	NBS1.	Both	systems	are	not	ideal	because	in	the	case	
of	 human	 NBS	 patient-derived	 cell	 lines,	 functional	 studies	 on	 NBS1	 mutants	
basically	means	 studying	 one	hypomorphic	mutation	 in	 the	 genetic	 background	of	
another	hypomorphic	mutation,	which	is	prone	to	artifacts.	In	the	mouse	system	loss	
of	mouse	NBS1	was	 compensated	 for	with	expression	of	human	NBS1.	This	 is	 also	
not	ideal	because	NBS1	is	the	least	conserved	subunit	of	the	MRN	complex	and	there	
are	 significant	differences	between	 the	mouse	and	 the	human	NBS1	 sequence.	 To	
perform	structure/function	analysis	focusing	on	the	FHA	and	BRCT	domains	of	NBS1,	
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we	generated	a	new	NBS1	complementation	system	based	on	siRNA,	which	allowed	
us	to	express	FHA	and	BRCT	domain	mutants	of	full-length	NBS1	in	cells	that	do	not	
express	 detectable	 levels	 of	 endogenous	 NBS1.	We	 utilized	 the	 osteosarcoma	 cell	
line	U2OS	for	the	generation	of	our	complementation	system	because	this	cell	line	is	
widely	used	in	the	DDR	field	and	thus,	we	were	able	to	directly	compare	our	data	to	
other	published	studies	using	the	U2OS	cell	line.		
	
The	rationale	behind	generating	a	siRNA	based	complementation	system	was	based	
on	the	long-standing	technical	difficulty	to	generate	somatic	knockouts	in	human	cell	
lines.	However,	in	the	final	stages	of	this	project,	with	the	arrival	of	the	new	easy-to-
use	 and	 highly	 efficient	 CRISPR/Cas9	 genome	 editing	 technology,	 we	 could	 also	
generate	NBS1	gene	knockouts	in	U2OS,	where	all	the	three	U2OS	NBS1	alleles	were	
inactivated	 by	 insertion/deletion	 mutations	 that	 cause	 frameshifts	 and	 nonsense	
mutations.	This	 indicated	 that	NBS1	null	mutations	are	not	 lethal	 in	human	cancer	
cell	 lines	and	 that	 structure/function	analysis	of	NBS1	could	also	be	done	 in	a	 real	
genetic	 null	 background	 in	 U2OS	 cells	 in	 the	 future.	 In	 the	 case	 of	 this	 study,	 we	
could	 use	 the	 NBS1	 knockout	 U2OS	 cell	 lines	 to	 rigorously	 test	 and	 validate	 our	
siRNA	 based	 complementation	 system.	 As	 we	 consistently	 observed	 the	 same	
phenotypes	in	the	NBS1	knockout	U2OS	cells	as	compared	to	the	cells	in	which	NBS1	
was	depleted	by	siRNA,	we	concluded	that	the	data	achieved	with	our	siRNA-based	
complementation	system	were	based	upon	solid	grounds.	
	
In	our	 genetically	 engineered	U2OS	 cell	 lines	 the	expression	of	ectopic	NBS1	upon	
induction	was	higher	as	compared	to	endogenous	NBS1	expression	levels.	However,	
overexpression	 of	 recombinant	 NBS1	was	 not	 toxic	 for	 the	 cells	 and	we	 observed	
complete	functional	complementation	with	the	wild	type	NBS1	expressing	cell	 line,	
thus	indicating	that	NBS1	expression	levels	are	not	a	critical	parameter	in	U2OS	cells.	
We	 also	 observed	 low	 levels	 of	 recombinant	 NBS1	 expression	 in	 the	 absence	 of	
induction	by	DOX	in	all	of	the	cell	 lines,	but	this	did	not	seem	to	be	influencing	cell	
growth	 and	 cell	 survival.	 The	 control	 and	 recombinant	 NBS1-expressing	 cell	 lines	
exhibited	 similar	 growth	 rates	 and	 similar	 cell	 cycle	 profiles,	 ruling	 out	 cell	 cycle	
artifacts	or	artifacts	caused	by	NBS1	overexpression.	Finally,	we	also	showed	that	the	
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recombinant	 NBS1	 is	 readily	 incorporated	 in	 the	 MRN	 complex	 indicating	 that	
functional	complementation	takes	place	in	the	context	of	the	intact	MRN	complex.	In	
summary,	our	siRNA	based	complementation	system	is	clearly	superior	to	the	NBS1-
iLB-based	complementation	system,	as	it	is	a	genetically	“clean”	system.	In	addition,	
our	system	may	also	be	superior	to	the	humanized	mouse	complementation	system	
because	we	 express	 recombinant	 human	NBS1	 in	 a	 human	 cellular	 background	 as	
compared	to	human	NBS1	in	a	mouse	cellular	background.	
	
	
4.2.			Role	of	NBS1	in	DNA	end	resection	
	
The	 precise	 regulation	 of	 DSB	 repair	 is	 crucial	 for	 the	 maintenance	 of	 genomic	
stability.	DSB	repair	by	HR	is	limited	to	S/G2	phases	of	the	cell	cycle	when	the	intact	
sister	 chromatid	 provides	 the	 template	 for	 homology	 directed	 repair.	 DNA-end	
resection	is	the	most	critical	regulatory	step	that	commits	the	repair	to	HR.	The	MRN	
complex	 is	essential	 for	the	 initiation	of	DNA-end	resection,	and	 its	 function	 in	this	
process	 is	 mainly	 attributed	 to	 the	 nuclease	 activity	 of	 MRE11.	 A	 contribution	 of	
NBS1	in	the	generation	of	ssDNA	at	sites	of	DSBs	has	been	observed	before,	mainly	
in	the	form	of	defective	RPA	foci	formation	in	its	absence,	(Chen	et	al.,	2008;	Falck	et	
al.,	 2012;	 Jazayeri	 et	 al.,	 2006)	 but	 its	 regulatory	 role	 in	 DNA	 end	 resection	 has	
remained	elusive	 so	 far.	 In	 this	 study,	we	 showed	by	different	methods	 that	NBS1	
plays	an	important	role	in	DNA	end	resection.	We	first	used	RPA2	foci	formation	as	a	
marker	for	ssDNA	generation	at	sites	of	DSBs	(Raderschall	et	al.,	1999;	Sartori	et	al.,	
2007)	 and	 observed	 that	NBS1	 depletion	 severely	 impairs	 RPA	 foci	 formation.	We	
then	substantiated	our	findings,	using	a	phospho-specific	anti-RPA2	pS4/S8	antibody,	
a	widely	used	surrogate	marker	for	ssDNA	generated	by	DNA-end	resection	(Murina	
et	al.,	2014;	Sartori	et	al.,	2007).	Because	RPA	and	pRPA	foci	formation	indicate	RPA	
binding	 to	 stretches	 of	 ssDNA,	 they	 are	 not	 direct	 markers	 for	 the	 generation	 of	
ssDNA	 at	 sites	 of	 DSBs	 by	 DNA	 end	 resection.	 Thus,	 we	 employed	 an	 anti-BrdU	
antibody	staining	technique	that	detects	BrdU	incorporated	in	DNA,	when	DNA	is	in	
single-stranded	form	(Bunting	et	al.,	2012;	Sartori	et	al.,	2007).	Analysis	of	DNA	end	
resection	 by	 BrdU	 antibodies	 revealed	 that	 as	 with	 RPA	 and	 pRPA	 staining,	 NBS1	
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depleted	cells	were	defective	in	ssDNA	generation	at	sites	of	DSBs.	Collectively,	our	
results	revealed	that	NBS1	plays	an	essential	role	in	DNA	end	resection	and	that	the	
resection	phenotype	of	NBS1	depleted	cells	is	almost	as	strong	as	the	one	elicited	by	
CtIP	depletion.	
	
An	important	observation	of	this	project	was	that	DNA	end	resection	is	independent	
of	MDC1.	 This	 also	 indicated	 that	 the	 formation	 of	MRN	 foci	 is	 not	 important	 for	
DNA	 end	 resection,	 as	 MRN	 foci	 formation	 depends	 on	 the	 interaction	 between	
NBS1	and	MDC1	(Chapman	and	Jackson,	2008;	Lukas	et	al.,	2004a;	Melander	et	al.,	
2008;	 Spycher	 et	 al.,	 2008).	 Based	 on	 these	 findings,	 we	 concluded	 that	 the	
recruitment	mechanism	of	 the	MRN	 complex	 to	microscopically	 discernible	 foci	 at	
ssDNA	 compartments	 is	 distinct	 from	 its	 recruitment	 mechanism	 in	 chromatin	
regions	flanking	DSBs,	which	 is	mediated	by	MDC1.	For	NBS1,	 it	has	been	reported	
that	 it	 is	 capable	 of	 binding	 to	 the	 ssDNA	 compartment	 in	 an	MDC1	 independent	
manner	 (Lukas	 et	 al.,	 2004a).	 Because	 neither	 MDC1	 nor	 MDC1-dependent	
chromatin	 association	of	 the	MRN	 complex	 are	 required	 for	DNA	end	 resection,	 it	
seems	likely	that	the	MDC1	independent	recruitment	of	a	small	fraction	of	NBS1	in	
the	form	of	“microfoci”,	represents	the	site	of	active	DNA	end	resection.	CtIP	is	not	
required	 for	 the	 recruitment	 of	NBS1	 to	DSB-flanking	 chromatin	 (You	 et	 al.,	 2009)	
and	it	is	generally	accepted	that	CtIP	is	not	recruited	to	DSB-flanking	chromatin	but		
its	DSB	recruitment	is	confined	to	the	ssDNA	compartment	(Chen	et	al.,	2008;	Yuan	
and	Chen,	2010).	However,	it	still	remains	unknown	if	the	MRN	complex	and	CtIP	are	
independently	 recruited	 to	 the	 ssDNA	 compartment	 at	 sites	 of	 DSBs.	 Although	 it	
would	be	interesting	to	investigate	if	NBS1	or	CtIP	can	influence	each	other’s	binding	
to	ssDNA,	the	interpretation	of	such	an	analysis	would	be	very	difficult.	This	is	mainly	
because	both	in	absence	of	CtIP	or	NBS1,	resection	is	impaired	and	hence	there	is	no	
or	 very	 low	 ssDNA	generation	 at	 sites	 of	DSBs.	 Therefore	we	would	 expect	 to	 see	
defective	 CtIP	 foci	 formation	 in	 the	 absence	 of	 NBS1	 and	 vice	 versa.	 However,	
whether	or	not	this	is	caused	by	defective	resection	or	by	a	more	direct	role	of	CtIP	
and	NBS1	in	the	regulation	of	protein	recruitment	at	sites	of	DSBs	and	foci	formation	
would	still	be	elusive.				
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We	also	observed	that	the	cells	depleted	of	MDC1	formed	brighter	RPA	foci	and	also	
exhibited	 more	 phosphorylation	 of	 RPA	 at	 S4/S8	 when	 compared	 to	 control	 cells	
(Figure	 31).	 At	 the	 moment	 we	 do	 not	 understand	 this	 phenomenon	 but	 we	
hypothesize	 that	 this	 observation	 could	 be	 explained	 by	 MDC1’s	 role	 in	 the	
maintenance	of	53BP1	at	sites	of	DSBs	(Stewart	et	al.,	2003).	In	the	G1	phase	of	the	
cell	 cycle,	53BP1	and	 its	 cofactor	RIF1	block	DNA	end	 resection,	while	 in	S	and	G2	
phase	exclusion	of	53BP1	from	chromatin	surrounding	DSBs	 leads	to	extensive	end	
resection	(Bouwman	et	al.,	2010;	Bunting	et	al.,	2010;	Callen	et	al.,	2013;	Chapman	
et	 al.,	 2012a;	 Di	 Virgilio	 et	 al.,	 2013;	 Escribano-Díaz	 et	 al.,	 2013).	 Based	 on	 these	
studies,	it	seems	likely	that	in	the	absence	of	MDC1,	the	physical	impediment	of	DNA	
end	resection	poised	by	53BP1	is	lost	and	this	leads	to	the	observed	hyperresection	
phenotype.	
Another	 important	 finding	 of	 this	 study	 is	 that	 the	 function	 of	 NBS1	 in	 DNA	 end	
resection	 is	 dependent	 on	 its	 FHA	 and	 BRCT	 domains.	 Three	 different	 resection	
based	markers	 -	RPA,	pRPA	and	BrdU	 in	 immunofluorescence	microscopy	 revealed	
that	 the	 FHA	 and	 BRCT	 domains	 of	 NBS1	 exhibit	 an	 “additive	 effect”	 on	 DSB	 end	
resection	(Figure	25,	Figure	26,	Figure	27).	The	single	FHA	and	BRCT	domain	mutants	
were	partially	defective	in	resection,	while	the	combined	FHA/BRCT	domain	mutant	
was	as	defective	as	NBS1	depleted	cells	in	the	generation	of	ssDNA	at	sites	of	DSBs.	
Remarkably,	the	BRCT	domain	mutant	was	more	defective	in	resection	than	the	FHA	
domain	mutant	in	all	the	assays.		A	flow	cytometry-based	method	was	also	adopted	
(Forment	et	al.,	2012)	to	assess	the	role	of	NBS1	and	its	FHA/BRCT	domains	in	DNA	
end	 resection,	 which	 also	 revealed	 that	 the	 FHA	 and	 BRCT	 domains	 of	 NBS1	 are	
indispensible	 for	 DNA	 end	 resection.	 Apart	 from	 the	 FHA	 and	 BRCT	 dependent	
interactions	of	NBS1	with	MDC1,	 the	 recruitment	of	MRN	complex	 to	sites	of	DNA	
damage	is	also	dependent	on	poly-ADP-ribose	polymerases	(PARPs),	that	load	poly-
ADP	 ribose	 (PAR)	 at	 the	 sites	 of	 DNA	 damage	 (Bryant	 et	 al.,	 2009;	 Haince	 et	 al.,	
2008).	 Interactions	 between	 the	 MRN	 complex	 and	 PAR	 have	 previously	 been	
attributed	to	the	MRE11	subunit	of	MRN	complex,	but	recently	the	BRCT	domains	of	
NBS1	were	 also	 implicated	 in	 PAR	 binding.	 In	 a	 screen	 for	 FHA	 and	 BRCT	 domain	
interactions	with	 PAR	 the	 BRCT	 domains	 of	 NBS1	were	 identified	 as	 efficient	 PAR	
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binding	 modules	 (Li	 and	 Yu,	 2013)	 .	 In	 this	 study,	 the	 DNA	 damage	 induced	
localization	 of	 the	MRN	 complex	 to	 DNA	 damage	 sites	 was	 delayed	 in	 the	 NBS1-
BRCT1	domain	mutant	(K160A),	which	was	also	impaired	in	binding	to	PAR.	However,	
these	findings	are	not	in	agreement	with	previous	studies	where	it	was	shown	that	
both	 that	 FHA	domain	 and	 the	BRCT	domains	of	NBS1	 are	 important	 for	 both	 the	
early	and	 late	 recruitment	of	 the	MRN	complex	 to	damage	sites	 (Hari	et	al.,	2010;	
Lukas	 et	 al.,	 2004b).	 Nevertheless,	 it	may	 be	 possible	 that	 at	 an	 early	 time	 point,	
interactions	 between	 the	 NBS1-BRCT	 domain	 and	 PAR	 could	 be	 implicated	 in	 the	
early	MDC1	independent	recruitment	of	the	MRN	complex	to	sites	of	DNA	damage.	
In	 line	 with	 these	 findings,	 we	 observed	 that	 the	 BRCT	 domain	 mutant	 of	 NBS1	
(K160M)	 is	 more	 impaired	 in	 DNA	 end	 resection	 when	 compared	 to	 FHA	 domain	
mutant.		
The	FHA	domain	of	NBS1	was	also	recently	proposed	to	interact	with	the	alternative	
clamp	 loader	 Rad17	 and	 this	 interaction	was	 suggested	 to	 promote	MRN	 complex	
retention	at	sites	of	DSBs.	A	direct	interaction	between	the	C-terminus	of	Rad17	and	
the	NBS1-FHA	domain	was	implicated	in	the	retention	of	the	MRN	complex	at	breaks	
(Wang	et	al.,	 2014b).	 It	was	also	 reported	 in	 the	 same	study	 that	Rad17	depletion	
resulted	in	a	decrease	of	RPA	as	well	as	of	pRPA	(Ser4/8)	and	BrdU	foci-positive	cells,	
implicating	the	function	of	Rad17	in	DNA	end	resection.	However,	when	we	depleted	
cells	of	Rad17	and	examined	DNA	end	resection	by	examining	RPA	phosphorylation	
at	S4/S8,	RPA	or	pRPA	(S4/S8)	foci-positive	cells	upon	IR	exposure,	we	observed	no	
effect	of	Rad17	depletion	on	DNA	end	resection.		
	
CDKs	are	emerging	as	 important	 regulators	of	 the	DNA	damage	response	and	they	
promote	DNA	end	resection	by	phosphorylating	key	proteins	of	DNA	end	resection	
such	as	CtIP	(Huertas	and	Jackson,	2009)	and	EXO1	(Tomimatsu	et	al.,	2014;	Zhu	et	
al.,	 2001).	 Two	 studies	 recently	 reported	 a	 cell	 cycle	 regulated	 phosphorylation	 of	
NBS1	 at	 S432	 residue.	 One	 of	 these	 studies	 implicated	 CDK	 dependent	 NBS1	
phosphorylation	at	S432	residue	in	DNA	end	resection	during	the	S	and	G2	phases	of	
the	 cell	 cycle	 (Falck	 et	 al.,	 2012).	 In	 contrast,	 another	 study	 reported	 normal	DNA	
end	resection	in	the	absence	of	NBS1-S432	phosphorylation	(Wohlbold	et	al.,	2012).	
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In	 order	 to	 resolve	 this	 discrepancy	 we	 decided	 to	 test	 the	 role	 of	 NBS1	
phosphorylation	at	S432	in	DNA	end	resection	and	thus,	we	generated	a	cell	line	that	
stably	expressed	S342A-NBS1myc	 in	an	 inducible	manner,	using	our	U2OS	Flp-In	T-
REx	 system.	 Expression	 of	 siNBS1	 resistant	 S432A-NBS1myc	 fully	 rescued	 the	
resection	defect	observed	in	U2OS	cells	depleted	of	endogenous	NBS1,	as	tested	by	
BrdU,	 pRPA	 and	 RPA	 foci	 formation.	 These	 results,	 together	 with	 the	 study	 by	
Wohlbold	 et	 al.	 2012	 thus	 indicate	 that	 NBS1	 phopshorylation	 at	 S432	 is	 not	
essential	for	DNA	end	resection	and	may	only	be	required	in	the	genetic	background	
of	the	NBS-iLB1	cell	line,	which	was	used	in	the	study	by	Falck	et	al.,	2012.	
	
In	a	further	quest	to	find	a	possible	mechanistic	explanation	of	the	effect	of	FHA	and	
BRCT	domains	mutations	of	NBS1	in	DNA	end	resection,	we	tried	to	find	a	possible	
DNA	 end	 resection	 associated	 interaction	 partner	 of	 NBS1.	 Many	 studies	 have	
reported	that	CtIP	interacts	with	the	MRN	complex,	although	the	mechanism	of	this	
interaction	is	not	clear.	The	collaborative	action	of	CtIP	and	the	MRN	complex	in	DNA	
end	 resection	 has	 been	 reported	 in	 many	 studies	 (Huertas	 and	 Jackson,	 2009;	
Murina	et	al.,	2014;	Sartori	et	al.,	2007).	 	A	recent	study	showed	that	mutations	 in	
the	 FHA/BRCT	 region	 of	 NBS1	 impairs	 DNA	 repair	 by	 HR	 (Wang	 et	 al.	 2013).	 This	
study	 reported	 novel	 CDK	 sites	 in	 CtIP,	 which	 mediate	 associations	 with	 the	
FHA/BRCT	domains	of	NBS1,	facilitating	phosphorylation	of	CtIP	by	ATM	at	T859	and	
recruitment	of	BLM1	and	EXO1	to	sites	of	damage.	Another	study	however,	reported	
that	 CtIP	 is	 phosphorylated	 at	 T818	 by	 ATR	 and	 phosphorylation	 of	 CtIP	 at	 T818	
promotes	 stable	 association	 of	 CtIP	 to	 damaged	 chromosomes,	 allowing	 CtIP-
dependent	resection	(Peterson	et	al.,	2013).	Importantly,	NBS1	binds	via	its	FHA	and	
BRCT	domains	to	a	very	specific	phosphorylated	consensus	motif	called	“SDT	motif”,	
where	a	Ser	and	a	Thr	residue	are	embedded	in	an	acidic	sequence	environment	and	
are	 constitutively	 phosphorylated	 by	 acidophilic	 kinases	 such	 as	 Caseine	 kinase	 2.	
This	 was	 observed	 in	MDC1	 (Chapman	 and	 Jackson,	 2008;	Melander	 et	 al.,	 2008;	
Spycher	et	al.,	2008))	and	TCOF1	(Larsen	et	al.,	2014)	in	human	cells,	as	well	as	in	in	
the	yeast	S.	cerevisiae	where	the	FHA	domain	of	Xrs2	(the	S.	cerevisiae	orthologue	of	
NBS1)	 interacts	with	the	XRCC4,	orthologue	Lif1	via	phosphorylated	SDT-like	motifs	
(Matsuzaki	et	al.,	2012).	The	fission	yeast	CtIP	orthologue,	Ctp1	contains	similar	SDT	
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motifs	that	are	important	for	its	interaction	with	the	FHA	domain	of	S.	pombe	Nbs1,	
which	 is	 important	 for	 DNA	 damage	 resistance	 (Lloyd	 et	 al.,	 2009;	Williams	 et	 al.,	
2009)	In	light	of	all	these	studies,	we	speculated	that	the	FHA/BRCT	region	of	NBS1	
would	 interact	 with	 SDT	motifs	 present	 in	 a	 DNA	 end	 resection	 associated	 factor	
such	as	CtIP,	rather	than	the	CDK	motifs	that	were	suggested	by	Wang	et	al	(Wang	et	
al.,	 2013b).	 Remarkably,	 a	 detailed	 protein	 sequence	 analysis	 and	 sequence	
alignment	 of	 human	 CtIP	 revealed	 a	 cluster	 of	 potential	 CK2	 “minimal	 consensus"	
sites	 towards	 the	 C-terminus	 (Figure	 38A).	 These	 sites	 resemble	 the	 known	 SDT	
motifs	 and	 thus	 can	 potentially	 interact	 with	 NBS1	 in	 human	 cells.	 Co-
immunoprecipitation	 experiments	 revealed	 that	 T671	 could	 be	 a	 potential	 site	 in	
CtIP	 that	mediates	 the	 interaction	 with	 NBS1	 (Figure	 38B).	We	 are	 thus	 currently	
generating	 cell	 lines	 that	 inducibly	 express	 CtIP	mutants	 in	which	 all	 the	 potential	
SDT-like	 motifs	 are	 altered.	 DNA	 end	 resection	 analysis	 in	 cell	 lines	 that	 express	
these	 phospho-mutant	 forms	 of	 CtIP	 in	 the	 absence	 of	 endogenous	 CtIP	 will	
eventually	 clarify	 whether	 or	 not	 these	 putative	 CK2	 sites	 in	 CtIP	 are	 functionally	
important.	If	they	are,	we	will	continue	to	analyze	these	sites	and	investigate	if	they	
are	phosphorylated	in	vivo	and	if	they	are	indeed	forming	an	evolutionary	conserved	
NBS1	interaction	region	in	CtIP.	
	
It	 could	 be	 very	 well	 possible	 that	 the	 NBS1	 and	 CtIP	 interaction	 is	 not	 the	 only	
association	 that	 links	 MRN	 complex	 to	 CtIP.	 Some	 previous	 work	 in	 the	 lab	 has	
elucidated	that	endogenous	CtIP	is	pulled	down	with	MRN	complex	in	reconstituted	
NBS1-iLB1	 patient	 cell	 lines.	 In	 contrast,	 no	 CtIP	 was	 co-immunoprecipitated	 with	
MRN	complex,	harboring	the	FHA	and	BRCT	domain	mutants	of	NBS1.	Surprisingly,	
even	 in	 non-complemented	 NBS1-iLB1	 cells,	 CtIP	 co-immunoprecipitated	 with	MR	
complex,	suggesting	that	there	could	be	multiple	point	of	 interaction	between	CtIP	
and	MRN	complex.	This	was	 in	agreement	with	previous	reports	that	CtIP	 interacts	
with	all	three	components	of	the	MRN	complex	in	vitro	(Sartori	et	al.,	2007;	Yuan	and	
Chen,	 2010)	 and	 although	NBS1	 can	directly	 interact	with	CtIP	 in	 vitro,	 the	 in	 vivo	
interaction	of	NBS1	with	CtIP	is	significantly	increased	when	NBS1	forms	a	complex	
with	MRE11	and	RAD50	(Chen	et	al.,	2008).	In	agreement	with	all	these	results,	we	
also	observed	that	the	interaction	between	NBS1	and	CtIP	is	strongest	between	full	
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lengths	 WT-NBS1	 and	 CtIP.	 	 The	 CtIP	 variant	 that	 lacks	 MRE11	 interaction	 sites	
(CtIPΔC),	interacts	much	weakly	compared	to	full	 length	CtIP	with	NBS1,	suggesting	
that	as	many	 studies	have	hinted,	multiple	points	of	 interaction	between	CtIP	and	
individual	 subunits	 of	 MRN	 complex	 could	 lead	 to	 a	 overall	 stable	 interaction	
between	CtIP	and	MRN	complex.		
	
Collectively,	 our	 data	 indicate	 that	 NBS1	 has	 an	 additional	 role	 distinct	 from	 the	
localization	 of	 MRN	 complex	 to	 the	 nucleus	 in	 DNA	 end	 resection,	 which	 is	
dependent	on	the	FHA	and	BRCT	domains	of	NBS1.	Although	it	is	still	not	clear	how	
exactly	 the	 FHA	and	BRCT	domains	of	NBS1	are	mechanistically	 implicated	 in	DNA	
resection,	 preliminary	 results	 suggest	 that	 they	 may	 mediate	 a	 direct	 interaction	
with	 the	key	 factor	of	 resection,	CtIP.	 	Future	studies	should	clarify	 if	putative	CK2	
sites	in	human	CtIP	that	mediate	the	interaction	of	CtIP	with	NBS1	(Figure	38B)	has	
any	functional	implication	in	DSB	repair,	DNA	end	resection,	and	cell	survival.	
	
	
4.3.			Role	of	NBS1	in	G2M	checkpoint	activation	and	maintenance	
	
One	 of	 the	 hallmarks	 of	 NBS1	 deficient	 cells	 is	 defective	 cell	 cycle	 checkpoint	
activation.	 Early	 studies	 mainly	 focused	 on	 NBS1’	 s	 role	 in	 the	 intra-S	 phase	
checkpoint.	However,	several	 lines	of	evidence	also	suggested	its	 implication	in	the	
G2M	checkpoint.	In	this	study	we	mainly	focused	on	a	potential	role	of	NBS1	in	G2M	
checkpoint	maintenance,	because	G2M	checkpoint	maintenance	has	 recently	been	
linked	to	DNA	end	resection	(Kousholt	et	al.	2012).	 	 In	agreement	with	most	of	the	
studies	 that	 addressed	 the	 role	 of	 NBS1	 in	 cell	 cycle	 checkpoint	 activation,	 we	
observed	 that	 NBS1	 deficient	 cells	 are	 defective	 in	 G2M	 checkpoint	 activation.	
Interestingly	though,	our	data	indicate	that	complete	silencing	of	NBS1	expression	is	
essential	 to	 yield	 a	 significant	 G2M	 checkpoint	 defect.	 Such	 complete	 silencing	
cannot	be	achieved	by	siRNA	transfection	but	only	by	a	complete	knock	out	of	the	
NBS1	gene.	Hence,	 in	cells	depleted	from	NSB1	by	siRNA	we	observed	a	significant	
defect	in	G2M	checkpoint	activation	only	upon	exposure	to	low	doses	of	irradiation	
(Figure	43).	 This	was	 in	 contrast	 to	NBS1	 knockout	 cells,	which	exhibited	 impaired	
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G2M	checkpoint	activation	both	at	low	and	high	IR	doses	(Figure	42),	suggesting	that	
the	 complete	 removal	 of	 NBS1	 protein	 is	 critical	 to	 yield	 a	 significant	 G2M	
checkpoint	activation	defect	at	higher	doses	of	radiation.		
	
A	recent	study	(Kousholt	et	al.,	2012)	proposed	that	DNA	end	resection	is	crucial	for	
the	maintenance	 of	 the	 G2M	 checkpoint.	 This	was	 based	 on	 the	 observation	 that	
CtIP-depleted	cells	were	not	significantly	impaired	in	the	initial	activation	of	the	G2M	
checkpoint	but	that	they	were	mainly	defective	in	the	G2M	checkpoint	maintenance.	
The	authors	of	 this	 study	concluded	 that	CtIP	mediated	 resection	was	 required	 for	
G2M	 checkpoint	 maintenance.	 This	 interpretation	 was	 further	 supported	 by	 the	
observation	 that	 EXO1	 and	BLM	depletion	 that	 also	 resulted	 in	 reduced	 resection,	
also	showed	premature	entry	into	mitosis	after	induction	of	DNA	damage	(Kousholt	
et	al.,	2012).	Since	our	data	showed	that	NBS1	is	crucial	for	DNA	end	resection,	we	
considered	 that	 its	 depletion	 would	 also	 yield	 a	 G2M	 checkpoint	 maintenance	
defect,	similar	to	the	one	induced	by	CtIP	depletion.	Surprisingly	though,	we	did	not	
observe	any	effect	of	NBS1	depletion	on	G2M	checkpoint	maintenance	(Figure	45).	
This	 was	 quite	 unexpected,	 given	 the	 observation	 that	 similar	 to	 CtIP	 depletion,	
NBS1	depletion	also	impairs	Chk1	activation	at	later	time	points	(Figure	46).		
	
Since	 NBS1	 depletion	 has	 a	 slightly	 less	 pronounced	 effect	 on	 DNA	 end	 resection	
when	compared	to	CtIP	depletion	(Figure	25,	26,	27),	we	considered	the	possibility	
that	 the	 residual	 resection	 activity	 upon	 NBS1	 depletion	 may	 be	 sufficient	 to	
maintain	the	G2M	checkpoint.	To	test	this	possibility,	we	depleted	CtIP	by	siRNA	in	
NBS1	 knock	 out	 cells.	 Surprisingly,	 these	 cells	 were	 still	 largely	 proficient	 in	 the	
maintenance	of	the	G2M	checkpoint,	even	though	CtIP	depletion	in	a	NBS1	wild	type	
background	 led	 to	 a	 dramatic	 G2M	 checkpoint	 maintenance	 defect.	 These	
observations	have	several	 implications:	first,	they	suggest	that	the	G2M	checkpoint	
maintenance	 defect	 observed	 in	 CtIP	 depleted	 cells	 is	 not	 primarily	 caused	 by	 the	
absence	of	DNA	end	resection.	Second,	they	also	suggest	that	NBS1	loss	is	dominant	
over	 CtIP	 loss	 in	 the	 context	 of	 G2M	 checkpoint	 maintenance.	 While	 CtIP	 down	
regulation	leads	to	a	G2M	checkpoint	maintenance	defect	in	the	presence	of	NBS1,	it	
does	not	in	its	absence.	While	we	do	not	yet	have	an	explanation	for	this	surprising	
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observation,	we	currently	think	that	some	other	function	of	CtIP;	independent	of	its	
function	in	DNA	end	resection	is	critical	for	the	maintenance	of	G2M	checkpoint.		
	
In	summary,	our	data	suggests	that	NBS1	has	an	important	function	in	the	activation	
of	G2M	checkpoint.	Moreover,	we	also	propose	 that	 the	maintenance	of	 the	G2M	
checkpoint	may	not	be	dependent	on	DNA	end	resection,	at	least	not	in	the	absence	
of	NBS1.	
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5.			Materials	and	Methods	
	
Cell	culture	
	
U2OS,	 MRC5,	 HeLA	 and	 HEK293T	 cells	 were	 grown	 in	 Dulbecco’s	 modified	 Eagle	
medium	 (DMEM,	 Gibco),	 supplemented	 with	 10%	 fetal	 calf	 serum	 (FCS,	 Gibco),	 100	
units/ml	each	of	penicillin	and	streptomycin.	U2OS	Flp-In	T-REx	cells	were	grown	in	the	
DMEM	 medium	 supplemented	 with	 10%	 fetal	 calf	 serum	 (FCS,	 Gibco),	 100	 U/ml	
penicillin/streptomycin,	50	µg/ml	hygromycin	B	and	10	µg/ml	blasticidin	S.	
	
	
Generation	of	stable	GFP-CtIP	cell	lines	
To	generate	a	siRNA	based	complementation	system	for	NBS1;	the	Flp-In	T-REx	system	
(Invitrogen,	 Life	 Technologies)	 was	 used	 to	 generate	 cell	 lines	 that	 express	 different	
siRNA-resistant	 NBS1myc	 variants	 in	 an	 inducible	 manner.	 The	 NBS1myc	 harboring	
pcDNA5/FRT/TO	 vector	 and	 the	 Flp	 recombinase	 expression	 plasmid	 pOG44	 were	
mixed	(1:9	ratio)	and	transfected	into	80-90%	confluent	6	cm	dish	of	Flp-In	T-REx	293	
using	 Lipfectamine-2000	 (Invitrogen,	 Life	 Technologies).	 After	 6	 h,	 the	 transfection	
reagent	was	removed	completely	and	the	cells	were	supplemented	with	fresh	DMEM	
medium.	 After	 24	 h,	 cells	 were	 replated	 at	 different	 dilutions	 in	 10-cm	 plates.	 Later	
after	24	h	250	µg/ml	of	hygromycin	B	and	10	µg/ml	of	blasticidin	S.	was	added	to	the	
medium.	 The	 medium	 was	 replaced	 every	 3–4	 days,	 and	 cells	 were	 selected	 for	
approximately	 3	 weeks.	 Resistant	 colonies	 were	 picked,	 expanded	 and	 then	
characterized	 for	 inducible	 NBS1myc	 expression	 both	 by	 immunofluorescence	
microscopy	 and	 immunoblotting.	 To	 induce	 the	 expression	 of	 NBS1myc,	 cells	 were	
treated	with	0.5	or	1	µg/ml	doxycycline	(DOX)	for	24	h	or	12	h	as	indicated.	
	
Immunofluorescence	Microscopy	
U2OS	cells	were	cultured	on	glass	coverslips	and,	 if	 indicated,	were	irradiated	at	24	h	
after	plating.	After	treatment,	cells	were	fixed	in	4%	formaldehyde	for	12	min	at	room	
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temperature.	After	washing	twice	with	PBS,	cells	were	permeabilized	with	0.25%	Triton	
X-100	in	PBS	for	5	min	at	room	temperature.	After	washing	twice	with	PBS,	cells	were	
blocked	with	 5%	 FCS	 in	 TBST	 buffer	 for	 30	min.	 Cells	 were	 then	 stained	with	 rabbit	
NBS1,	mouse	myc,	 rabbit,	 cyclin	 A,	 RPA	 antibodies,	 diluted	 in	 PBS,	 0.05%	 Tween-20,	
2.5%	 BSA	 for	 1	 h	 at	 room	 temperature.	 After	 washing	 thrice	 with	 PBST,	 cells	 were	
stained	with	Alexa488-,	Alexa568-,	or	Alexa647-conjugated	secondary	antibodies	for	30	
min	at	room	temperature	and	counterstained	with	DAPI.	Images	were	obtained	using	a	
Leica	DM6000B	microscope,	equipped	with	63×-immersion	 lens	 (PL-S-APO,	numerical	
aperture:	1.30)	and	Xenon	light	source	using	LAS-AF	software	(Leica).		
For	the	counting	of	the	foci,	the	macro	used	is	mentioned	below:	
	
n	=	roiManager("count");		
for	(i=0;	i<n;	i++)	
{		
	roiManager("select",	i);		
	run("Analyze	 Particles...",	 "size=0.00-infinity	 show=Nothing	 display	 exclude	 clear		
summarize");	
	filename	=	"/User/ResultsMacro/Results"	+	i	+	".xls";	
	saveAs("Results",	filename);	
}	
	
Clonogenic	and	short-term	survival	assays	
	
For	clonogenic	survival	U2OS	Flp-In	T-REx	cell	lines	were	transfected	with	siNBS1	for	48	
h	and	 then	plated	 in	 triplicates	at	 clonal	density,	DMEM	medium	supplemented	with	
0.5	µg/ml	doxycycline.	24	h	later,	the	cells	were	exposed	to	1,	2,	or	4	Gy	of	IR.	After	12-
14	days,	 colonies	were	 fixed	and	stained	using	methanol/acetic	acid/water	 in	a	5:2:3	
ratio,	supplemented	with	0.01%	Coomassie	brilliant	blue	and	the	number	of	surviving	
colonies	 for	 each	 cell	 line	was	 tabulated.	 Percentage	 Survival	 for	 each	 cell	 type	was	
calculated	using	the	plating	efficiencies	with	non-irradiated	cells	of	each	cell	 line	as	a	
reference.	 Survival	 experiments	 were	 carried	 out	 on	 at	 least	 thrice	 in	 mutant	 and	
control	U2OS	Flp-In	T-Rex	cell	lines.		
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	Western	blotting	
	
Total	cell	lysates	were	prepared	in	Laemmli	sample	buffer	(50	mM	Tris,	pH	6.8,	100	mM	
dithiothreitol,	 2%	 SDS,	 0.1%	 bromophenol	 blue	 and	 10%	 glycerol).	 Alternatively,	 cell	
extracts	were	prepared	 in	 the	 following	buffer	 (50	mM	Tris,	pH	7.5,	150	mM	NaCl,	2	
mM	MgCl2,	1%	NP-40,	and	1	mM	EDTA)	supplemented	with	phosphatase	and	protease	
inhibitors	and	 incubated	 for	30	min	at	4°C.	 Lysates	were	cleared	by	centrifugation	at	
14,000g	 for	 15	min	 and	 protein	 concentration	was	measured	 using	 Bradford	 protein	
assay.	Immunoprecipitations	were	done	using	Anti-Flag	M2	affinity	gel	(Sigma,	A2220),	
Monoclonal	 anti-HA,	 A2095,	 Dynabeads	 M-280	 Streptavidin	 (Invitrogen,	 112.05D).	
Proteins	were	 resolved	by	 SDS–PAGE	and	 transferred	 to	nitro-	 cellulose.	Membranes	
were	 blocked	 in	 5%	 non-fat	 dry	 milk	 in	 0.1%	 TBST	 (1xTBS	 supplemented	 with	 0.1%	
Tween-20)	 for	at	 least	one	hour	and	 incubated	with	primary	antibodies	over	night	at	
4°C	in	blocking	buffer.	Membranes	were	washed	3	times	with	0.1%	TBST,	10’	each	and	
secondary	antibodies	were	added	for	1h	at	room	temperature.	Membranes	were	again	
washed	3	times	with	0.1%	TBST,	10’	each	and	detected	with	ECL	detection	reagent	(GE	
healthcare).		
	
Antibodies	 used	 in	 this	 study	were:	mouse	 γH2AX	 (Millipore,	 JBW302,	 1:500),	 rabbit	
NBS1	 (Novus	 Biologicals,	 NB100-143,	 1:500),	 mouse	 NBS1	 (Genetex,	 Clone	 1D7,	
GTX70224,	 1:500),	 rabbit	 HA	 (Abcam,	 ab9110,	 1:2,000),	 rabbit	 Flag	 (Sigma,	 F7425,	
1:1,000),	 rabbit	 SMC1	 (Abcam,	 ab9262,	 1:500),	 mouse	 Mcm7	 (Santa	 Cruz,	 DCS141,	
sc65469,	 1:500),	 mouse	 GFP	 (Roche,	 11814460001,	 1:1,000),	 mouse	 tubulin	 (Sigma,	
DM1A,	T6199,	1:2,000),	mouse	Mre11	(Abcam,	12D7,	ab214,	1:500),	sheep	MDC1	3835	
(gift	 from	 S.	 Jackson,	 1:2,000),	 mouse	 CtIP	 (Santa	 cruz,	 sc-271339,	 1:250),	 rabbit	
pRPA32	 (S4/S8)	 (Bethyl,	 A300-245A,	 1:300),	 mouse	 BrdU	 (Amersham/GE	 healthcare,		
BU-1,	 RPN202,	 1:100),	 rabbit	 Cyclin	 A	 (Santa	 Cruz,	 H-432,	 MAB3400,	 1:100),	 rabbit	
pChk1	 S345	 (Cell	 Signaling,	 133D3,	 1:500),	 rabbit	 pChk1	 S317	 (Cell	 Signaling,	 2665,	
1:500),	mouse	BRCA1	(Santa	Cruz/	LabForce,	D-9,	sc-6454),	1:100),	rabbit	Rad17	(Santa	
Cruz,	 sc-5613,	 1:500),	mouse	Myc	 (GeneTex,	 9E10,	GTX80249,	 1:250),	 rabbit	 Chk1	 (),	
rabbit	pRPA	S33	(Bethyl,	A300-246A,	1:250),	RPA32	(Abcam,	9H8,	ab2175,	1:250)	rabbit	
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pATM	S1981	 (Epitmics,	 YE070901r,	1:5000),	 rabbit	ATM	 (Calbiochem,	PC-116,	1:250),	
mouse	RAD50	(Gene	Tex,	13B3,	GTX70228,	1:1000)		
	
	
Generation	of	DNA	damage	
	
	Prior	 to	 laser	 irradiation,	 cells	were	 grown	on	 coverslips	 in	 cell	 culture	dishes	 in	 the	
presence	 of	 10	 μM	 BrdU	 (Bromodeoxyuridine;	 Sigma)	 for	 24	 h.	 Coverslips	 were	
transferred	into	LabTek	chamber	slides	(Nunc)	and	mounted	on	the	microscope	stage	
for	irradiation.	 	The	MMI	CELL	TOOLS	software	with	MMI	UV	CUT	plug-in	assisted	the	
laser	operation	using	an	energy	output	of	50%	(Larsen	et	al.,	2014).	After	 irradiation,	
cells	were	placed	back	in	the	incubator	for	30-60	min	before	fixation.	To	generate	DNA	
damage	in	subnuclear	volumes,	cells	were	irradiated	with	X-Rays,	using	YXLON.SMART	
160E	 –	 1.5	 device	machine	 (150	 kV,	 6	mA;	 YXLON	 International	 A/S),	 delivering	 11.8	
mGy	s−1.	 Soft	X-rays	were	 largely	 filtered	out	with	a	3	mm	aluminum	filter.	The	 laser	
microirradiation	was	performed	with	a	MMI	CELLCUT	system	containing	a	355	nm	UVA	
laser	(55	Hz,	Molecular	Machines	&	Industries,	Switzerland)	embedded	in	an	Olympus	
IX71	microscope	station	and	focused	through	an	LUCPLFLN	40X	objective.		
	
	
Checkpoint	analysis	
	
Cells	were	harvested	at	1	h	after	IR	and	fixed	in	70%	ethanol	at	-20°C	overnight.	After	
fixation,	the	cells	were	resuspended	in	1	ml	of	0.25%	Triton	X-100	in	PBS	and	incubated	
on	ice	for	15	min.	After	centrifugation,	the	cell	pellet	was	suspended	in	100	µl	of	PBS	
containing	1%	bovine	serum	albumin	 (BSA)	and	0.75	µg	of	a	polyclonal	antibody	that	
specific	 recognizes	 the	 phosphorylated	 form	 of	 histone	H3	 (Histone	H3	 pS10,	 rabbit,	
Millipore,	 1:200)	 and	 incubated	 for	 2	 h	 at	 room	 temperature.	 The	 cells	 were	 then	
rinsed	twice	with	PBS	containing	1%	BSA	and	incubated	with	FITC-conjugated	goat	anti-
rabbit	immunoglobulin	G	antibody	diluted	at	a	ratio	of	1:30	in	PBS	containing	1%	BSA.	
After	a	30-min	incubation	at	room	temperature	in	the	dark,	the	cells	were	stained	with	
PI	and	data	were	acquired	with	a	flow	cytometer	(FC500;	Becton	Dickinson).	
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Nocodazole	trap	Experiments:	
	
Cells	were	 either	 left	 untreated	or	 irradiated	 (4	Gy)	 and	 then	 either	 collected	 at	 2	 h	
after	 IR	 treatment	 or	 treated	 with	 nocodazole	 (50	 ng/ml).	 At	 6	 h,	 after	 nocodazole	
treatment,	 the	 cells	 were	 collected	 and	 analyzed	 for	 H3-S10p–positive	 cells	 by	 flow	
cytometry,	as	described	previously	(checkpoint	analysis)	
	
	
HR	and	NHEJ	DNA	repair	assay	
	
DSB	 repair	 efficiency	 by	 HR	 was	 measured	 in	 DR-GFP	 U2OS	 cell	 lines	 previously	
(Bennardo	et	al.,	2008).	Briefly,	20,000	cells/cm2	were	plated	 in	6-well	plates	 (poly-L-	
lysine	coated)	and,	after	24	h,	cells	were	transfected	with	3	µl	of	40nM	siRNA	oligos.	
The	 next	 day,	 siRNA	 treated	 cells	 were	 reseeded	 in	 12-well	 plates,	 so	 that	 they	 are	
around	70-80%	confluent	the	next	day.	24	h	later	(48	h	after	siRNA	transfection),	cells	
were	 either	 mock-transfected	 or	 transfected	 with	 0.6	 µg	 I-SceI	 expression	 plasmid	
(pCBASce)	 in	 with	 0.2	 µg	 of	 using	 2	 µl	 of	 Lipfectamine-2000	 (Invitrogen,	 Life	
Technologies).	At	4	h	after	plasmids	 transfection,	media	were	 replaced	and	a	 second	
transfection	 with	 1	 µl	 of	 40nM	 siRNA	 oligos	 was	 performed	 using	 Lipofectamine	
RNAiMAX.	At	48	h	after	 I-SceI	transfection,	cells	were	analyzed	for	GFP	expression	by	
flow	cytometry	on	LSRII	Fortessa	(BD).	
	
	
DNA	resection	quantification	by	Flow	cytometery	
	
U2OS	 Flp-In	 T-REx	 cell	 lines	 were	 seeded	 in	 35	 mm	 dishes,	 so	 that	 they	 are	 50%	
confluent	 the	 next	 day.	 Cell	 lines	 were	 then	 transfected	with	 siNBS1	 and	 24	 h	 later	
splitted	and	reseeded	so	that	they	are	around	80%	confluent	after	48	(72	h	after	siNBS1	
treatment).	Cells	were	then	pulse-labeled	with	10	µM	EdU	30	min	before	IR	treatment	
(10	Gy).	Cells	were	harvested	by	trypsinization,	3	h	after	IR	treatment,	washed	1x	with	
PBS	 and	 pre-extracted	 for	 removal	 of	 non-chromatin	 bound	 RPA2	 by	 resuspending	
pelleted	cells	in	100	µl	of	PBS-T	and	incubating	for	10	min	on	ice.	After	pre-extraction	
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cells	were	washed	with	2	ml	of	1x	PBS	containing	1	mg/ml	of	bovine	 serum	albumin	
(PBS/BSA).	 	 Cells	 were	 fixed	 with	 4%	 paraformaldehyde	 in	 1xPBS	 for	 15	 min	 and	
permeabilized	 in	 1x	 PBS	 containing	 0.2%	 Triton	 X-100	 for	 30	 min).	 After	
permeabilization	cells	were	washed	twice	with	1	ml	of	PBS/BSA	and	suspended	in	50	µl	
of	PBS/BSA	supplemented	with	the	RPA	antibodies	(1:300).	After	at	least	2	h	incubation	
at	room	temperature,	cells	were	washed	with	2	ml	of	PBS/BSA.	Cell	pellets	were	then	
resuspended	in	50	µl	of	PBS/BSA	with	the	Alexa488-	conjugated	secondary	antibodies,	
and	incubated	for	30	min	at	room	temperature	in	the	dark.	EdU	detection	reaction	was	
carried	 out	 at	 this	 point.	 After	 washing	 with	 2	 ml	 of	 2	 ml	 of	 PBS/BSA,	 cells	 were	
resuspended	 in	0.5	ml	of	1x	PBS	 containing	0.02%	sodium	azide,	250	µg/ml	RNase	A	
and	2	µg/ml	of	40,6-diamidino-2-pheny-lindole	 (DAPI),	 then	 incubated	at	37°C	 for	30	
min	 in	 the	 dark.	 cells	 were	 analyzed	 DNA	 end	 resection	 by	 flow	 cytometry	 on	 LSRII	
Fortessa	(BD).	
	
	
DNA	plasmids	and	RNA	interference:	
	
Plasmids	were	transfected	in	HEK-293	cells	by	the	standard	calcium	phosphate	method.	
The	epitope-tagged	expression	vectors	for	human	CtIP	were	kind	gift	 from	Sartori	 lab	
and	 have	 been	 described	 previously	 (Sartori	 et	 al,	 2007).	 All	 NBS1	 and	 CtIP	 Point	
mutations	 were	 introduced	 by	 using	 the	 QuickChange	 site-directed	 mutagenesis	 kit	
(Stratagene,	 Cedar	 Creek,	 TX,	 USA).	 For	 transient	 siRNA	 experiments	 RPE-1,	 MRC5,	
HeLa,	 HEK-293	 or	 U2OS	 cells	 were	 plated	 in	 6-well	 plates	 and	 transfected	 with	 the	
indicated	 amounts	 of	 siRNA	 oligos	 (40	 nM)	 using	 Lipofectamine	 RNAiMAX,	 following	
manufacturer’s	 guidelines	 (Invitrogen,	 Life	 Technologies).	 In	 brief,	 medium	 was	
replaced	with	Opti-MEM	(Gibco,	Life	Technologies)	prior	to	incubation	with	siRNAs	and	
Lipofectamine.	After	12	h,	medium	containing	FCS	(10%	final	concentration)	was	added	
and	cells	were	analyzed	at	72	h	after	siRNA	transfection.		
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siRNA	and		mutagenesis	primers		
	
The	siRNA	oligonucleotides	were	obtained	from	Microsynth	AG	(Balgach,	Switzerland).	
The	sense	strand	sequences	of	all	siRNAs	used,	are	the	following:	
NBS1	#1:	5’-GGAGGAAGAUGUCAAUGUUTTdTdT-3’	(Larsen	et	al.,	2014)			
NBS1	#2:	5’-CCAACUAAAUUGCCAAGUATTdTdT-3’	(Larsen	et	al.,	2014)			
CtIP:	5’-GCUAAACAGGAACGAAUCTTdTdT-3’	(Sartori	et	al,	2007)		
MDC1:	5’-GUCUCCCAGAAGACAGUGAdTdT-3’		
Rad17:	5’-	CAGACUGGGUUGACCCAUCdTdT-3'	(Wang	et	al.,	2014b),		
BRCA1:	5’-GGAACCUGUCUCCACAAAGTTdTdT-3’	
	
For	 site	 directed	 mutagenesis	 primers	 (PAGE	 purified),	 were	 also	 ordered	 from	
Microsynth	 AG	 (Balgach,	 Switzerland).	 The	 site	 directed	 mutagenesis	 PCR	 was	
performed	 as	 described	 in	 the	 manual	 provided	 with	 mutagenesis	 kit	 (Agilent	
Technologies,	#	200516).	The	sense	strand	sequences	of	all	DNA	oligonucleotides	used,	
as	mutagenesis	primers	are	the	following:	
NBS1	siNBS1	#1:			
5’-	GTTCAAAAACAGGAGGAAGACGTGAACGTTAGAAAAAGGCCAAGG-3’	
NBS1	S432A:	
5’-CCAAACTATCAGCTTGCACCAACTAAATTGCCA-3’	
NBS1	R28A:	
5’-GAGTACGTTGTTGGAGCGAAAAACTGTGCC-3’	
NBS1	K160M:	
5’-GGTATCAGTGAAAGTTACCATTATGACAATATGTGCACTCATTTGTGG-3	
CTIP	T671A:	
5’-CTCAGTATAAAATCGTTGCTGTAATAGATACAAAGGATG-3’	
CTIP	T687A:	
5’-CAAAATTAGGAGGAGAGGCAGTGGACATGGAC-3’	
CTIP	T698A	
5’-CTGTACATTGGTTGCTGAAGCCGTTCTCTTAAAAATG-3’
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